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Greenhill et al. (2011) developed a gene regulatory network of the main genes and 
interactions known to play a role in melanocyte biology, and generated a 
mathematical model to describe the behaviour of this complex network using semi 
quantitative data (ISH expression data). In this project we sought to collect 
expression data from four genes of the melanocyte GRN (sox10, kit, mitfa and dct) to 
develop a quantitative model that is able to describe the data more accurately. 
Moreover, we intended to identify more genes that are part of the melanocyte 
development process to be incorporated to the GRN. 
We analysed microarray data that compared differentially expressed genes between 
sox10 mutant and wild type embryos and validated five genes with a key role in 
melanocyte biology as downregulated in mitfa mutant embryos, which are 
downstream of mitfa in the GRN. We suggest that kit plays the role of factor Y in the 
Greenhill et al. (2011) GRN: Mitfa drives kit expression, and kit expression is 
transiently driven by Sox10 at early stages of development. As part of the feedback 
loop, kit seems to drive and maintain mitfa expression, however this needs to be 
validated. Finally we developed an experimental set up to obtain an estimate of gene 
expression per melanocyte from sox10, kit, mitfa and dct, using both qPCR and ISH 
cell count measurements. With this estimate we performed a parameter 
optimisation procedure, and found a set of parameters for the mathematical model 
that predicted the experimental data very accurately. The new model suggests that 
low expression values of sox10 are sufficient to drive mitfa expression in high levels. 
It also predicts that high expression of sox9b is needed to achieve the high expression 
levels of dct seen in the data, although these predictions need to be experimentally 
tested. 
This study represents the first attempt to obtain fine-scale gene expression data from 





μg  microgram 
μl  microlitre 
μM  micromolar 
bp  base pair 
cDNA  complementary DNA 
ChIP  chromatin immunoprecipitation 
DNA  Deoxyribonucleic Acid 
dpf  days post fertilisation 
FACS  Fluorescence Activated Cell Sorting 
FDR  False Discovery Rate 
GFP  Green Fluorescent Protein 
GRN  Gene Regulatory Network 
HCM  High Content Microscope 
HM  Hybridisation Mix 
hpf  hours post fertilisation 
ISH  in situ hybridisation 
mRNA  messenger Ribonucleic Acid 
NC  neural crest 
NCC  neural crest cell 
NTC  No Template Control 
ODE  Ordinary Differential Equation 
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PCR  Polymerase Chain Reaction 
qPCR  Quantitative RT-PCR 
RNA  Ribonucleic Acid 
TF  Transcription Factor 






Introduction to development 
Multicellular organisms do not originate fully formed, they arise from a series of 
progressive changes called development. The development of a multicellular 
organism starts with a single cell (the zygote) which divides to produce all the cells of 
the organism. 
Developmental biology tries to answer essential questions in biology such as how 
different cell types organise themselves to form tissues and organs, how our cells 
know when to stop dividing and growing, or how to generate reproductive cells with 
all the information to make a new organism. However, the most fundamental process 
that developmental biology is trying to understand (and the one we are focusing on 
in this project) is the question of cell differentiation. A single cell, the fertilised egg, 
gives rise to hundreds of different cell types—muscle cells, epidermal cells, neurons, 
lens cells, lymphocytes, blood cells, fat cells, and so on. We need to understand how 
all these different types of cells are produced from the same set of genetic 
instructions (since each cell of the body, with very few exceptions, contains the same 
set of genes) (Gilbert, 2000). 
In vertebrates the first step in development is the union of male and female gametes 
to produce the zygote, a process called fertilisation. Following fertilisation, the zygote 
starts dividing into a larger number of cells. This will result in a tightly packed mass 
of about 32 cells that is called morula, with each individual cell referred to as a 
blastomere. As the blastomeres continue to divide, they secrete a fluid into the 
centre of the morula. Eventually, a hollow ball of 500 to 2000 cells, the blastula or 
blastocyst in mammals, is formed. The pattern of cleavage division is influenced by 
the presence and location of yolk, which is abundant in the eggs of many vertebrates. 
In a mammalian blastocyst, each cell is in contact with a different set of neighbouring 
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cells, and these interactions will influence the developmental fate of each cell. This 
positional information will set up different patterns of development along three 
embryonic axes: anterior-posterior, dorsal-ventral, and proximal-distal. After the 
completion of cleavage, certain groups of cells invaginate from the surface of the 
blastula in a carefully orchestrated activity called gastrulation. By the end of 
gastrulation, the cells of the embryo have rearranged into three primary germ layers: 
ectoderm, mesoderm, and endoderm; with very different developmental fates. In 
general, cells from the ectoderm are destined to form the epidermis and neural 
tissue; the mesoderm gives rise to connective tissue, skeleton, muscle, and vascular 
elements; and the endoderm forms the lining of the gut and its derivatives. The 
events of gastrulation are one of the first fate choice events in the differentiation 
process (Gilbert, 2000). 
More than half a century ago, Waddington proposed an epigenetic landscape to 
describe the cell differentiation process (Figure 1). In this figure a differentiating cell 
is represented by a ball, and it starts out in a valley at the back of the landscape. As 
the ball rolls forward and downward, the valley splits or bifurcates into two new 
valleys separated by a ridge. These new valleys represent alternative cell fates. 
External stimuli and/or internal genetic influences, determine which of the two 
valleys a particular cell chooses. The valleys continue to split, and eventually the cell 
ends up in one of many terminal sub-valleys, which represent terminally 
differentiated states. The cell is held permanently in its terminally differentiated 




Figure 1. Waddington’s epigenetic landscape. Differentiating cells are represented by a ball 
rolling through a surface. Valleys represent alternative differentiated cell states, and ridges 
keep cells from switching fates (Waddington, 2014). 
 
However, there are some fundamental differences between Waddington’s view of 
what happens to the landscape during differentiation, and what happens according 
to the current models based on experimentation. In Waddington’s landscape, a cell 
begins at the bottom of a single well, and then as development proceeds this well 
successively splits into many more, representing the possible differentiation states 
of the cell. Therefore his model allows the reversibility of developmental events. 
However, the current models propose that differentiation mainly involves the 
disappearance of valleys from the landscape, not the appearance of new valleys. And 
this valley disappearance provides an irreversibility to the process of differentiation 
that was missing from Waddington’s original view (Ferrell, 2012). Despite these 
differences his view is still attractive and useful for understanding development.  
Cells contain many components, including genes, proteins, and metabolites. The 
cellular state at a particular time is determined by the abundance of its components 
at that time. Interactions among these components, such as the activation and 
repression of gene expression, causes changes in the cellular state, a phenomenon 
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that can be depicted as a trajectory in the Waddington’s landscape, which represents 
differentiation (Furusawa and Kaneko, 2012). 
Those interactions between genes, transcription factors and other components of 
signalling pathways form an intricate and network-like architecture known as a gene 
regulatory network (GRN). They are maps that state in detail the inputs and outputs 
into the elements regulating a developmental program. They also provide predictions 
on how the relations will evolve along the developmental program. The GRNs provide 
an explanation of the genetics interactions that drive differentiation (Levine and 
Davidson, 2005). 
Neural crest development 
The neural crest (NC) is a highly migratory multipotent cell population that forms in 
the early stages of embryonic development. Neural crest cells originate when neural 
tissue is formed in the ectodermal (the outer) layer of the developing embryo. The 
ectoderm is divided in three regions: the neural ectoderm or neural plate that will 
produce the central nervous system; the non-neural ectoderm, which will give rise to 
the epidermis; and the cells at the border of both regions that will form the neural 
crest cells. This neural tissue invaginates to form the neural tube, a process known 
as neurulation (Figure 2). During this process the neural plate border bends to form 
the neural fold and then the dorsal part of the neural tube (Bronner-Fraser, 1995, 
2002; Gammill and Bronner-Fraser, 2003). This process might be slightly different 
depending on the organism: in zebrafish the process initiates with the 
columnarisation of an existing epithelium in the ectoderm to form the neural plate, 
which then forms a neural keel and solid tube; subsequently the lumen of the neural 




Figure 2. Neural crest formation. The figure shows the neurulation process, in which the 
neural plate folds to form the neural tube. Neural crest cells originate from the closing neural 
fold or from the dorsal part of the neural tube, depending on the organism (Gammill and 
Bronner-Fraser, 2003). 
 
Specification of NC in the neuroectoderm is initiated in response to some factors, like 
BMPs, FGFs and WNTs which drive the expression of transcription factors involved in 
neural crest cells specification. BMPs have been shown to be sufficient to induce 
neural crest in birds (Liem et al., 1997). However, additional work showed that neural 
crest formation requires BMP signalling only after the initial induction step, indicating 
that BMPs might have a maintenance role in the induction process, or that they signal 
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the emigration of neural crest cells from the neural tube (Sela-Donenfeld and 
Kalcheim, 1999). It now seems that the inducing signal from the non-neural ectoderm 
is a Wnt protein, and that Wnts are both necessary and sufficient for robust induction 
of neural crest in isolated neural tissue (García-Castro et al., 2002). However, the role 
of Wnts and BMPs seems to be slightly different in zebrafish. It appears that in 
zebrafish a gradient of both BMP and Wnts is behind neural crest cell specification 
(Dorsky et al., 1998). FGF signalling can also induce neural crest in neuralised 
ectoderm, although through a Wnt intermediary, as was proven in Xenopus (Gammill 
and Bronner-Fraser, 2003). 
These factors initiate changes in cell adhesion and motility promoting their 
delamination from the neural tube in a process called epithelial-to-mesenchymal 
transition (EMT). NC cells will migrate through specific paths towards their 
destination (a process controlled by adhesion molecules and cues) while they start 
to differentiate into the appropriate cell type (Ruhrberg and Schwarz, 2010).  
During and after migration, cells differentiate into a very wide range of derivatives 
that are grouped into two categories: ectomesenchymal, which include bone, 
cartilage, dentine and adipocytes (Billon et al., 2007); and non-ectomesenchymal, 
including neurons, glia and pigment cells (Figure 3). Their multipotency (they give rise 
to many different cell types) and migratory ability (they are deployed at a wide 
variety of sites in the embryo) make them a very interesting and useful model to 




Figure 3. Neural crest derivatives. NC cells give rise to pigment cells, several neuron types, 
glia and skeletogenic cells (Donoghue et al. 2008) 
 
After their delamination from the neural tube, NC cells disperse away and organise 
into different subgroups. Their migration direction is guided by cell to cell 
interactions, chemotactic signals and extracellular matrix. In the head NCC organise 
in different subpopulations that will migrate to specific locations to give rise to glia, 
neurons, cartilage or bones, among others. In the trunk two main migration 
pathways are observed (Figure 4): the dorsolateral pathway, mainly used by pigment 
cell precursors; and the ventromedial pathway primarily used by glial and neuronal 




Figure 4. Migratory pathways of NCC derivatives. The schematic shows a transverse section 
of a zebrafish embryonic trunk and outlines the migratory pathways followed by NC 
derivatives with representative key marker genes. Red arrows represent mitfa-positive 
melanocyte precursors. Green and blue arrows represent iridophore and xanthophore 
precursors, respectively. Black arrows represent Neurogenin1 positive neural progenitors, 
which primarily generate both neuronal and glial components of the dorsal root ganglia. The 
purple arrows represent further glial progenitor types. dm, dermomyotome; myo, 
myoseptum; nt, neural tube (Lapedriza et al., 2014). 
 
Melanocytes as a model for 
development 
The complexity of the genetic interactions that regulate the differentiation and 
specification of a neural crest derivative from their progenitor make these cells a very 
interesting and powerful model to understand cell differentiation and stem cell fate 
choice. As a multipotent stem cell differentiates, its GRN becomes reconfigured from 
a state where multiple fates can be chosen to a more stable state that indicates 
commitment to a specific cell fate. We still lack a deep understanding on how these 
changes in the cell gene regulatory network are produced (Levine and Davidson, 
2005; Greenhill et al., 2011) 
In our lab, we are particularly interested in the genetic regulations which control the 
differentiation of the pigment cells from neural crest. Among all the pigment cells 
produced from the neural crest cells, melanocytes are one of the most useful and 
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interesting to study this fundamental aspect of development: they are large cells, 
well-characterised genetically and easy to identify (because of their colour) especially 
in zebrafish embryos which are transparent ; they are also affected in many human 
pigmentation diseases. 
Zebrafish is a very suitable model to study developmental genetics. One of the main 
reasons for that is that the transparency of its embryos allows to observe how 
melanocytes develop better than in any other of the main genetic model organisms. 
The rapid development of melanocytes and pigment cells gives us a fast access to 
biological material in comparison to other organism. Furthermore, the evolutionary 
conservation of melanocytes in other organisms suggests the conservation of the 
genes and interactions responsible for melanocyte development (Sato et al., 2001; 
Hallsson et al., 2004). Lastly, we possess many zebrafish pigmentation mutants that 
have been and still are an invaluable tool to understand melanocyte development 
and development in general (Henion et al., 1996; Kelsh et al., 1996; Odenthal et al., 
1996; Gaiano et al., 1996; Johnson et al., 1995; Patton and Zon, 2001). 
Neural crest-derived pigment cells (or chromatophores) are very diverse and 
conserved in evolution with fish, reptiles and amphibians having up to at least 6 
pigment cell types (Mellgren and Johnson, 2002), including melanocytes (usually 
black or brown), iridophores (reflective silver, blue or gold), leucophores (white) and 
xanthophores/erythrophores (yellow/red).  Mammals and birds have secondarily lost 
most of this diversity, retaining only melanocytes (and perhaps iridophores in birds; 
(Bagnara and Matsumoto, 2007)). Different pigment cells are characterised because 
they contain different pigment molecules (which they synthetise or obtain from the 
diet) usually stored in specialised pigment organelles. Pigment cells are usually 
associated with the skin, residing in the dermis and/or epidermis (Schartl et al., 
2015).  
Melanocyte genetics is perhaps better characterised than that of any other cell-type 
(Lamoreux et al., 2010). In contrast, other pigment cells have been less studied. 
Xanthophores are usually highly dendritic cells that appear yellow under white light. 
They contain granules of pteridine pigment, synthesised from guanosine 
triphosphate through complex and incompletely defined biochemical pathways 
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(Ziegler, 2003). Erythrophores are a closely-related cell-type and, although appearing 
red or orange, are sometimes difficult to distinguish from xanthophores as their 
appearance depends on the quantity and type of pteridine derivatives present within 
their granules (Goodrich et al., 1941; Matsumoto, 1965). Both cell-types also may 
contain carotenoid granules: membrane bound organelles containing dietary 
carotenoids (Ichikawa et al., 1998). Iridophores (appearing blue, silver or gold), and 
leucophores (white or cream) are non-dendritic cells that contain organelles termed 
reflective platelets, composed of crystalline guanine. The distinctive appearance of 
these two cell-types is primarily due to the organisation of the reflecting platelets; in 
leucophores they are found in all orientations, whereas in iridophores the spacing 
and orientation of the platelets is carefully orchestrated to generate the iridescence 
by a thin layer interference mechanism (Morrison, 1995). Cyanophores were 
identified in mandarin fish as blue pigment cells, owing to a so-far uncharacterised 
cyan biochrome within their granules (Goda and Fujii, 1995). Finally, irido-
erithrophores are a recently discovered pigment cell that contains both reflecting 
platelets and vesicles containing an uncharacterised violet pigment (Goda et al., 
2011). 
Melanocytes are characterised by the production of melanin, a high molecular 
weight polymer derived from tyrosine, within membrane-bound organelles known 
as melanosomes. In most species, melanosomes remain exclusively within the 
melanocytes, but often they can be moved around within the cell along microtubules, 
a process with a key role in the rapid colour changes so characteristic of fish and 
reptiles (e.g. chameleon). In contrast, in the skin of amniotes (birds and mammals), 
melanosomes are exported from melanocytes to adjacent keratinocytes; skin colour 
and tanning reactions are mostly due to this process of epidermal melanosome 
transfer (Lin and Fisher, 2007). Melanosome transfer is also prominent in the hair 
follicle where melanin is deposited in the developing hair (made from keratinocytes) 
as it grows. To facilitate this, mammalian melanocytes tend to be highly dendritic 
cells whose cell body rests on the basal lamina; their dendrites project into different 
layers of the epidermis where they are intimately associated with the keratinocytes 
of the skin (Kippenberger et al., 1998).  
19 
 
Melanocytes produce two kinds of melanin: black to brown eumelanin and yellow to 
red pheomelanin, although the latter is thought to be restricted to mammals and 
birds (Ito and Wakamatsu, 2003). Eumelanin acts as a photoprotective anti-oxidant, 
whereas pheomelanin is phototoxic and a pro-oxidant (De Leeuw et al., 2001). In 
mammals, natural melanin pigments consist of a mixture of both eumelanin and 
pheomelanin in varying proportions, with the overall colour reflecting the bias in 
ratios (Simon et al., 2009). 
Our understanding of the genetic regulation of melanocyte development has 
improved throughout the last decades as many new genes have been identified and 
studied. Moreover the various genetic screens in zebrafish have supplemented that 
understanding (Henion et al., 1996; Odenthal et al., 1996; Kelsh et al., 1996; Gaiano 
et al., 1996; Patton and Zon, 2001) and have finally allowed insight into the origin of 
and genetic mechanisms controlling other pigment cell types.  
Pigment cells originate through progressive fate restriction from neural crest and 
they may share a partially restricted progenitor common to all pigment cell types, i.e. 
a chromatoblast. Large-scale mutagenesis screens in zebrafish embryos have 
identified numerous loci that affect all three pigment cell-types (Henion et al., 1996; 
Kelsh et al., 1996; Gaiano et al., 1996). For example, sox10 mutant displays a severe 
reduction in all pigment cell-types, which may imply that this gene has a broader role 
in the neural crest (Kelsh et al., 2000). Clonal analysis studies of premigratory trunk 
neural crest cells in wild-type zebrafish embryos show that individual clones 
expressing these genes may contribute to more than one pigment cell-fate. 
Interestingly, clonal analysis in sox10 mutants indicated that all pigment cell 
progenitors, but not neural progenitors, remained stuck in a premigratory position 
(Dutton et al., 2001). The phenotype of the mitfa mutant in zebrafish combines 
absence of melanocytes with increased iridophores, which is interpreted as resulting 
from redirection of fate choice of multipotent precursors, although this remains to 
be formally tested (Lister et al., 1999; Curran et al., 2009). A recent study relied on 
co-visualisation of Mitf:GFP cells and different chromatophore lineage markers to 
suggest the existence of a bipotent melano-iridophore precursor (Curran et al., 
2010). These studies suggests that there are close links between different pigment 
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cells, however one question that remains unanswered is if there is just one common 
chromatoblast progenitor, or several bi-potent pigment cell progenitors.   
Specification and fate commitment of pigment cell types from the NC forms an 
attractive model system for understanding the cellular and genetic basis of stem cell 
development. Furthermore, the importance of hair, skin and eye pigmentation in 
humans, and the numerous human congenital diseases result from disruption of 
pigment cell development make melanocyte an important cell to study. Further 
understanding of melanocyte development and the underlying gene regulatory 
networks will, therefore, not only help clarify the principles of stem cell regeneration 
and differentiation but will also confer significant medical insight. 
Melanocyte biology 
Melanoblasts, the precursors of melanocytes, migrate along the dorsolateral 
pathway in chick and mouse. In zebrafish, however, the migration pattern is more 
complex, with melanoblasts migrating along the dorsolateral and medial pathways, 
whereas iridophores and xanthophores use the medial and dorsolateral pathways 
respectively (Figure 4). 
Certain genes playing a key role in specification of melanocytes from the neural crest 
have been well-characterised. At the core of melanocyte fate-specification is the 
transcriptional activator microphthalmia-associated transcription factor (MITF; Mitfa 
in zebrafish). This conserved transcription factor is a member of the basic helix-loop-
helix leucine zipper (bHLH-LZ) family, members of which possess DNA-binding and 
dimerization domains. MITF has an amino-terminal transactivation domain which 
triggers transcription and a domain mediating dimerisation (HLH-LZ) in the carboxy-
terminal region. It is expressed in all melanocytes throughout their development and 
maintained in the differentiated cell (Lister et al., 1999; Steingrímsson et al., 2004; 
Hodgkinson et al., 1993; Tachibana et al., 1994). In mouse Mitf and zebrafish mitfa 
null mutants, all melanocyte markers are absent in embryos and adults, except for 
transient expression of Mitf/mitfa itself (Opdecamp et al., 1997; Lister et al., 1999; 
Greenhill et al., 2011). In humans, MITF mutations cause two distinct syndromes: 
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Tietz syndrome (OMIM #103500) and Waardenburg syndrome type 2A (WS2A; 
OMIM #193510). Tietz syndrome, also called Tietz albinism-deafness syndrome, is 
characterised by loss of pigmentation (without affecting the eyes) and complete 
sensorineural hearing loss (Levy et al., 2006). WS2A is characterised by complete 
absence of pigmentation in patches of skin and hair, especially in the ventral midline 
and forelock and sensorineural hearing loss (Opdecamp et al., 1997). Mitf mutations 
also cause forms of albinism (including ocular albinism) and sensorineural deafness 
(OMIM #103470). Finally, Mitf mutation (amino acid substitution E318K) increases 
the susceptibility to cutaneous malignant melanoma (OMIM #614456). Mitf 
expression is driven by several transcription factors including Sox10, Pax3, CREB and 
the Wnt pathway. The protein is required for initial melanoblast specification, 
melanocyte differentiation, and has an ongoing role in melanocyte maintenance 
(Lister et al., 1999; Johnson et al., 2011). Sox10 directly regulates the activity of Mitf. 
In zebrafish mitfa gene promoter contained several Sox10 protein binding sites which 
bind directly Sox10 and were necessary for adequate Mitf expression (Elworthy et 
al., 2003). PAX3 has been shown to regulate MITF expression by binding to the MITF 
gene promoter in studies performed using 624-mel cells cultures (Watanabe et al., 
1998), and HeLa cells (Bondurand et al., 2000). Lang et al. proposed that Pax3 
cooperated with Sox10 to activate Mitf expression, while it simultaneously prevented 
Mitf from activating downstream genes (Lang et al., 2005). Activated CREB binds the 
cAMP response element consensus motif, which is located in the MITF promoter to 
increase the MITF gene expression (Bertolotto et al., 1998). Moreover, both α-MSH 
(Melanocyte-stimulating hormone) and ultraviolet can initiate the activation of CREB, 
which is followed by the up-regulation of MITF (Luger et al., 1997). LEF-1 is a 
transcription factor that is involved in the Wnt signal transduction pathway. Saito et 
al. proposed that MITF expression in melanocytes was triggered by the Wnt signalling 
pathway through LEF-1 and temporally benefited from the functional cooperation of 
LEF-1 and MITF (Saito et al., 2002). 
Work in mouse and zebrafish indicates that SOX10 drives Mitf/mitfa transcription 
from the very earliest stages, making it an early marker of neural crest cells (Dutton 
et al., 2001; Elworthy et al., 2003). Curran et al. showed that most of the zebrafish 
22 
 
NCC transiently turn on mitfa. However, only around half of them activate expression 
of melanocyte markers such as dct; other cells switch to other fates, including 
iridophores (Curran et al., 2010). Forced expression of mitfa in zebrafish sox10 or 
mitfa mutants, rescues the melanocyte phenotype equally well, strongly suggesting 
that the primary role of Sox10 in melanocyte development is to activate mitfa 
expression in melanocyte progenitors (i.e., to specify melanoblasts) (Elworthy et al., 
2003). However, in mammals, PAX3 has also been shown to have a role in the early 
specification of melanoblasts. SOX10 and PAX3 have been suggested to promote 
synergistically the activation of the Mitf promoter. Moreover, PAX3 can also directly 
activate the Mitf promoter. Hence, PAX3 is proposed to enhance the specificity and 
effects of SOX10 (Watanabe et al., 1998; Bondurand et al., 2000; Potterf et al., 2000). 
Wnt signalling also plays a role in melanocyte specification. An elevated Wnt 
signalling biases cranial NCC to adopt a melanocyte fate (Dorsky et al., 1998). Wnt-
induced signaling is mediated by Tcf/Lef transcription factors, which binds directly to 
the mitfa promoter (Dorsky et al., 2000). 
Choosing between alternative fates is a fundamental problem in stem cell biology. In 
mouse, melanocytes may be derived from bipotent Schwann cell progenitors (SCPs), 
and hence these cells choose between melanocyte and the alternative Schwann cell 
fate. Although much remains unknown regarding the molecular basis of this fate 
decision, current data identifies four factor interactions that may be important: First, 
melanocyte formation from SCPs is inhibited by ErbB signaling. Secondly, in mouse 
and chick, SOX2 represses Mitf expression and thus inhibits melanocyte formation. 
Conversely, MITF represses Sox2 expression, hence these mutually repressive 
interactions are important for SCPs’ commitment to either Schwann cell fate or 
melanocyte lineages (Adameyko et al., 2009). Finally, in avian and murine SCPs, loss 
of Foxd3 function induces differentiation into melanocytes, suggesting that FOXD3 
suppresses a melanocyte fate, while promoting Schwann cell and glial fates (Nitzan 
et al., 2013). 
There are several features of the melanocyte GRN in zebrafish that play a role in 
melanocyte commitment (Greenhill et al., 2011). Sox10 maintains multipotency 
(Kelsh, 2006), and its loss would be expected to contribute to commitment. Mitfa 
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and Sox10 initially establish a positive feedback loop that promotes melanoblast 
specification, but subsequently, Mitfa-dependent activation of the Hdac1 complex, 
represses sox10 in melanoblasts promoting both differentiation and fate 
commitment (Greenhill et al. 2011). 
Two key signalling factors play crucial roles in melanocyte migration. First, 
endothelins (ET) are ligands for seven pass G-protein coupled endothelin receptors 
(Ednr) and have been found to be expressed in early melanoblasts. A number of 
studies suggest that ET3/EDNRB2 signalling is crucial for melanoblast migration 
(Lecoin et al., 1998). Mutations in the human EDNRB gene lead to Waardenburg 
syndrome type 4A, an auditory-pigmentary syndrome characterised by patchy 
hypopigmentation, congenital sensorineural hearing loss, and Hirschsprung disease 
(OMIM #277580). Interestingly, Et3 has also been reported to drive proliferation of 
melanocytes at least in cell culture, suggesting that Ednrb signalling may have 
multiple functions (Lahav et al., 1996; Reid et al., 1996). In zebrafish, ednrb1a has a 
clear role in adult pigment pattern formation. However, although ednrb1a is 
expressed in early pigment cells, there are no pigment pattern defects in ednrb1a 
mutant embryos (Parichy, Ransom, et al., 2000). 
In mice, the major signalling molecule promoting melanocyte migration has been 
shown to be KIT. KIT is a type III receptor tyrosine kinase that responds to Stem Cell 
Factor (SCF, also called Steel factor) binding by inducing PI(3) kinase and MAP kinase 
cascades. KIT has multiple conserved roles in melanocyte development, including 
melanoblast survival, proliferation and appropriate dispersal along the dorsolateral 
migratory pathway. First, Kit is expressed from premigratory stages in melanoblast 
development in mouse and zebrafish (Wehrle-Haller et al 1995, Parichy et al 1999). 
Second, Kit and SCF mutant mice and zebrafish display reduced numbers of 
melanocytes, with severe deficits in ventral regions (Alexeev and Yoon, 2006), 
suggesting reduced migratory capacity of melanocyte precursors. Kit signalling was 
proposed to initiate melanoblast migration, attracting them onto the dorsolateral 
pathway lined by cells expressing SCF. In zebrafish kit mutants, melanocytes are 
specified and differentiate, but they fail to migrate properly and tend to accumulate 
in premigratory positions (dorsal to the neural tube, and in a cluster posterior to the 
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inner ear) (Parichy et al., 1999). This second role of KIT is proposed to be a 
chemokinetic effect: KIT increases the melanoblasts’ rate of movement and, 
therefore, their chance of encountering the follicle (Jordan and Jackson, 2000). 
There needs to be an increase in cell numbers to produce the full complement of skin 
pigment cells from the limited number of NCC, so it is clear that proliferation and 
survival of melanocyte precursors are important. In zebrafish and mammals, survival 
and proliferation of NC-derived melanoblasts appears to be critically dependent on 
Kit signalling. In fish, a temperature-sensitive conditional kit allele has enabled 
demonstration that Kit’s role in survival begins from around 2 dpf and continues until 
approximately 4 dpf (Rawls and Johnson, 2003). Melanoblast apoptosis in kit mutants 
results from a failure of the receptor tyrosine kinase to activate the PI(3) kinase and 
MAP kinase cascades. PI(3) kinase delivers a powerful anti-apoptotic signal via the 
activation of the kinases PDK1 and AKT (Goding, 2000). Another target of Kit signaling 
is Bcl2, a known pro-survival gene. Disruption of Bcl2 function in melanocytes results 
in their apoptotic loss in mice and in cell culture (McGill et al., 2002). Cell-cycle exit, 
and thus the termination of proliferation, appears to also be MITF-dependent, and 
results from activation of p21 (WAF1) expression, a cyclin-dependent kinase inhibitor 
(Carreira et al., 2005). 
The melanosome is a specialised membrane-bound organelle, which is involved in 
the synthesis, storage and transport of melanin. Melanosome organellogenesis 
progresses through four stages of maturation involving multiple enzymatic and 
structural proteins. Many proteins have been identified as melanosome-specific, 
including tyrosinase (TYR), tyrosinase-related protein 1 (TRP1), dopachrome 
tautomerase (DCT), ocular albinism type 1 protein (OA1), melanoma-associated 
antigen recognised by T cells (MART-1), vesicle amine transport protein 1 homolog 
(VAT-1), oculospanin, syntenin, and glycoprotein non-metastatic melanoma protein 
b (GPNMB) (Hoashi et al., 2010). Their roles are diverse, including melanin synthesis, 
regulation of ion transport across the melanosome membrane and structural 
functions, which we will briefly touch upon here. 
Melanocytes are highly dendritic cells that reside in the basal layer of the epidermis 
once they have migrated. In mammals, dendrites are used to transport melanosomes 
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from the cell body to the neighbouring keratinocytes. In contrast, in fish, amphibians 
and reptiles, melanosomes and pteridine granules are not secreted, but they are 
often motile, allowing for changes in coloration and the skin pigment pattern. 
Dendrite formation, maintenance and activity ae reliant upon a specialised 
cytoskeleton (Lacour et al., 1992). Ednrb signalling promotes dendricity in zebrafish 
melanocytes (Parichy et al. 2000). 
Actin filaments are the main structural component of dendrites and they play a 
central role in melanosome transport. This role may be mediated by actin binding 
proteins like myosin Va, melanophilin, RAB27A, and SLP2-A, all shown to transport 
melanosomes (Matesic et al., 2001; X. Wu et al., 2002; X. S. Wu et al., 2002; Fukuda 
et al., 2002). The currently accepted model describes that RAB27A recruits 
melanophilin to the melanosome membrane, which allows the recruitment of 
myosin Va to link the organelle to the actin cytoskeleton (Hume and Seabra, 2011). 
Melanin is produced in the melanosomes by the cooperative action of enzymes of 
the tyrosinase family. Tyrosinase is considered as the key enzyme in this process. It 
is a membrane glycoprotein with a single transmembrane helix. The C-terminal sits 
in the melanocyte cytosol and the N terminal is located inside the melanosome 
lumen. The enzyme is activated by cytosolic protein kinase C (PKCβ) (Hearing and 
Jiménez, 1987). Tyrosinase can use both L-tyrosine and L-DOPA, which is formed in 
melanosomes from L-tyrosine by the enzyme tyrosine hydroxylase isoform I (THI), as 
substrates (Marles et al., 2003). The concentration of L-tyrosine in the melanosome 
depends on the conversion of the amino acid L-phenylalanine by phenylalanine 
hydroxylase (PAH) (Schallreuter et al., 1994). Therefore, all the three enzymes PAH, 
THI and tyrosinase are crucial for the initial steps of the melanogenesis. The activities 
of PAH, THI and tyrosinase are controlled by the cofactor 6BH4 which acts as the 
essential electron donor for PAH to produce L-tyrosine from L-phenylalanine and for 
THI to convert L-tyrosine to L-DOPA (Schallreuter et al., 2008). Tyrosinase converts 
tyrosine to DOPAquinine and DOPAchrome that will be used by other melanogenic 
enzymes such as DCT or TYRP1 to produce eumelanin or pheomelanin (Hearing, 
2011). Mitf, the melanocyte main transcription factor, drives the expression of these 
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melanogenic enzymes through the M-box or E-box that they contain in their 
promoter (Hou et al., 2006). 
The pigment-type switching system that controls whether melanocytes produce 
black/brown eumelanin or yellow/red pheomelanin, is regulated by the 
melanocortin 1 receptor (MC1R), a G-protein-coupled receptor expressed in 
melanocytes. It involves the action of α-melanocyte-stimulating hormone (α-MSH) 
and the opposing agouti signal protein (ASP) (Walker and Gunn, 2010).  MC1R activity 
is sufficient to produce eumelanin in its basal state, but production increases upon 
α-MSH stimulation. The increased MC1R signalling results in the activation of Mitf, 
and then of the melanogenic enzymes (e.g., TYR, TYRP1, DCT), resulting in the 
production of more eumelanin (García-Borrón et al., 2005). ASP competes with α-
MSH for binding to MC1R. When MC1R is inactivated by ASP pheomelanin is 
produced instead (Rouzaud et al., 2003). Fish melanophores contain only eumelanin 
(as they cannot produce pheomelanin).  Melanocortins are involved in the 
melanocyte production in fish, probably through its binding to Mc1R leading to the 
upregulation of the melanogenic genes (Logan et al., 2006). Recent studies suggest 
that agouti may also have a role in fish melanogenesis (Guillot et al., 2012). 
All the information above suggests that melanocyte development is a very complex 
process, regulated by many different genes, with several different functions (some 
are transcription factors, some are membrane receptors, and others are enzymes). 
All these genes interact in a dynamic way to form an intricate gene regulatory 
network that drives melanocyte development. 
Introduction to gene regulatory 
networks  
To understand the behaviour of the complex interactions that occur in gene 
regulatory networks and their function a mathematical modelling approach might be 
useful and informative. Intuition alone is not enough to comprehend the effects of 
multiple simultaneous interactions within these networks and their dynamical 
evolution. Mathematical models are particularly useful to understand the effects of 
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nonlinear interaction such as those that describe the oligomerisation of subunits to 
form a functional TF, as well as to predict the genetic response of normal and mutant 
organisms (Smolen et al., 2000). 
There are two main approaches to build a GRN model: the logical-network or 
“Boolean” method and the dynamic-systems one. The former takes into account only 
the simple details: the expression of each gene is modelled as either on or off, there 
is no intermediate level. These simple models allow use of large time steps and 
minimise computational time required for simulations. The dynamic-systems 
approach uses ordinary differential equations to describe the rate of change of the 
concentration of mRNA or proteins. The terms of the equations describe how the 
gene expression is modified by changes in the effector molecule(s) (transcription 
factor(s)). Where appropriate, stochastic fluctuations in molecule numbers due to 
random events in its synthesis or degradation can be incorporated to the model. This 
method is usually preferred over the logical-network one because it is more accurate, 
since gene expression levels are continuous variables rather than ideal “on or off” 
switches. However, dynamic-systems methods use much shorter time steps and as a 
consequence they require much more computer time.  Also we do not always know 
enough about gene concentrations and how they change. That is why sometimes 
logical networks represent the only practical alternative to model lengthy processes 
such as development of tissues (Smolen et al., 2000). 
Gene regulatory networks have been successfully used to describe biological 
processes in several organisms and tissues: in the yeast Saccharomyces cerevisiae 
(Alcasabas et al., 2013), in the mammalian immune system (Singh et al., 2014), in the 
plant Arabidopsis thaliana (Wellmer et al., 2006), in the sea urchin (Davidson et al., 
2002) or the fly Drosophila (Aguilar-Hidalgo et al., 2013) just to name a few. However, 
the combined use of both GRN and mathematical modelling to investigate biological 
processes is not as extended. One of the most studied GRNs is the one that describes 
the sea urchin development. The Davidson lab have been working on this GRN for 
many years, and they have developed a very complete and detailed network of this 
organism. Part of their work was focused on the development of a gene network that 
explains how endomesoderm specification in sea urchin is controlled (Davidson et 
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al., 2002). Another group used this GRN to create a mathematical model that 
describes endomesoderm specification, which allowed them to predict new 
interactions and genes that where initially located in erroneous positions; therefore 
it contributed to the improvement of the model (Kühn et al., 2009). Mathematical 
modelling was also used to understand the GRN underlying the development of the 
Drosophila ocellar complex. The model allowed them to expand the GRN to 
incorporate new genes that explain how the interaction between Hedgehog 
signalling pathway and the GRN results in stable gene expression that allows ocellar 
development (Aguilar-Hidalgo et al., 2013). Hence, mathematical modelling of GRN 
have proven to be very useful to understand better how a GRN works and to improve 
them. 
Gene regulatory network of 
melanocyte development 
Greenhill et al. (2011) used a systems biology approach to identify and develop the 
GRN underlying melanocyte specification and differentiation in zebrafish. They used 
a mathematical modelling approach in conjunction with experimental data in an 
iterative process to create a model that makes specific predictions about the 
properties of unidentified factors in melanocyte differentiation and explains the 
melanocyte development in a semi-quantitative manner. 
They constructed a dynamical model of the GRN based on ordinary differential 
equations, considering the transcription levels as dynamic variables. The external 
activatory signal in the network was designed as Factor A, comprising several 
transcription factors whose function in the regulation of the network is poorly 
understood: Lef/Tcf (Wnt pathway), Sox9, FoxD3, Pax and AP2. These input factors 
regulate Sox10 which had been shown to activate the expression of Mitfa directly 
(Elworthy et al 2003), termed the master regulator of melanocyte specification, 
which will activate the melanogenic genes (Dct, Tyr, Tyrp1 and Si) as well as the sox10 
promoter. Subsequently, Sox10 represses the expression of the melanogenic genes 
and its expression is repressed by the recruitment to the sox10 promoter an Hdac1 
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complex that deacetylates its chromatin and represses sox10 transcription by Mitfa. 
In that way, Factor A-dependent sox10 expression as well as Mitfa-dependent 
expression will both be inactivated. The model proposed also the existence of a 
Sox10-independent, Mitf-dependent transcriptional activator of mitfa (Factor Y) that 
provides a positive feedback loop to allow stable melanocyte differentiation. This 
feature was not initially part of the model, but was incorporated because the model 
simulations highlighted the need of this factor to guarantee stable melanocyte 
development. This was also supported by experimental data that showed a reduction 
of mitfa expression in mitfa mutant, due to the absence of the positive feedback 
through Factor Y. Finally, Sox9b drives Sox10 and Mitfa-independent melanisation 
and it is activated by Factor B, which has a transient role and is restricted to the early 
phase of melanocyte development (Greenhill et al., 2011) (Figure 5). 
 
 
Figure 5. Core GRN driving melanocyte differentiation proposed by Greenhill et al. (2011) 
 
The mathematical model was constructed as a one stage process: binding and 
unbinding of TF to DNA regulate protein production in a single step of synthesis, 
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without taking into account mRNA levels. The model was produced using ordinary 
differential equations. TF binding and unbinding to the DNA was described as a faster 
process than protein synthesis and degradation, in that way the dynamics were 
solved in conditions of quasi-equilibrium for the TFs. The result was a description of 
both activatory and repressive regulations in terms of Hill-like functions (Greenhill et 
al. 2011). The equations that make up the model have the following structure: 
𝑑𝐴
𝑑𝑡
= 𝑔𝛼𝐵 − 𝑑𝐴 
Where A is the TF concentration, g is the rate of TF synthesis, B is the concentration 
of the regulatory TF, d is the rate of TF degradation and α is a factor that measures 
the rate for binding and unbinding of the regulatory TF i.e. B. The whole set of 
ordinary differential equations that form the model can be found in Appendix 1. 
Greenhill et al. (2011) developed the current GRN model by expanding and refining 
an initial melanocyte GRN and model in an iterative approach to obtain the model 
that best described the data they had. Thanks to the use of this systems biology 
approach they proposed new network players and interactions which were not 
present in the initial model, including the Sox10-mediated repression of many Mitfa 
target genes; the transient expression of Sox10 in differentiating melanocytes as a 
consequence of the Mitfa-dependent repression of sox10 through a mechanism 
involving Hdac1 complex; a Sox10 independent weak activation of melanogenesis 
genes; and that mitfa expression is directly or indirectly, Mitfa-dependent.  
This model allowed them to predict the evolution of gene expression of the GRN 
genes along the first 100 h of zebrafish embryonic development. Figure 6 represents 
the changes on expression levels of the different genes of the network along time. 
However, the data they have was very limited: in situ hybridisation expression 
patterns that can be used to get coarse expression data. Therefore, when they had 
to find the parameters of the model they chose the ones that produced gene 
expression curves that were similar in shape to what they expected to happen based 
on the in situ data. That means that the quantities and exact detail of the curves are 




Figure 6. Evolution of gene expression in the GRN over time. The graphic shows that the input 
factors (A and B) start acting at 12 hpf. Factor B is only transient and it ends at 24 hpf, while 
factor A keeps acting during all the simulation. The rest of the curves represent the evolution 
of gene expression levels of the genes in the network (Greenhill et al. 2011). 
 
This model represented a big improvement on the information previously available 
on the melanocyte GRN, and helped understand much better how these genes 
interact to drive melanocyte development. However, in order to obtain a model that 
is closer to reality we need to base it on quantitative data. Thus in this study we aimed 
to obtain quantitative data from some genes of the GRN using qPCR to develop a 
quantitative mathematical model, that represents better the reality. At the same 
time this network includes some of the main genes involved in melanocyte 
development, but there are more important genes involved that are not currently 
described. Hence in this work we intend to identify novel genes involved in this 
process that should be part of the melanocyte GRN. 
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Aim and objectives 
The aim of this study is to expand the GRN including more genes involved in 
melanocyte development and to develop a quantitative mathematical model for the 
GRN by: 
- Identifying novel genes involved in the melanocyte gene regulatory network 
and their function. 
- Understanding how these novel genes interact with the current genes that 
form the core melanocyte GRN and finding their place in the network. 
- Obtaining quantitative data from some of the main gene in the melanocyte 
GRN in several time points throughout melanocyte development. 
- Developing a quantitative mathematical model of the GRN using the obtained 





Materials and Methods 
Materials 
Chemical Reagents 
UltraPure Agarose     Invitrogen Life Technologies, UK 
Low Melting Agarose     Invitrogen Life Technologies, UK 
Phenol-Chloroform-isoamyl alcohol   Sigma Aldrich, Germany 
Tricaine (Ethyl 3-aminobenzoate methanesulphonate) Sigma Aldrich, Germany 
Tween 20      Sigma Aldrich, Germany 
Luria agar      Sigma Aldrich, Germany 
Luria broth      Sigma Aldrich, Germany 
Formaldehyde      Sigma Aldrich, Germany 
Ethanol      Sigma Aldrich, Germany 
Methanol      Sigma Aldrich, Germany 
PBS       Fisher Scientific, UK 
 
Kits 
DIG RNA labelling kit SP6/T7    Roche Diagnostics, Germany 
NycleoBond Xtra Midi     Macherey-Nagel, Germany 
Zymoclean Gel DNA Recovery kit   Zymo Research, USA 
DNA Clean & Concentrator    Zymo Research, USA 
GeneJET Plasmid Miniprep Kit   Life Technologies, UK 
Zero Blunt TOPO PCR Cloning Kit   Life Technologies, UK 
Experion RNA StdSens Analysis Kit   Bio-Rad, USA 
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geNorm 12 gene kit for zebrafish   PrimerDesign, UK 
TSA Plus Cyanine 3/Fluorescein System  PerkinElmer, USA 
 
Antibiotics, Indicators and Dyes 
Ampicillin      Sigma Aldrich, Germany 
Ethidium Bromide     Sigma Aldrich, Germany 
Kanamycin      Sigma Aldrich, Germany 
Fast Red tablets     Roche Diagnostics, Germany 
NBC/BCIP      Roche Diagnostics, Germany 
 
Enzymes 
Proteinase K      Fisher Scientific, UK 
RNase A      Promega, UK 
RNase inhibitor     Promega, UK 
Pronase      Sigma Aldrich, Germany 
T4 ligase      Promega, UK 
Go Taq polymerase     Promega, UK 
KOD Hot Start DNA polymerase   Novagen, USA 
SuperScript III Reverse Transcriptase   Invitrogen Life Technologies, UK 
RNase-Free DNase     Promega, UK 
Precision DNase     PrimerDesign, UK 
nanoScript 2 Reverse Transcriptase   PrimerDesign, UK 
PrecisionPLUS Mastermix    PrimerDesign, UK 
 
Nucleic acids 
dNTP mix      Promega, UK 
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DIG labelled dNTPs     Roche Diagnostics, Germany 
DNA ladder 100 bp     New England BioLabs, UK 
DNA ladder 1kb plus     Thermo Scientific, USA 
  
Solutions and Buffers 
Alkaline phosphate buffer 
100 mM Tris-HCl pH 9.5 
50 mM MgCl2 
100 mM NaCl 
0.1% (v/v) Tween20 
Blocking reagent stock solution 
10 % (w/v) of Blocking Reagent (Roche) in 1xMAB can be prepared and kept 
in the freezer. 
Embryo medium (50x stock solution) 
0.5 µM NaCl 
0.17 µM KCl 
0.33 µM CaCl 
0.33 µM MgSO4 
0.1 % methylene blue 
In distilled water 
Hybridisation mixture (HM) 
50 % (v/v) formamide 
5x SSC 
50 ng/mL heparin  
500 ng/mL tRNA 
0.1% (v/v) Tween20 
9.2 mM citric acid 
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In DEPC-treated Milli-Q water 
Luria Agar 
3.7 % (w/v) Luria agar base in distilled water. Autoclave. 
Luria broth 
2.5 % (w/v) Luria broth base in distilled water. Autoclave. 
MAB 5x 
500 mM maleic acid 
450 mM NaCl 
In Milli-Q water, adjust pH to 7.5 and autoclave 
MABT 
Dilute MAB 5x with Milli-Q water 
Add 0.1% (v/v) Tween20 
Phosphate buffered saline Tween (PBST) 
0.1% (v/v) Tween20 in PBS 
Paraformaldehyde (PFA) 
4% (w/v) paraformaldehyde in PBS 
Autoclaved PBS is firstly warmed to 60ºC and then PFA is added, pH is adjusted 
to 7.0 to improve PFA solubilisation, solution should never be warmed above 
60ºC and should be frozen in aliquots as soon as cleared to prevent 
degradation.  
Pronase 
20 mg/mL stock solution of Pronase (Protease from Streptomyces griseus, 
Sigma-Aldrich) in PBS, dilute to 2 mg/mL in EM prior to use. 
SSC 20x 
3 M NaCl 
300 mM sodium citrate 
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In Milli-Q water adjusting pH to 7.0 with 1 M HCl 
SOB (Super optimal broth) 
0.5% (w/v) yeast extract 
2% (w/v) tryptone 
10 mM NaCl 
2.5 mM KCl 
20 mM MgSO4 
Per litre: 
5 g yeast extract 
20 g tryptone 
0.584 g NaCl 
0.186 g KCl 
2.4 g MgSO4 
Adjust to pH 7.5 prior to use. 
SOC (Super optimal broth with catabolite repression) 
1 L SOB 
20 mM glucose solution (20 ml) 
TE 1x 
10 mM Tris-HCl (pH 8.0) 
1 mM EDTA (pH 8.0) 
10 mM NaCl 
TAE 1x 
40 mM Tris-HCl 
20 mM sodium acetate 
2 mM EDTA  
In Milli-Q water adjusting the pH to 7.8 with glacial acetic acid 
Tricaine stock solution (3-amino benzoic acidethylester) 
400 mg tricaine powder 
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87.9 ml dd water 
2.1 ml 1M Tris (pH 9). Adjust pH to 7. 
To use tricaine as anaesthetic, dilute 4.2 ml of tricaine solution in 100 ml of 
water 
Primers 
Primers were purchased either from SourceBioscience, Invitrogen, Eurofins or 
PrimerDesign and are listed in table X. 
Table 1. Primers. The sequences are given in the 5’ to 3’ direction of their respective DNA 
strands. 
Primer name Primer sequence 
Sox10 Sense (PrimerDesign) GCATCCATCCTTCCTGAACT 
Sox10 Anti-sense (PrimerDesign) AAAGATTATTCATTCATACAAATACAGA 
Kita Sense (PrimerDesign) GCGATTTGGAAAAACTCTTGGAT 
Kita Anti-sense (PrimerDesign) GCACTCGGTTTCAGCATCTT 
Dct Sense (PrimerDesign) CAGTGACCCATCCCGAATC 
Dct Anti-sense (PrimerDesign) CCTCATTGGTGCCGTTACA 
Mitfa Forward CTGGACCATGTGGCAAGTTT 






Zebrafish and zebrafish embryos were manipulated in accordance with the Home 
Office regulations and as suggested in “The zebrafish book” (Westerfield, 2000). Fish 
stocks were maintained in the University of Bath zebrafish facility. 
Embryos were obtained from crosses of wild type AB fish and several mutants: 
sox10m618, sox10t3 (Dutton et al., 2001), mitfaw2 (Lister et al., 1999)and kitj1e249 (Rawls 
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and Johnson, 2003). Embryos were raised and staged according to Kimmel et al. 
(1995). Embryos were grown in embryo medium using 90mm Petri dishes in a MIR-
155 incubator (Sanyo) at 28.5 ºC, unless stated otherwise. 
PTU TREATMENT 
To prevent melanin synthesis to achieve better internal imaging of the embryos, they 
were incubated in EM with 0.003% of PTU (1-phenyl-2-thiourea) (Sigma-Aldrich) from 
24 hpf onwards until embryos were fixed. 
DECHORIONATION 
Embryos were dechorionated using either the manual method or the enzymatic one. 
Manual dechorionation involved using two Watchmakers’ forceps No. 5. One of them 
was used to hold the embryo and the other one to pull apart the chorion. 
The enzymatic dechorionation involved the use of Pronase. Embryos were incubated 
with 1x Pronase in EM at 28.5ºC during some minutes, until the embryos are outside 
the chorion. Pronase was then removed and embryos were rinsed several times with 
fresh EM. 
ANESTHETISING EMBRYOS 
Embryos older than 15 hpf were anesthetised with tricane (ethyl 3-aminobenzoate 
methanesulfate salt) to approximately 0.2% of the final volume prior to 
manipulation. 
DISSECTION OF EMBRYO TRUNKS FOR QUANTIFICATION EXPERIMENT 
A pool of 40 embryos were transferred to a plate with fresh PBS where there were 
manually dechorionated and then anesthetised with tricane. 5 of these embryos 
were transferred with a small amount of PBS to a coverslip and their trunks were cut 
with dissecting pins under a dissecting scope. The fragment of the fish dissected goes 
from the beginning to the end of the yolk extension in all the stages. The 5 trunks 
were collected with a micropipette taking as little PBS as possible and deposited in a 
PCR tube. The tube was spun down and as much liquid as possible was removed 
without taking out the trunks. 50 µl of QIAzol was added, tube was vortexed for a 
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couple of minutes and then stored at -80ºC until the RNA extraction was performed. 
The remaining 35 embryos were collected into tubes and fixed with 4% PFA and 
stored at 4ºC to be used in ISH. 
Molecular Methods 
BACTERIAL GROWTH 
Glycerol stocks or agar stabs of bacterial stocks were propagated by streaking on LB-
agar plates containing appropriate selective antibiotics and incubated overnight at 
37ºC. 
Bacterial cultures were grown in LB-medium supplemented with the required 
antibiotics at the following concentrations: 50 µg/ml of ampicillin or 25 µg/ml of 
kanamycin. After inoculation with a single colony, the culture was incubated 
overnight at 37ºC in a shaking incubator. 
TRANSFORMATION OF BACTERIAL CELLS 
The transformations of plasmid DNA into E. coli were performed by heat shock. 
During the entire project DH5αF’ (Clontech Laboratories) strain was used; these were 
prepared in the lab using chemically induced competency and aliquoted in 1.5 mL 
centrifuge tubes (following the protocol from Dr. K Kaji lab). Aliquots were defrosted 
on ice for 20 min with occasional tapping of the tube. 5 µl of ligation or 1 µl of a stock 
plasmid were added and the cells were left on ice for 30 min with occasional gentle 
mixing. Tubes were incubated at 42ºC for 45 s and immediately placed on ice and left 
for 2 min. After transformation, cells were incubated in 1 ml of SOC medium for one 
hour at 37ºC with gentle shaking before streaking 200 µl on LB-agar plates containing 
the appropriate antibiotic. Plates were incubated overnight at 37ºC and positive 
colonies were then picked and grown in LB-medium with the appropriate antibiotic 
at 37ºC overnight in a shaking incubator. The culture volume was chosen according 





PHENOL/CHLOROFORM/ISOAMYL EXTRACTION AND ALCOHOL PRECIPITATION OF 
DNA 
For the extraction of RNA or DNA, Milli-Q water was added to the sample of dirty 
DNA to 100 µl, followed by 100 µl of phenol/chloroform/isoamyl alcohol pH 8 (Sigma-
Aldrich). Sample was vortexed for 15 s and centrifuged for 3 min at maximum speed. 
Supernatant was recovered and 2.5 volumes of ethanol and 1/10 volume of NaOAc 
(3 M, pH 5.4) were added. Sample was then precipitated overnight at -20ºC or 30 min 
at -80ºC. Sample was centrifuged at maximum speed for 30 min at 4ºC, supernatant 
was decanted and pellet rinsed with 70% ethanol. Pellet was dried for 10 min at room 
temperature and re-suspended in water. 
PLASMID DIGESTION 
Plasmid digestion by restriction enzymes was performed in a minimal volume, using 
the conditions recommended by the manufacturer. When required BSA was added 
and heat inactivation at 65ºC was carried out unless the reaction was used to run on 
an agarose gel or for Phenol/Chloroform precipitation. 
IN SITU HYBRIDISATION PROBE SYNTHESIS 
Prior to probe synthesis 10 µg of midi-prep plasmid DNA containing the cDNA of 
interest (template) was linearised by digesting the 3’ end of the antisense sequence. 
The reaction was cleaned by phenol/chloroform/isoamyl alcohol extraction followed 
by alcohol precipitation. 
For in situ hybridisation a RNA probe labelled with digoxigenin was created using the 
DIG RNA Labelling Kit (Roche, Cat# 11175025810). Probe was synthesised in an 
RNAse-free tube with the following components: 1 µg of the purified template, 2 µl 
of dNTP labelling mix, 2 µl of 10x transcription buffer, 1 µl of RNase inhibitor, 2 µl of 
100 mM DTT, 2 µl of the appropriate RNA polymerase (SP6, T7 or T3) and DEPC water 
to a final volume of 20 µl. This was mixed gently and spun to the bottom of the tube 
before placing the tube in a 37ºC incubator for 2 – 4 hours. The cDNA template was 
digested by adding 2 µl of RNase-free DNase incubating it at 37ºC for 15 min. The 
reaction was stopped and the probe was precipitated by adding 2 µl of 0.5 M EDTA 
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pH 8, 2.5 µl of 4 M LiCl and 75 µl of 100% ethanol. The mixture was placed in -80ºC 
for 30 min and then it was centrifuged at maximum speed for 30 min at 4ºC. 
Supernatant was removed and the pellet washed with 70% ethanol centrifuging it for 
5 min. The supernatant was discarded and pellet was dried briefly and resuspended 
in 100 µl of Milli-Q water. 
PROBE FRACTIONATION 
Alkaline hydrolysis was used to fragment a probe in order to increase its permeability 
inside the embryo, following the Parichy laboratory protocol. This is generally 
recommended for probes longer than 300 nucleotides. The following components 
had to be mixed: 50 µl of the intact probe, 30 µl of DEPC water, 10 µl of 0.4 M 
NaHCO3, 10 µl of Na2CO3. This reaction had to be heated in a water bath at 60ºC for 
the time calculated by the following equation: 
Time (min) = (starting kb – desired kb) / (0.11 x starting kb x desired kb) 
Hydrolysed probe was then precipitated by mixing 100 µl of the fractionated probe, 
100 µl of DEPC water, 20 µl of 3 M NaOAc pH 4.5, 2.6 µl of glacial acetic acid and 600 
µl of ethanol. Mixture was precipitated for 30 min at -80ºC and then centrifuged at 
maximum speed for 30 min at 4ºC. Supernatant was removed and dried briefly and 
the pellet was resuspended by vortexing in 50 µl of DEPC water. 
RNA EXTRACTION FOR QPCR 
The embryo trunks stored at -80ºC in QIAzol were thawed in ice. Half the volume of 
chloroform was added (i.e. 25 µl) to the tube and then thoroughly vortexed for 15 s. 
The tubes were centrifuged for 10 min at 4ºC at maximum speed. The aqueous phase 
(supernatant) was collected and transferred into a new tube. 2 µl of linear acrylamide 
was added, the tube was vortexed and an equal volume of isopropanol (around 40 
µl) was added before mixing it with the vortex again. The samples were left resting 
at room temperature for 5 min before centrifuging them for 30 min at 4ºC and max 
speed. The isopropanol was removed and 100 µl of 80% ethanol were added. The 
tubes were centrifuged again for 3 min at 4º and max speed and the supernatant was 
removed carefully to avoid losing the pellet. The pellet was dried briefly and then re-
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dissolved in 12µl of water before measure the concentration using a Nanodrop 
spectrophotometer.  
REVERSE-TRANSCRIPTION 
The extracted RNA was reverse-transcribed to cDNA using the nanoScript2 kit from 
PrimerDesign following the manufacturer’s instructions. 
qPCR 
The qPCR was run in 20 µl reaction containing 19 µl of the reaction mix and 1 µl of 
the cDNA template in 48-well plates. We prepared a reaction mix containing the 
PrecisionPLUS master mix (PrimerDesign), the appropriate primers (Table 1) and 
water. We put 19 µl of that mix into all the wells and 1 µl of the suitable template 
following the layout in Table 2. 
Table 2. Layout of the qPCR plates followed in the quantification experiment. Sam means 
sample, Stcur means Standard Curve and NTC means no template control. 
Sam1x1 Sam1x2 Sam1x3 Sam7x1 Sam7x2 Sam7x3 Stcur1x1 Stcur1x2 
Sam2x1 Sam2x2 Sam2x3 Sam8x1 Sam8x2 Sam8x3 Stcur2x1 Stcur2x2 
Sam3x1 Sam3x2 Sam3x3 Sam9x1 Sam9x2 Sam9x3 Stcur3x1 Stcur3x2 
Sam4x1 Sam4x2 Sam4x3 Sam10x1 Sam10x2 Sam10x3 Stcur4x1 Stcur4x2 
Sam5x1 Sam5x2 Sam5x3 Sam11x1 Sam11x2 Sam11x3 Stcur5x1 Stcur5x2 
Sam6x1 Sam6x2 Sam6x3 Sam12x1 Sam12x2 Sam12x3 NTCx1 NTCx2 
 
STANDARD CURVE 
To produce the standard curve for the qPCR the plasmids containing the cDNA for 
the genes of interest were used (Table 3). In order to get these plasmids at high 
concentration a Midiprep was done (following the instructions of the kit 
manufacturer). Using the length of the insert and plasmid the copy numbers were 
calculated and the appropriate dilutions performed to obtain the 5 points needed for 





Table 3.Details of the plasmid containing our gene of interest amplicons that were used for 
the qPCR standard curves. 
Gene name Insert length Plasmid backbone and length Total length 
dct 1800 bp pBluescriptIISK, 3000 bp 4800 bp 
mitfa 1600 bp pBluescriptIISK, 3000 bp 4600 bp 
sox10 2000 bp pGEM-T Easy, 3015 bp 5015 bp 
kit 3100 bp pKRX, 2956 bp 6056 bp 
 
AGAROSE GEL ELECTROPHORESIS 
DNA products were normally visualised using agarose gel electrophoresis. Agarose 
gels 0.8-2% (w/v) in 1xTAE buffer were made by heating in a microwave with regular 
mixing until agarose was fully dissolved. Solution was allowed to cool down and 
ethidium bromide (10 mg/ml) was added to a final concentration of 0.4 mg/ml, 
mixture was then poured into an electrophoresis tray. Once solidified these were 
submerged with 1xTAE buffer in the electrophoresis tank. Samples were loaded into 
the gel with 1x loading dye and run at between 80-120V (PowerPac 300, Bio-Rad), 
depending on the purpose of the experiment and type of nucleic acid. The agarose 
gels were then visualised and photographed under UV light. 
BLEACH GEL 
This gel was used to check the integrity of RNA following the protocol described in 
Aranda et al. (2012). Agarose was measured accordingly to produce a 1% gel in 50 ml 
of 1xTAE buffer. 1 ml of commercial bleach was added and incubated for 5 min. The 
mixture was melted in the microwave and after adding the ethidium bromide the gel 
was casted and used in electrophoresis as usual. 
Whole mount in situ hybridisation (ISH) 
Dechorionated embryos were fixed in 4% PFA, 5 hours at room temperature or 
overnight at 4ºC. After fixation, embryos were rinsed in PBT and washed 3 times for 
5 min in MeOH. Dehydrated embryos were stored at -20ºC in MeOH until needed but 
at least overnight. 
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The in situ protocol started with the rehydration of the embryos washing them for 5 
min in a series of 75% MeOH/25% PBT, 50% MeOH/50% PBT and 25% MeOH/75% 
PBT, followed by five 5 min washes in PBT. 
Embryos that already contain melanised cells were bleached to avoid the melanin 
interfering with the in situ staining. The bleaching process consisted in mixing 100 µl 
of 10% KOH, 50 µl of 30% H2O2 and 850 µl of Milli-Q water, transferring the embryos 
to a plate or well, and adding the mixture. Embryos were incubated in this mixture 
until they looked clear and the melanised cells were transparent; then embryos were 
transferred back to a tube and washed 3 times for 5 min in PBT. 
Embryos were then incubated in Proteinase K (10 µg/mL) in PBT to permeabilise the 
cell walls and allow effective probe penetration. The incubation time depends on 
their developmental stage (Table 1). 
Table 4. Proteinase K digestion times. 
Developmental stage Treatment time 
Prior to 24 hpf No treatment 
24 hpf 5 min 
26 hpf 5 min 
30 hpf 8 min 
32 hpf 8 min 
36 hpf 10 min 
48 hpf 12 min 
60 hpf 12 min 
72 hpf 15 min 
96 hpf 20 min 
 
After the treatment, embryos were fixed in 4% PFA for 1 hour at room temperature 
and then they were washed 5 times for 5 min in PBT. The previous steps (PFA fixation 
and PBT washes) were not necessary if the embryos were not digested with 
Proteinase K. 
Embryos were then prehybridised for at least 1 hour at 68ºC in HM. Then the HM was 
removed and the embryos were incubated overnight at 68ºC with 200 µl of pre-
warmed HM plus probe at 1/100 dilution. 
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The next day, embryos were washed for 5 min at 68ºC in 66% HM/33% 2xSSC, 33% 
HM/66% 2xSSC and 2xSSC. Then, embryos were washed twice for 20 min in 
0.1xSSC+0.1% Tween20 at 68ºC. Afterwards, the samples were washed for 5 min at 
room temperature in 66% 0.2xSSC/33% PBT, 33% 0.2xSSC/66% PBT and PBT. 
Blocking solution (diluting to 1% the stock solution) was added to the samples for 1 
hour at room temperature. Then embryos were incubated for 2 hours at room 
temperature in anti-DIG-AP antibody (Roche) (1:5000 in 1% blocking solution). Finally 
embryos were washed 5 times for 15 min in PBT and left overnight at 4ºC. 
The following day, embryos were washed 4 times for 5 min in AP buffer before 
staining with NBT/BCIP solution or FastRed tablets following the manufacturer’s 
guidelines (Roche). The staining reaction was carried out in the dark and was stopped 
when the signal was strong or background started to appear. The reaction was 
stopped by rinsing with PBT and fixing the embryos with 4% PFA for 2 hours at room 
temperature or overnight at 4ºC. Finally, the embryos were transferred through a 
glycerol series of 30 %, 50% and 80% in PBS, before storing them at -20º. 
Whole mount double fluorescence in situ hybridisation 
The protocol was carried out as in non-fluorescence in situ hybridisation up to the 
step where the embryos were incubated with the antibody. In the case of a 
fluorescent in situ, instead of using anti-DIG-AP, the antibody used was anti-DIG-POD 
because the tyramide amplification reaction was going to be used in the next steps. 
The TSA System kit from PerkinElmer was used. 
The anti-DIG-POD antibody was also pre-adsorbed and it was diluted 1:1000 in 1% 
blocking solution. After incubating the sample with the antibody for 2 hours at room 
temperature, the embryos were washed six times for 10 min each in PBT and they 
were stored in PBT overnight at 4ºC. 
The day after, the samples were incubated in amplification buffer for 10 min and then 
incubated for 1 hour protected from light in 50 µl of Cy3 tyramide working solution, 
made diluting Cy3 1:100 in 0.0015% H2O2/Amplification buffer. The embryos were 
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washed three times in PBT for 15 min and stored in SlowFade Antifade solution 
(Invitrogen) for detection under the microscope. 
For a double fluorescence in situ hybridisation, two probes had to be hybridised: one 
labelled with DIG and the other with Flu (fluorescein). The protocol continued after 
the first fluorescent staining and instead of storing the sample in SlowFade Antifade 
solution, the anti-DIG-POD was stripped away incubating the sample in 0.1 M Glycine 
pH2.2 for 10 min.  
The embryos were washed 5 times for 5 min in PBT and then incubated for one hour 
in 1% blocking solution. After that, pre-adsorbed anti-Flu-POD 1:500 in 1% blocking 
was added to the samples and they were incubated for 2 hours before washing 6 
times for 10 min and storing the samples at 4ºC overnight. 
Finally, the last day the samples were incubated in amplification buffer for 10 min 
before incubating them for 1 hour protected for light in 50 µl of FITC tyramide 
working solution, made diluting FITC 1:50 in 0.0015% H2O2/Amplification buffer. The 
samples were washed three times for 15 min in PBT and stored in SlowFade Antifade 
solution. 
Embryo mounting and microscope techniques 
Low power microscopic analysis and general embryo handling was performed under 
a Leica MZ12-FL dissecting microscope. Fixed embryos in glycerol were mounted in 
slide with a coverslip spacer and a coverslip on the top. Imaging was performed either 
on the Nikon Eclipse E800 microscope or the Zeiss Axio Imager.M2 microscope using 
the Apotome technology. Confocal microscopy was carried out using the Zeiss 







The analysis of the microarrays Affymetrix Cell Intensity Files (.cel files) was 
performed using the Bioconductor package for the R statistical programming 
language. An R script was produced to perform this analysis (Appendix 3).  
The “.cel” files were loaded into the workspace and then the data was pre-processed 
to eliminate the variation between arrays due to non-biological factors like sample 
processing. To get the differentially expressed genes the T-Test statistical test was 
used. The T-Test produced a list of genes ranked by t-statistics with the genes down-
regulated in mutant embryos in the top of the list. The p-value is a measure of the 
probability of the test statistic being equal or greater than the observed result 
assuming that the null hypothesis is true. If the p-value is smaller or equal to the 
significance level then the null hypothesis (no difference between wild type and 
mutant embryos) can be rejected. In the T-Test all the genes with a p-value lower or 
equal than 0.05 were selected. When analysing microarray data thousands of test 
are conducted (one for each gene) leading to an accumulation of false positives. To 
address this, methods to correct multiple testing can be applied. In this analysis the 
False Discovery Rate (FDR) was applied. This method defines the proportion of false 
positives among all the genes identified as differentially expressed. At a defined FDR 
significance level (0.05) a known proportion of genes will be false positives and 
therefore these are removed from the list of differentially expressed genes. Finally 
the genes list was annotated including gene names, GeneBank accession code, 
description and gene ontology. For some of the probes this information was not 
available and they conserved the Affymetrix probe code. 
CELL COUNTING 
The fluorescent in situ hybridisation Z-stacks images of the embryonic trunk region 
used for counting cells were acquired using the Zeiss Axio Imager.M2 microscope 
with the Apotome technology. To count the cells we used a cell counter plug-in in the 
ImageJ software that allows you to mark each cell you have counted with the mouse. 
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It also keeps those markers in the different planes of the Z-stack to avoid double 
counting of the same cell present in adjacent planes. Once you have gone through all 
the planes in a stack, the plug-in gives you the number of cells you have counted. 
IMAGE PROCESSING 
Microscope images were processed using the Zeiss’s microscopy software ZEN and 
Adobe Photoshop CS6 to cut the region of interest of our photographs and adjust the 






Expanding the GRN 
Introduction 
Greenhill et al. (2011) set up the core GRN underlying melanocyte specification and 
differentiation in vivo through a systems biology approach. This GRN includes some 
of the main genes involved in this process, but there are still many other known and 
unknown genes that need to be incorporated in the model to understand the basis 
for stable melanocyte differentiation. Several methods can be used to identify new 
players involved in the melanocyte GRN. The classic method is to perform in situ 
hybridisation using a mutant of a gene affecting melanocyte pigmentation. Then we 
evaluate the gene expression of other genes that may be related to melanocyte 
biology. A reduction or loss of expression in the in situ hybridisation indicates that 
the gene is regulated by the original mutant gene, and hence it would be involved in 
melanocyte development. The limitations with this method are that we need to have 
some prior knowledge of the candidate genes to test (and produce the ISH probes), 
and we do not know if the interaction is direct or not. 
Another method that can be used and is also based on melanocyte mutant fish is 
microarrays. This is a high throughput method, which means that we can test 
thousands of genes at a time, but unfortunately in microarray experiment a probe is 
needed for every gene in the genome, which implies that a prior knowledge of the 
organism’s genome is needed. The method is based on performing a microarray 
experiment comparing gene expression in melanocyte mutant fish and wild type fish. 
The genes that are up or down-regulated in the mutant would be predicted to be 
regulated by the original mutated gene. However, this method presents some 
limitations: we do not know if the regulation is direct or not, and also it may not be 
very sensitive if we use the whole organism as some genes may be highly expressed 
in tissues that we are not studying, masking the important results. 
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An evolution of this method is based on RNAseq. This new technology uses the 
capabilities of high throughput sequencing to identify all the RNA molecules present 
in a cell or tissue at a certain time, hence it determines all the genes expressed at 
that stage. This can be used to compare the transcriptome of a melanocyte mutant 
with a wild type fish, following the same logic as in the microarray experiment (Wang 
et al., 2009). It has the same advantages and issues of the microarray-based methods.  
Lastly, if we want to determine if a certain transcription factor directly regulates a 
target gene we can use chromatin immunoprecipitation (ChIP) integrated with 
sequencing (ChIP-seq) or microarray hybridisation (ChIP-chip). ChIP is based on the 
in vivo cross-linking of the chromatin at the moment in time we want to study, then 
the chromatin is extracted and fragmented, finally an antibody against the TF we are 
studying is used to immunoprecipitate the DNA fragments bound to the TF. The 
cross-linking is then reversed and this is followed by a sequencing step to identify the 
bound DNA fragments, or the hybridisation to a DNA array to find the gene bound to 
the TF (Carey et al., 2009). The approach chosen in this project was to use microarray 
analysis to identify candidate genes for the melanocyte GRN. 
Chipperfield (2009) used a microarray approach to identify candidate direct and 
indirect targets of Sox10 by comparing the expression profiles of sox10 expressing 
cells from both wild type and sox10 mutant embryos. Those genes whose expression 
is regulated by sox10 will appear downregulated in sox10 mutants. The transgenic 
lines Tg(-7.2sox10:EGFP) and Tg(-4.9sox10:EGFP), that express GFP under the control 
of a 7.2 kb and 4.9 kb region of the sox10 promoter respectively, were used for the 
microarray experiments. These fish display GFP expression in the neural crest derived 
cells although the Tg(-7.2sox10:EGFP) line shows a stronger GFP expression in the 
otic epithelium than the other line (Carney et al., 2006; Dutton et al., 2008). 
GFP expressing cells were purified by fluorescent activated cell sorting (FACS). Gene 
expression levels are compared between GFP positive cells from WT embryos 
carrying the transgenic lines and GFP positive cells from sox10 mutant embryos using 
the Affymetrix zebrafish GeneChip microarray, which can detect almost 15000 
different transcripts (Affymetrix, 2008). In this system, each independent sample is 
hybridised to an array and the comparisons are made between arrays (in this case 
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WT versus mutant arrays). Microarray data was generated using 24 hpf embryos as 
this is when neural crest cells are undergoing and expressing key genes for 
specification, differentiation and migration, as well as being the earliest stage at 
which mutant and WT embryos can be distinguished. The data from the Tg(-
7.2sox10:EGFP) line consisted of three WT and three mutant arrays, and the data 
from the Tg(-4.9sox10:EGFP) consisted of two WT and two mutant arrays. 
Chipperfield performed the microarray analysis using the freely available web tool 
GEPAS (Gene Expression Profile Analysis Suite, www.gepas.org). To normalise the 
data, the expresso module on the GEPAS website was used. The analysis of 
differentially expressed genes was carried out using the T-rex tool from GEPAS with 
the T-test option. This generated a list of genes ranked by t-statistic with 
downregulated genes presenting a negative value and upregulated genes positive 
values. No correction methods for multiple testing were applied in the analysis. 
From the top 100 most downregulated genes in sox10 mutant (Table 5), 89 were 
analysed through ISH for validation. 25 of them were validated as downregulated in 
sox10 mutants. Some of these genes that were expressed in the melanocyte lineage 
were already well known melanocyte markers such as mitfa or dct. 5 were novel 
genes that were previously unknown to have a role in melanocyte biology and to be 
regulated by sox10: atp6v1ab, atp6v1e1b, degs1, pah and tspan36 (Figure 40 
Appendix 2). 
The process to generate sox10 mutants expressing GFP under the control of the 
sox10 promoter is fully explained in Chipperfield (2009) thesis, as well as all the 
details of the FACS, microarray and in situ hybridisation experiment. 
Table 5. List of the 100 most downregulated genes in sox10 mutant embryos, ranked by t-
statistic from Chipperfield's thesis. The most up to date gene names are provided in brackets. 
The list shows the 100 most down-regulated genes identified by Chipperfield from the 
7.2sox10:GFP microarray data analysis using the GEPAS online tool. The genes are ranked by 
t-statistic that was obtained from the T-test analysis.
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Gene Symbol t-statistic 
Dr.16789.1.A1_at -25.393 
wu:fc31e04 -18.127 
Dr.13919.1.S1_at (fzd7b) -17.892 
LOC565706 (pde4ba) -16.778 




wu:fj94a03 (rbm47) -14.789 
bhlhb3l -14.48 
ndrg1 -12.15 




wu:fc46b01, zgc:100933 -11.345 
nfkb2 -10.857 
zgc:158673 (si:dkey-23o10.3) -10.73 
tmem169 -10.723 
Dr.22614.1.A1_at (myo5b) -10.704 
pax7 -10.592 
wu:fj38e08 -10.548 




bhlhb2 (bhlhe40) -9.713 
wu:fc17h11 -9.55 
ell -9.492 
mg:cb01g09 (mfn2) -9.401 
coro1c -9.323 
wu:fi46h04 -8.871 
wu:fc54b10 (mon1bb) -8.801 
zgc:110718 (ankrd49) -8.793 
dohh -8.766 
si:dkeyp-86b9.2 (vamp5) -8.714 
LOC568088 (rbm25a) -8.689 
cx33.8 (cx30.3) -8.688 
zgc:112072 (slc24a4a) -8.672 
atic -8.667 






Dr.3972.1.S1_at (si:dkey-226k3.4) -8.302 
zgc:110343 (prdx1) -8.217 
keap1 -8.161 
mitfa -8.03 
zgc:152987 (si:ch211-137a8.2) -7.965 
wu:fb95f11 -7.965 
wu:fc08b04 (dync1li2) -7.946 







aldh2 (aldh2.1/aldh2.2) -7.748 
crestin -7.728 
Dr.18158.1.A1_at -7.71 

















zgc:112247 (sptlc1) -6.854 















si:ch211-218c6.1 (zc3h18) -6.296 








We sought to use the microarray data obtained by Chipperfield (2009) to examine it 
using the most up to date microarray analysis algorithms and the most recent gene 
expression information available in the ZFIN database to discover new candidate 
genes with an important function in melanocyte development that will be 
incorporated to the melanocyte gene regulatory network. 
Results 
Microarray analysis using R 
Chipperfield performed this analysis several years ago and the algorithms and tools 
to analyse microarrays have advanced in this time. Also, coming from a 
bioinformatics background I have some experience in microarray analysis, so I 
decided to get his raw data and repeat his analysis to verify whether I would obtain 
similar results with the up to date algorithms. 
The analysis of the Affymetrix Cell Intensity Files (.cel files) that Chipperfield (2009) 
produced was performed using the Bioconductor package for the R statistical 
programming language. The objective was to analyse microarray data using a more 
versatile and better established approach in the bioinformatics community than the 
one he used before, which was based on a website that is no longer maintained and 
available, asking whether I obtained a similar list of differentially expressed genes.  
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An R script (Appendix 3) was produced where the “.cel” files were loaded and then 
the data was pre-processed to eliminate the variation between arrays due to non-
biological factors such as sample processing. To get the differentially expressed genes 
the T-Test statistical test was used. The T-Test produced a list of genes ranked by t-
statistics with the most downregulated genes at the top of the list (with most 
negative values). The T-Test produced an associated p-value for each gene, which 
measures the probability of the test statistic being equal or greater than the observed 
result assuming that the null hypothesis is true. If the p-value is smaller or equal to 
the significance level then the null hypothesis (no difference between wild type and 
mutant embryos) can be rejected (Chipperfield, 2009). In the T-Test all the genes with 
a p-value lower or equal than 0.05 were selected. Finally the gene list was annotated 
with the most up to date gene names and a table was produced (Table 6). This 
analysis was carried out using the same settings that Chipperfield used in 2009 so the 
list could be compared.  
Table 6. List of 100 top downregulated genes from my analysis using the Bioconductor 
package for R and the same settings that Chipperfield used in 2009. The list shows the 100 
most down-regulated genes from the 7.2sox10:GFP microarray data analysis ranked by t-
statistics. The T-Test produces an associated p-value for each gene, which measures how 
significantly downregulated each gene is. These genes have been selected for having a p-
value lower or equal than 0.05, making them significantly downregulated. 




































































Reassuringly, the list obtained by this analysis was the same as the one obtained by 
Chipperfield in 2009. Some of the gene names in the Chipperfield list were out of 










































gene names found in the ZFIN database, which allowed us to establish that both lists 
contain the same genes, with the same p-values.  
Sox10 dependent genes are also Mitfa dependent 
Chipperfield performed an ISH screen to validate the genes identified as 
downregulated in sox10 mutant embryos in the microarray analysis. He synthesised 
probes and performed ISH for 89 genes using wild type and sox10 mutant embryos 
at 30 hpf. From these genes many were false positives, and some others were 
validated as expressed in the xanthophore and otic vesicle. This study validated 5 
novel genes as downregulated in 30 hpf sox10 mutant embryos in the melanocyte 
lineage. However, this study left open the question of whether these genes might be 
regulated by some other TF downstream of sox10. In order to find out if these genes 
were directly or indirectly regulated by mitfa, ISH was done using 30hpf mitfa mutant 
embryos. The same probes synthesised by Chipperfield were used in this 
experiments. Figure 7 shows that all the 5 genes are expressed in melanocytes in wild 
type embryos, and are downregulated in mitfa mutant embryos. This indicates that 




Figure 7. ISH expression pattern of the 5 verified melanocyte genes in 30 hpf wild type and 
mitfa mutant embryos. All images are lateral views of the mid trunk. All 5 genes (atp6v1ab, 
atp6v1e1b, degs1, pah and tspan36) are expressed in melanocytes of wild type embryos but 
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are not expressed in mitfa mutant embryos. Image orientation: embryo head is on the left 
and tail on the right of the images. Scale bar: 100 µm 
Analysis of the combined microarray dataset using 
improved script 
Chipperfield performed the same process of FACS sorting and microarray 
hybridisation with the transgenic line Tg(-4.9sox10:EGFP) a few months after he did 
the 7.2sox10:GFP line. These two lines display similar GFP expression, but the 4.9 line 
displays a weaker otic epithelium expression. However for our study this is not very 
important as we want to identify genes involved in pigment cell development. The 
data from the 4.9 line consisted of two WT versus two mutant arrays. Due to time 
constraints Chipperfield only used the data from the 7.2sox10:EGFP microarray 
analysis to perform the ISH screen to validate the sox10 targets, as he gathered the 
7.2sox10:GFP data before the 4.9sox10:EGFP. The aim of this section was to use the 
combined dataset to perform a more robust statistical analysis of the differentially 
expressed genes. 
All the 10 microarrays, 6 from the 7.2 line and 4 from the 4.9 line were used in the 
analysis. For the pre-processing we used the threestep function with the default 
settings: RMA background correction, quantile normalisation, no perfect match 
evaluation and median polish summarisation (Gautier et al., 2004). Then we 
performed a filtering step to remove the genes that are absent in all samples. In order 
to identify the differentially expressed genes between mutant and wild type embryos 
the eBayes statistical test is applied (Ritchie et al., 2015). This test produces more 
reliable results than T-test with small samples. The test calculates an associated p-
value that measures the significance of a given gene to be downregulated. The p-
values were corrected using the Benjamini and Hochbergh method to control the 
false positive rate (Pollard et al., 2004). These adjusted p-values were used to rank 
the genes, where the lower the p-value the higher the significance of that gene to be 
downregulated in mutant versus wild type embryos. A significance level of 0.05 was 
used, and all the genes with an adjusted p-value higher than that were excluded. 
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Finally, the genes were annotated with their gene symbol and they were saved into 
a table (Table 7). The resulting gene list contained 113 genes. 
Table 7. List of the 113 downregulated genes obtained from the combined dataset analysis 
with a p-value lower than 0.05 after applying the FDR adjustment. The genes highlighted in 
green were also present in the list obtained in the analysis where we used just the 7.2 arrays 
dataset and the t-test statistical analysis (Table 6). 























































































































45 out of the 113 genes (highlighted in green) were also present in the top 100 
downregulated genes obtained using the 7.2 microarrays and the t-test analysis 
(Table 6). This analysis has found four of the genes that were validated by ISH as 
downregulated in sox10 mutants in the melanocyte lineage using the previous 
analysis: atp6v1ab, atp6v1e1b, pah and tspan36 (Figure 7). Degs1 was not found in 
this analysis despite having been validated as driven by sox10.  
ZFIN expression pattern of novel candidate genes 
The analysis of the combined microarray dataset has provided 68 new candidate 
genes that might be downregulated in sox10 mutants. These genes should be 
validated using an ISH screen approach similar to the one used by Chipperfield in 
2009, unfortunately due to time constraints it was not possible to perform the ISH 
with all these genes. The approach that we selected was to use the online database 
ZFIN (Howe et al., 2013) to find out the published expression pattern images and the 
annotated expression structures of these genes to check if they are expressed in the 
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neural crest or pigment cells. This was done by manually searching for every gene on 
the database, then identifying the expression structures that have been annotated, 
and examining the expression pattern images where available. All these data has 
been collated in Table 8, with a description of the expression pattern image. 
 
Table 8. Expression patterns of the 68 new candidate genes with their ZFIN expression 
structures tags and a description of the expression pattern images when available. Most of 
the genes are expressed in many tissues in the fish and therefore have been annotated with 
many expression structure tags. Here we include the genes annotated with the neural crest 
or pigment cell tags and use the word “others” if they are expressed in other structures. A 
subjective description of the expression pattern image is also included when available. The 
genes highlighted in yellow are the ones annotated with the pigment cell tag. The genes 
highlighted in blue are the ones annotated with the neural crest tag or those whose 





npr3 others No neural crest or pigment cells expression 
hoxc8a others 
It’s widely expressed. Difficult to reject 
neural crest or pigment cells expression. 
ca2 others No neural crest or pigment cells expression 
pvalb7 others No neural crest or pigment cells expression 
ginm1 others 
Images aren’t detailed enough. Difficult to 
tell. 
Dr.4838.1.A1_at No information  
si:dkey-73n10.1 No information  
nradd No information  
Dr.10941.1.A1_at No information  
vac14 others 
Images aren’t detailed enough. Difficult to 
tell. 
uap1 others 
Images show diffused expression along the 
trunk. Difficult to tell. 
atp6v1g1 others 
Images show expression along the trunk. 
Difficult to tell. 
fbp1a others No neural crest or pigment cells expression 
rab32a 
neural crest, pigment 
cell, trunk neural 
crest cell and others 
Very likely pigment cells expression. Worth 
exploring further. 
bace2 
neural crest, pigment 
cell and others 
Very likely pigment cells expression. Worth 
exploring further. 
sulf2a others No neural crest or pigment cells expression 
ap5m1 No information  
jag2 others No neural crest or pigment cells expression 
dmtn others No neural crest or pigment cells expression 
wu:fj65h10 No information  
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vegfc others No neural crest or pigment cells expression 
syngr1a 
neural crest, pigment 
cell and others 
Very likely pigment cells expression. Worth 
exploring further. 
wu:fc26d05 others  
ednrba 
head neural crest, 
iridophore, pigment 
cell, trunk pigment 
cell 
Known to be expressed in pigment cells. 
zic2b 
cranial neural crest 
and others 
No neural crest or pigment cells expression 
Dr.20434.1.A1_at No information  
dlb others No neural crest or pigment cells expression 
si:ch211-195b13.1 No information  
fkbp1ab others No neural crest or pigment cells expression 
ankrd27 No information  
Dr.752.1.A1_at No information  
pcdh10a 
neural crest and 
others 
Expressed in migrating neural crest. 
Further study needed. 
cdon 
neural crest and 
others 
No neural crest or pigment cells expression 
dcn others No neural crest or pigment cells expression 
ppp1r13ba others No neural crest or pigment cells expression 
lrrtm4l1 others No neural crest or pigment cells expression 
slc37a2 No information  
pla2g15 No information  
gart 
neural crest, pigment 
cell and others 
Very likely pigment cells expression. Worth 
exploring further. 
zgc:154045 No information  
slc3a2a others 
Shows a spotty pattern, so it may be 
expressed in pigment cells. Further study 
needed. 
pank1a others No neural crest or pigment cells expression 
rnaseka No information  
wu:fj94h02 No information  
sigmar1 others No neural crest or pigment cells expression 
mov10b.1 No information  
atp6ap1b 
pigment cell and 
others 
Very likely pigment cells expression. Worth 
exploring further. 
Dr.14210.1.A1_at No information  
acss1 others No neural crest or pigment cells expression 
epha6 No information  
atp6v1f others No neural crest or pigment cells expression 
vps26a others No neural crest or pigment cells expression 
ppat 
neural crest and 
others 
Image is not very clear but it may be 





neural crest, pigment 
cell and others 
Very likely pigment cells expression. Worth 
exploring further. 
sb:cb8 others No neural crest or pigment cells expression 
rab7 
neural crest and 
others 
Pattern suggest that it may be expressed in 
pigment cells. Further study needed. 
hoxc8a.1 others No neural crest or pigment cells expression 
cyb5a 
neural crest and 
others 
Shows a spotty pattern, so it may be 
expressed in pigment cells. Further study 
needed. 
tspan18a No information  
wu:fj35f12 No information  
rcan2 No information  
fa2h others No neural crest or pigment cells expression 
tnfrsf9a No information  
hapln1b others No neural crest or pigment cells expression 
jagn1b No information  
cd63 others No neural crest or pigment cells expression 
slco3a1 others No neural crest or pigment cells expression 
sypl2b 
neural crest and 
others 
Image is very faint but it suggest that it 
may be expressed in pigment cells. Further 
study needed. 
  
From the ZFIN database search (Table 8) there are 7 genes (highlighted in yellow in 
the table) whose expression pattern is very similar to the one of other pigment cell 
markers and they are annotated as expressed in pigment cells: rab32a, bace2, 
syngr1a, ednrba, gart, atp6ap1b and pttg1ipb. The pigment pattern available in ZFIN 
is from Thisse et al. 2001, 2004 and 2005, and the images of the ISH carried out using 
wild type fish in stages between Prim 15 (30 hpf) and Prim 25 (36 hpf) are shown in 




Figure 8. ISH expression pattern of rab32a (A), bace2 (B) and syngr1a (C) genes from wild 
type embryos. The images are from the ZFIN database and were submitted by Thisse et al. 
2001, 2004 and 2005. The ISH are from stages in between Prim 15 (30 hpf) and Prim 25 (36 




Figure 9. ISH expression pattern of gart (A), atp6ap1b (B) and pttg1ipb (C) genes from wild 
type embryos. The images are from the ZFIN database and were submitted by Thisse et al. 
2001, 2004 and 2005. The ISH are from stages in between Prim 15 (30 hpf) and Prim 25 (36 
hpf). Image orientation: embryo head is on the left and tail on the right of the images. 
 
The quality of the ISH images submitted to ZFIN for these genes is not perfect, but it 
is good enough to observe that most of these genes are expressed in the dorsal and 
ventral stripe of the trunk, as well as in cells migrating on the medial pathway, 
locations that correspond with the places where we expect to find pigment cells. 
Ednrba (also highlighted in yellow in Table 8) had already been reported as expressed 
in the pigment cell lineage by Parichy et al. (2000). 
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There are some genes (highlighted in blue) in the Table 8 list whose expression 
pattern is not very clear in the images, but which were suggestive of expression in 
neural crest or pigment cells: pcdh10a, slc3a2a, ppat, rab7, cyb5a and sypl2b. Their 
expression patterns from wild type fish in stages from Prim 15 (30 hpf) to Prim 25 (36 
hpf) obtained from the ZFIN database (Thisse et al. 2001, 2004 and 2005) are shown 
in Figure 10 for reference. As the expression pattern is not as clear as in the previous 
7 genes, they will need to be studied more in depth to determine if they are involved 
in melanocyte development. 
 
 
Figure 10. ISH expression pattern of pcdh10a (A), slc3a2a (B), ppat (C), rab7 (D), cyb5a (E) 
and sypl2b (F) genes from wild type embryos. The images are from the ZFIN database and 
were submitted by Thisse et al. 2001, 2004 and 2005. The ISH from stages in between Prim 
15 (30 hpf) and Prim 25 (36 hpf). Image orientation: embryo head is on the left and tail on 




Location of Sox10 or Mitfa binding sites in candidate 
genes 
All of the previous 13 genes were found to be downregulated in sox10 mutant 
embryos in the microarray analysis, therefore they are regulated (directly or not) by 
Sox10 transcription factor. Some of these genes may be part of the melanocyte GRN, 
but they might also have a role in other pigment cells biology (iridophore or 
xanthophore) or other sox10 expressing cells (glia, oligodendrocytes or sensory 
neurons). An analysis of their function from the published literature may help us 
understand if these genes have a function in melanocyte biology or in other cell 
types. If they have a melanocyte function, it will be helpful to know it they are directly 
regulated by mitfa (the melanocyte master regulator), as this would indicate that 
they are part of the melanocyte GRN and will help us to find its location within the 
network. That is why we decided to carry out an in silico search of Mitfa binding sites 
in these gene’s promoters. 
The first 7 genes were annotated as being expressed in pigment cells and their ZFIN 
expression patterns also suggests that. Therefore these were strong candidates to 
investigate if they were part of the melanocyte GRN. In order to determine their 
position in the network we need to know which gene regulates them. As they have 
been obtained from a microarray analysis comparing sox10 mutants with WT 
embryos, we are going to test if they are directly or indirectly regulated by sox10 or 
mitfa (as a transcription factor gene that is a direct downstream target of sox10 and 
a master regulator of melanocyte development). For the other 6 genes the 
expression pattern is a bit unclear, but they may also be part of the network so it may 
be interesting to know if they are regulated by Sox10 or Mitfa. 
In order to find out if these 13 genes are regulated by Sox10 or Mitfa, a program was 
designed to find their binding site in their promoter. A region of 3000 bps of the 
promoter and 5’UTR (Kristiansson et al., 2009) was downloaded from the Ensembl 
genome repository (Danio rerio GRCz10 version) using the Biomart tool in Ensemble. 
Then a Perl program was designed to look for the binding site motifs of the Sox10 or 
Mitfa transcription factors in these gene’s promoters (Appendix 4). 
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The study carried out by Elworthy et al. (2003) demonstrated that Sox10 directly 
regulates the expression of mitfa. Mitfa promoter has two Sox10 binding sites in 
melanocytes in the zebrafish embryo. The site S1 (CTCAAAG) is necessary for mitfa 
expression; the site S3 (GATTGTA) also drives mitfa expression but to a lesser extent. 
Regarding Mitfa binding sites, no sequence has been identified yet in zebrafish, 
however Pogenberg et al. (2012) stablished that in mouse MITF has the ability to bind 
to the palindromic CACGTG E-box motif. Moreover, unlike other bHLHZip 
transcription factors, MITF also binds to the asymmetric TCATGTG M-box sequence. 
The mitfa and dct promoters were used as a positive control, as they are known to 
be directly regulated by Sox10 and Mitfa respectively (Elworthy et al., 2003; Ludwig 
et al., 2004). Two genes were used as negative control: cherp and mif. These genes 
were randomly selected from the list of differentially expressed genes between 
mutant and wild type embryos as ones whose gene expression was not significantly 
different i.e. their p-value is close to 1. The expression of these genes is not supposed 
to be controlled by Sox10, and hence the Perl program should not find Sox10 or Mitfa 
binding sites on their promoters. This analysis tests if the program finds random 
Sox10 or Mitfa binding sites in promoters of genes that are not related to pigment 
cell biology. 
The Perl program takes the promoters of the 17 genes as input and looks for the 





Figure 11. Representation of the promoter of the 8 genes where a sox10 or mitfa binding site 
was found, as well as the two positive (mitfa and dct) and negative (cherp and mif) controls. 
The two sox10 binding sites are labelled as S1 and S3. The two mitfa binding sites are labelled 
as M-box and E-box. The stripes represent a region of 3000 bp of the promoter upstream of 
the start codon, which is located on the right hand side of the stripes. The stripes and location 
of the binding sites within are drawn to scale. 
 
Both the mitfa and dct promoters that were used as positive control contained Sox10 
and Mitfa binding sites. The mitfa promoter contained two Sox10 binding sites as 
demonstrated by Elworthy et al. (2003), and the dct promoter contained a Mitfa 
binding site as established by Ludwig et al. (2004). Both negative control genes, that 
were not meant to be regulated by Sox10 or Mitfa, did not contain any Sox10 or Mitfa 
binding sites. This proves that the Perl scrip can successfully find transcription factor 
binding sides in the promotor of genes that are supposed to be regulated by Sox10 
or Mitfa. 
From the 13 genes only 8 contained one of the 2 binding motifs for Sox10 or Mitfa in 
their promoter. Three genes contained at least one of the two Sox10 binding sites. 
Ppat is the only one with the S1 site, and rab32a and atp6ap1b contain the S3 site, 
which according to Elworthy et al. (2003) is a weaker motif. 
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Seven genes contain one of the two Mitfa motifs. bace2 has the M-box motif, but it 
is quite far from the translation initiation codon. gart and sypl2b also contain just one 
Mitfa motif (E-box), closer to the initiation codon. syngr1a, atp6ap1b, slc3a2a and 
ppat contain at least 2 Mitfa binding sites.  
atp6ap1b and ppat are the only two genes containing binding sites for both Sox10 
and Mitfa. 
Discussion 
Microarray analysis using R 
Chipperfield used the freely available online tool GEPAS to analyse the microarray 
data he produced. This tool is based on the Bioconductor package in R, but provides 
a very user friendly interface, where the user can select options with buttons and 
drop down lists, instead of having to deal with writing an R script and using the 
command line in the computer. Therefore, it is a very powerful tool for biologists 
without a bioinformatics background. The tool works by uploading the files with your 
microarray results to the webpage, selecting the analysis you want to perform 
following the workflow, and finally you obtain the results. Unfortunately, this online 
tool is no longer maintained by the authors, and it is not available any more. This is 
why when we decided to use Chipperfield’s data to try to reproduce his analysis we 
had to look for another option. 
Coming from a bioinformatics background I have experience in analysing microarrays 
with the Bioconductor package for the R programming language. And, as the GEPAS 
tool used by Chipperfield was based in that same software, we decided to run the 
same analysis using the same settings, but designing our own R script. 
The analysis was carried out using the 6 microarrays generated from the 7.2 
transgenic line. In order to detect the differentially expressed genes between sox10 
mutant and wild type embryos the t-test statistical test was used. This test generates 
a list of genes ranked by t-statistic with genes downregulated in mutant embryos 
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having negative t-statistics values and genes upregulated in mutant embryos having 
positive t-statistic values. The higher the value, the more up or downregulated the 
gene is compared to the gene expression in wild type embryos. A p-value is produced 
for every t-statistic to measure the significance level of the test. The p-value 
measures the probability of the test statistic being equal or greater than the observed 
result under the assumption that the null hypothesis (no difference between wild 
type and mutant embryos) is true. The t-test may, however, have low power when 
the sample size is small, as the error variance (used to do the t-tests) is hard to 
estimate and subject to fluctuations when sample sizes are small (Cui and Churchill, 
2003).  
Two types of errors can be committed when a hypothesis test is done. The false 
positive error happens when a gene is declared to be differentially expressed when 
it is not in reality. The false negative error occurs when a true differentially expressed 
gene is not detected by our analysis (Cui and Churchill, 2003). Usually a statistical test 
to control for the false positive errors is carried out in the analysis. In microarray 
experiments, we perform thousands of statistical tests, one for each gene, so a large 
number of false positives will accumulate. Therefore, a correction for multiple testing 
should always be done. When Chipperfield applied the correction methods for 
multiple testing in his analysis no significant differentially regulated genes (with a p-
value≤0.05) were detected, this includes some genes that are well known to be 
downregulated in sox10 mutant embryos by in situ hybridisation such as mitfa or dct. 
This may be because the sample size is not large enough (they were comparing three 
WT versus three mutant arrays), as the performance of the t-test improves when 
increasing the sample size (Cui and Churchill, 2003). Therefore, the multiple testing 
correction was ignored in the analysis. 
Chipperfield used an ISH screen to validate the top 100 downregulated genes he 
obtained from the t-test (Table 5). From those 100 candidates, he investigated 89 
genes, as some were duplicated array probes for the same gene, and some ISH 
probes couldn’t be synthetised. From the 89 genes that were assessed, 25 were 
validated as downregulated in pigment cells or otic vesicle in sox10 mutants. This 
means that 72% of the genes identified as downregulated in the microarray analysis 
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were false positives (64/89). This high false positive rate is likely to be caused by the 
small sample size of microarrays analysed, because ISH experiment is not sensitive 
enough for validation purposes, as some of these genes might have been 
downregulated in sox10 mutant embryos but ISH is not sensitive enough to detect it, 
and by not performing a false discovery correction in the analysis.  
In any case, Chipperfield identified 5 novel genes as downregulated in sox10 mutants 
expressed in the melanocyte lineage that did not have a published expression pattern 
before. These genes are regulated by sox10 and are likely to play an important role 
in melanocyte biology: atp6v1ab, atp6v1e1b, degs1, pah and tspan36 (Figure 40 
Appendix 2). The rest of the 20 genes were validated as expressed in the xanthophore 
lineage and the otic vesicle. 
The list of the top 100 downregulated genes obtained through my analysis using the 
R script was the same as the one that Chipperfield obtained using the GEPAS online 
tool (Table 6). Initially both lists looked different but this was because some of the 
gene names in the Chipperfield’s list were out of date. The zebrafish genome 
assembly has been updated several times since 2009, and many more genes are now 
annotated. Therefore, we had to search the new gene name for some of the genes 
in the Chipperfield’s list in the ZFIN database. Once all the genes were annotated with 
their current name we quickly identified that both lists have the same genes. This is 
not surprising because we were essentially using the same Bioconductor functions 
that the online tool used. However, it was reassuring to know that we were capable 
of reproducing the initial analysis with the most up-to-date algorithms. This means 
we could confidently carry on using R for the rest of the analysis. 
Sox10 dependent genes are also Mitfa dependent 
Chipperfield identified and validated 5 novel melanocyte genes as downregulated in 
sox10 mutants: atp6v1ab, atp6v1e1b, degs1, pah and tspan36. The expression of 
these genes is regulated by Sox10, and therefore they are downstream of Sox10 in 
the melanocyte GRN. However, while sox10 is mainly expressed in premigratory and 
migrating NC at early stages of development and is downregulated as melanocytes 
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differentiate (Kelsh, 2006b), mitfa is a marker of melanocyte cell fate: it drives the 
expression of melanogenic enzyme genes and it is also required for melanocyte 
survival and differentiation (Elworthy et al., 2003). Therefore, we wanted to know if 
these genes are regulated by Mitfa, which itself is directly activated by Sox10 
(Elworthy et al., 2003). For that an ISH was done for each of these 5 genes in mitfa 
mutant embryos, and compared the expression pattern to the one in wild type 
embryos. The expression of all the genes was reduced or absent in mitfa mutant 
embryos, which means that they may have a role in melanocyte differentiation. 
Although we would need a mutant for each gene to test their role in differentiation, 
we may understand a bit more about their role in melanocyte biology by investigating 
their published function. 
Both atp6v1ab and atp6v1e1b encode V1 subunits of the V-ATPase ion transporter. 
V-ATPase is the main H+ pump in animal cells, it is a multi-subunit complex where 
the V1 subunit catalyses the ATP hydrolysis. This protein transports H+ ions to 
generate a chemical gradient that contributes to vital functions in several cell 
processes such as the acidification of endosomes and lysosomes (Monteiro et al., 
2014). This protein is expressed in melanosomes, the organelles where melanin is 
synthesised, stored and transported. It was initially thought that an acidic 
environment in melanosomes facilitates melanogenesis. However, later observations 
suggested that some of the melanogenic enzymes are inhibited in an acid 
environment. It is now thought that acidification is important in the development 
and maturation of melanosomes. These organelles accumulate fiber-like structures 
in their lumen called striations where melanin is deposited. The formation of these 
striations requires an acidic environment in immature melanosomes. Later on, 
mature melanosomes lose their V-ATPase activity, favouring melanin synthesis 
(Tabata et al., 2008).  
degs1 is a dihydroceramide desaturase, the last enzyme in the de novo biosynthesis 
pathway of ceramides. This protein is required for the initiation of the meiosis in 
spermatogenesis. It was proposed that DEGS1 is a component of the contractile ring 
in the anaphase and telophase stages of meiosis in the spermatocyte, where its 
protein dysfunction leads to male sterility: DEGS1 mutants are unable to condensate 
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the chromosome in their nuclei. DEGS1 is also involved in apoptosis, autophagy, cell 
cycle regulation and lipid homeostasis (Rodriguez-Cuenca et al., 2015). Its role in 
melanocyte development is still unclear. 
pah codes for the phenylalanine hydroxylase enzyme. Tyrosinase uses tyrosine as 
one of its substrates to synthesise melanin, and the concentration of tyrosine 
depends on the conversion of the essential amino acid phenylalanine by the Pah 
enzyme (Schallreuter et al., 2008). Thus, pah is a key gene in melanocyte biology. 
tspan36 is a member of the tetraspanin superfamily of proteins that regulate 
adhesion, migration, proliferation and cell–cell fusion. Tspan36 mutation is the cause 
of the dali mutant phenotype, which shows broadened adult stripes of xanthophores 
and melanophores, similar to the jaguar phenotype. Tspan36 contributes to 
melanophore motility and also mediates interactions between melanophores and 
xanthophores in zebrafish (Inoue et al., 2014).  
All these genes, but degs1 whose function is still unclear, have a clear role in 
melanocyte biology. They were all downregulated in sox10 and mitfa mutant 
embryos, which means that their expression is mitfa dependent. Thus, these genes 
were placed downstream of the Mitfa transcription factor in the melanocyte GRN 





Figure 12. GRN underlying melanocyte development. This expanded network includes the 
core GRN published by Greenhill et al. (2011) and the five novel genes identified in the 
microarray experiment as regulated by mitfa: atp6v1ab, atp6v1e1b, degs1, pah and tspan36. 
 
Analysis of the combined microarray dataset using 
improved script 
In microarray analysis, as in all statistical testing, the higher the sample size the more 
powerful the statistical analysis is. Therefore, a higher number of microarrays will 
make the analysis more powerful, provide better results and reduce the number of 
false positives. Besides the 6 arrays that Chipperfield hybridised from the 7.2 line, he 
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also processed 4 more from the 4.9 line, although he did not used the later ones for 
the ISH screen due to time constraints. Hence, our aim was analyse the combined 
microarray dataset (10 arrays) to increase the power of the analysis and obtain better 
results.  
For this analysis a modified and improved R script was used. After pre-processing the 
10 microarrays together to eliminate the variability between arrays due to non-
biological factors, a filtering step was carried out. This filter eliminated from the 
analysis the array probes that are absent in all the 10 arrays. A probe absent in all the 
arrays, both from wild type and mutant embryos, may indicate that the gene is not 
expressed in the FACS sorted cells, or that there was some issue with the array 
hybridisation. However, this will not be confused with a gene that is genuinely 
downregulated, as it will be absent in both wild type and mutant embryos.  
In order to detect the differentially expressed genes, the t-test was used in the 
original analysis. The main issue with the t-test is that the sample variance, which is 
estimated using the expression values of the gene replicates, is used to calculate the 
t-value. With few replicates, this estimate may fluctuate considerably, making the t-
value variable and unreliable. Instead of the t-test we can use linear models to assess 
the differentially expressed genes (Cui and Churchill, 2003).  
This approach requires two matrices to be specified. The first is the design matrix 
which indicates which phenotypes (wild type or mutant) have been applied to each 
array. The second is the contrast matrix which specifies which comparisons we would 
like to make between the microarray samples (wild type versus mutant). For 
assessing differential expression, the empirical Bayes (eBayes) method is used 
(Ritchie et al., 2015). eBayes finds a compromise between the variance estimated for 
the gene under consideration and the average variance from all the genes, giving a 
more reliable result with a smaller sample size and reducing the number of false 
positives (Ritchie et al., 2015).  
As said, in a microarray experiment we conduct thousands of statistical tests, one for 
each gene, and a substantial number of false positives may accumulate. To address 
this problem, there are some multiple testing correction methods that we can apply 
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to our analysis. The method we applied in this analysis is called False Discovery Rate 
(FDR), which is the proportion of false positives among all of the genes initially 
identified as being differentially expressed. The FDR is typically computed after a list 
of differentially expressed genes has been generated. It uses information available in 
the data to estimate the proportion of false positive results that have occurred. In a 
list of differentially expressed genes a proportion of these will represent false 
positive results at a defined FDR criterion. This method can achieve more power in 
reducing the false positives than other multiple testing correction methods (Cui and 
Churchill, 2003). As we applied an FDR correction, this analysis should contain a lower 
number of false positives, and therefore more true positives, than the initial one, 
where no multiple correction method was applied. 
After filtering, applying the FDR correction and selecting the significantly 
downregulated genes with a p-value≤0.05 we obtain a list with 113 genes (Table 2). 
This list contains 45 genes from the initial list of the top 100 downregulated list 
obtained the initial analysis (using the 7.2 dataset and the t-test statistical method). 
The new list contains four out of the five genes that were validated as downregulated 
in sox10 and mitfa mutants by ISH: atp6v1ab, atp6v1e1b, pah and tspan36. The only 
gene that was validated but was not found on the list is degs1. Degs1 is an enzyme 
involved in fatty acid metabolism, whose role in melanocyte biology is still unclear. 
So it may be that it is not involved in melanocyte development despite being 
downregulated in sox10 mutant embryos and detected in our analysis of the 7.2 
transgenic line arrays. Hence, this might be a case of false negative gene that was 
found in the analysis of the 7.2 dataset but was rejected in the new analysis 
incorporating the combined dataset; or it might really have a function in neural crest 
derived cells that is still unknown and will required further investigation. An ISH 
screen should be done to validate these genes. 
The rest of the genes (68) have not been tested through ISH for validation yet. Thus, 
we cannot be sure if this analysis using the combined dataset and linear models to 
assess the differentially expressed genes is more powerful and produces less false 
positives than the initial analysis. However it seems that from the 48 genes that were 
also present in the 7.2 dataset analysis and were tested through ISH only four were 
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validated. This seems to indicate that the rate of false positives might be very similar 
to the initial analysis. An ISH screen would be needed to validate these genes. 
Nevertheless, it may be that ISH is not sensitive enough to perform this validation, so 
we would suggest to use quantitative PCR to validate these genes by checking if their 
expression is absent or downregulated in sox10:EGFP cells sorted by FACS from sox10 
mutant and wild type embryos. 
ZFIN expression pattern of novel candidate genes 
In our new analysis, 68 out of 113 genes were not investigated in the ISH screen 
carried out by Chipperfield in 2009. Therefore, these genes should be validated 
though a similar ISH screen. However, this was not possible due to time constraints. 
Consequently, the approach we followed was to use the ZFIN database to look for 
the annotated expression structures and ISH images available for each gene. Some 
genes are very well annotated because they have been thoroughly studied: the 
anatomical structures where they are expressed as well as images of their ISH 
expression pattern are available in ZFIN. Other genes have just the annotated 
anatomical structures or the ISH image. And some genes do not have any information 
because they have not been studied at all. 
Most of the genes in our list are expressed in several anatomical structures in the 
embryo. We were especially interested in the genes expressed in structures with 
“neural crest” or “pigment cells” tags, and we labelled as “others” in Table 8 where 
expression was noted in any other structures. We also analysed the ISH images 
available and provided a description of their expression pattern. Unfortunately, some 
of the ISH images available in ZFIN had a low resolution, but they helped us to get a 
better understanding of the pattern described in the anatomical structure tags. There 
were 7 genes annotated as expressed in pigment cells, and their expression pattern 
in the ISH images looks similar to that of a pigment cell expressed gene: rab32a, 
bace2, syngr1a, ednrba, gart, atp6ap1b and pttg1ipb. 
Rab32a is a protein that regulates endosomal trafficking. This protein is required for 
the formation and maintenance of notochord vacuole together with the acidification 
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role performed by the H+ATPase family of proteins (Ellis et al., 2013). It has a role in 
controlling the transport of vesicles that contain the melanogenic enzymes to the 
melanosomes, the organelles where melanin is synthetised and stored (Raposo and 
Marks, 2007). 
Bace2 is a type I transmembrane aspartyl proteases. In humans BACE1 is involved in 
the APP cleavage, which is consecutively cleaved by γ -secretase to generate Aβ, 
which is the main component of amyloid plaques that cause Alzheimer's Disease 
(according to the Aβ hypothesis). Until now, very little information has been available 
regarding the function of its homologue BACE2 in human. However, as therapeutic 
inhibition of BACE1 might also inhibit BACE2, knowledge of the physiological 
requirement of both protease is crucial. In bace2 mutant embryos the migration of 
melanocytes is disrupted (van Bebber et al., 2013). The authors suggest that the 
abnormal migration pattern of melanocytes resembles the parade zebraﬁsh pigment 
mutant, although in bace2 mutants iridophore migration is not affected. The 
underlying molecular mechanism of the pigment phenotype is still unclear and 
requires further investigation.  
Syngr1a is a transmembrane protein that belongs to the synaptogyrin family. In 
humans SYNGR1a shows mainly neuronal expression. They are involved in vesicle 
trafficking, but not much more is known (Kedra et al., 1998). 
ednrba codes for an endothelin receptor that recognises the endothelin ligand. 
Endothelin receptor signalling is involved in the proliferation and differentiation of 
neural crest-derived cells including melanocytes and their precursors, and in 
promoting the dendricity of fully differentiated melanocytes. It is also expressed by 
the iridophore and xanthophore lineages (Opdecamp et al., 1998; Sviderskaya et al., 
1998). Zebrafish ednrba mutant embryos do not exhibit pigment pattern defects, 
pointing to a possible nonessential role in the development of pigment cells at early 
stages, although they have an adult pigment phenotype (rose mutant) In contrast in 
mouse, Ednrb is required by virtually all melanocyte precursors such that a failure of 
Ednrb signalling results in a near complete absence of melanocytes and melanoblasts 
(Parichy, Mellgren, et al., 2000). 
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gart encodes an enzyme that is part of the de novo purine biosynthesis pathway 
together with ppat, pfas and paics. Gart encodes a trifunctional enzyme that 
catalyzes steps 2, 3 and 5 of IMP synthesis. gart and paics homozygous mutants are 
microphthalmic and they possess pigmentation defects in which nearly all 
xanthophore-derived yellow pigmentation and iridophore-derived silver/reflective 
pigmentation is absent (Ng et al., 2009). Melanophore/RPE-derived black 
pigmentation is present but embryos appeared lighter than their wild-type siblings, 
possessing less melanin (Ng et al., 2009). The pigmentation phenotype is due to their 
inability to synthesise the pigment molecule, rather than a defect on specification or 
migration, as transmission electron microscopy quantification of melanin levels in 
mutant embryos reveals a reduction in the pigment molecule. Gart and Paics function 
in IMP synthesis upstream of the ATP and GTP synthesis pathways. The ATP pathway 
modulates retinoblast proliferation and cell cycle duration within the developing 
vertebrate eye (Pearson et al., 2002, 2005). The GTP pathway is involved in zebrafish 
pigmentation, probably serving as a precursor for the biosynthesis of each of the 
pigment molecules (Le Guyader et al., 2005; Ziegler, 2003). 
atp6ap1b codes for a V-ATPase-associated protein. The vacuolar ATPase (V-ATPase) 
is a proton pump that creates an acidic medium, necessary for lysosome function and 
vesicular traffic as well as for several other developmental processes. It has multiple 
subunits, each one performing a specific function required to achieve full activity. 
The zebrafish V-ATPase has 15 different subunits and mutations in any of them 
induce hypopigmentation or pigment dilution phenotype. V-ATPase function is 
essential for melanosome biogenesis, as the lack of such organelles cause the 
pigment dilution phenotype and may also induce melanocyte degradation, which is 
observed in the form of melanin spots in the zebrafish pigment dilution mutants 
(Ramos-Balderas et al., 2013). 
pttg1ipb codes for the pituitary tumour-transforming 1 interacting protein b. Not 
much is known about the role of pttg1ipb in melanocyte biology, however more is 
known about the related protein pttg1. PTTG1 also known as securin, participates in 
cell cycle regulation, DNA repair, gene transcription, apoptosis and metabolism. It 
plays a crucial role in the regulation of sister chromatid separation during mitosis. 
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PTTG1 is considered as an oncogene because of its effects on tumour development 
and growth. PTTG1 is abundantly expressed in multiple cancer cell lines such as 
melanoma (A375 and GL-Mel). High PTTG1 levels are correlated with higher tumour 
grade, invasiveness, and tumour vascularity (Tong and Eigler, 2009; Caporali et al., 
2012). 
All the previous 7 genes were annotated as expressed in pigment cells in the ZFIN 
database, however after some investigation into their function the role in 
melanocyte biology of two of them (syngr1a and pttg1ipb) remains unclear. In 
addition to the previous genes, there are 6 other genes that are annotated as 
expressed in the neural crest and whose ISH expression pattern image suggests that 
they may be expressed in pigment cells: pcdh10a, slc3a2a, ppat, rab7, cyb5a and 
sypl2b. We studied these genes further to check if they may have a function in 
pigment cell biology. 
pcdh10a codifies for the protocadherin 10a. The cadherins are transmembrane 
glycoproteins responsible for calcium-dependent cell-to-cell adhesion. The cadherins 
constitute a large superfamily that includes the classic cadherins, desmosomal 
cadherins, protocadherins, and atypical cadherins. Pcdh10 might serve as another 
cell adhesion factor in paraxial mesoderm (PAM) and somite development. pcdh10 
was also expressed in other parts of the embryo, such as epiphysis, hindbrain or 
otocyst epithelium, but pigment cell expression has not been reported (Murakami et 
al., 2006). 
Slc3a2a is a solute carrier family 3 member 2 (Slc3a2a). This membrane protein plays 
a critical role in yolk syncytial layer (YSL) formation and YSL organization by regulating 
microtubule networks in the YSL. Expression of slc3a2a has been investigated at 
stages of embryo development prior to 24hpf, and no pigment cell function has been 
reported, although they did not focus on this (Takesono et al., 2012). 
ppat codes for the first enzyme in the IMP de novo biosynthesis: phosphoribosyl 
pyrophosphate amidotransferase. ppat together with gart, pfas and paics are 
involved in the synthesis of the pigment molecules precursors (Ng et al., 2009). 
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Therefore, it is a key enzyme in melanogenesis and its defect is likely to hinder 
melanocyte function. 
Rab7 is a member of the Rab small glutamyl transpeptidase (GTP)-binding protein 
family and it is essential for the regulation of vesicular transport, organelle motility, 
phospholipid signalling, phagocytosis and autophagocytosis. Both tyrosinase and 
Tyrp1 (key enzymes in the production of melanin) are transported from the trans-
Golgi network to melanosomes through endosomal compartments. Rab7 is a crucial 
regulator for Tyrp1 sorting in the endosomal compartment, promoting its exit from 
the degradative process (Hida et al., 2011). Rab7 is also involved in melanoma, as the 
RAB7-controlled vesicular trafficking was found to be hyperactivated at very early 
stages of melanoma development (Alonso-Curbelo et al., 2015). 
Cyb5a is a membrane-bound cytochrome that reduces methemoglobin to ferrous 
haemoglobin, and defects in this gene cause type IV methemoglobinemia. 
Additionally, it functions as an electron carrier for several oxygenases and plays a key 
role in the detoxification of arylhydroxylamines in mammals (Giovannetti et al., 
2014). No link has been reported with pigment cell biology to date. 
Sypl2b is member of the synaptophysin (SYP) family, which comprises integral 
membrane proteins involved in vesicle-trafficking events. The presynaptic SYP 
protein controls neurotransmitter release, while SYP-like 2 (SYPL2) contributes to 
maintain normal Ca2+-signalling in the skeletal muscles. While SYPL2 has a role in 
muscular excitation–contraction coupling in mammals, no role has been described in 
pigment cell biology (Andersen et al., 2015).  
From the previous 6 genes only ppat and rab7 had a reported role in melanocyte 
biology, the rest perform important but apparently unrelated roles to pigmentation.  
Location of Sox10 or Mitfa binding sites in candidate 
genes 
All of the previous 13 genes were found to be downregulated in sox10 mutant 
embryos in the microarray analysis, therefore they are regulated (directly or not) by 
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sox10 transcription factor. Some of these genes may be part of the melanocyte GRN, 
but they might also have a role in other pigment cells biology (iridophore or 
xanthophore) or other sox10 expressing cells (glia, oligodendrocytes or sensory 
neurons). The analysis of their function from the published literature suggests that 
seven of them have a function in melanocyte biology. Hence, it will be helpful to 
know it they are directly regulated by mitfa (the melanocyte master regulator), as 
this would indicate that they are downstream of mitfa in the melanocyte GRN. 
To find out if these 13 genes are regulated by Mitfa we downloaded from the 
Ensemble zebrafish genome repository a region of 3000 bps of the promoter and 
5’UTR of the 13 genes. Subsequently, we built a Perl program to find the Mitfa (and 
Sox10) transcription factor binding motifs on these gene’s promoters. There are 
programs available to find TF binding sites (ConTra or JASPAR), but all of them use 
binding motifs from ChIP experiments, so only those TF that have been investigated 
through this technique will have a binding motif in the database, and the program 
will be able to find them in the candidate promoters. Because Mitfa does not have a 
transcription factor binding motif for zebrafish in the database, we could not use the 
available programs, so we decided to build our Perl program. 
mitfa is known to be directly regulated by Sox10 (Elworthy et al., 2003), and dct has 
been identified as regulated by Mitfa (Ludwig et al., 2004). Hence, we used the 
promoters of both of these genes as a positive control to test if our Perl program 
could find transcription factor binding sites. As expected the program found that the 
mitfa promoter contained Sox10 binding sites, and the dct promoter contained Mitfa 
binding sites. However, we still needed to check that our program was finding true 
positives and it was not finding binding sites for Sox10 and Mitfa in any random gene. 
For that we selected two genes from the list of differentially expressed genes 
obtained from the microarray analysis whose expression was not statistically 
different between sox10 mutant and wild type embryos (both genes presented a p-
value close to 1). The genes selected were cherp and mif. cherp is a calcium 
homeostasis endoplasmic reticulum protein (Gene ID: 10523) and mif is a 
macrophage migration inhibitory factor (Gene ID: 4282). The function of both of 
these genes is not related to melanocyte biology, and hence it was not expected to 
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find Sox10 or Mitfa binding sites. As predicted our Perl program did not identify any 
Sox10 or Mitfa binding sites in the cherp and mif promoters, which confirmed that 
our program was successful in finding real binding sites. 
From the 13 genes analysed 8 contained Sox10 or Mitfa binding sites in their 
promoter. Rab32a, atp6ap1b and ppat are the only ones containing Sox10 binding 
sites. Seven genes contain one of the two Mitfa motifs. Bace2 has just one M-box 
motif, and Gart and sypl2b also contain just one Mitfa motif (E-box). syngr1a, 
atp6ap1b, slc3a2a and ppat contain at least two Mitfa binding sites. Atp6ap1b and 
ppat are the only two genes containing binding sites for both Mitfa and Sox10. 
Rab32a has an important role in melanocyte biology, as it controls the transport of 
the melanogenic enzymes to the melanosomes. However its promoter contains just 
a Sox10 S3 binding site, which is weaker driving expression than S1 (Elworthy et al 
2003).  
Bace2 may be involved in melanocyte migration as it has a Mitfa M-box site in its 
promoter. The role of syngr1a in pigment cell biology is not well understood, 
however it contains an M-box and two E-boxes in tis promoter, which makes it quite 
likely to be regulated by mitfa. Nevertheless further study is needed. 
Gart is an enzyme involved in the biosynthesis of the pigment molecules together 
with Ppat. ppat has a Sox10 S1 binding motif, which is the strong one (Elworthy et al 
2003), and two Mitfa E-boxes, suggesting that it may likely to be controlled by Mitfa 
(or Sox10). gart has a single Mitfa E-box in its promoter, and as its role is also very 
important for melanocyte biology it may be regulated by Mitfa. 
Atp6ap1b is involved in the acidification of the melanosome, which is essential for 
melanocyte development. It contains both Sox10 S3 and two Mitfa E-box sites. That 
makes it likely to be regulated by Mitfa. 
slc3a2a contains two Mitfa M-boxes in its promoter, however, its role in pigment cell 
biology is not clearly understood. sypl2b contains one Mitfa E-box in its promoter. 
The unknown role in pigment cell biology of these genes make them unlikely to be 
regulated by Mitfa, although further investigation would be needed to test this. 
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Hence, to sum up, it is very likely that gart, ppat and atp6ap1b are regulated by Sox10 
or Mitfa. It may be possible that rab32a and bace2 are also regulated by Sox10 or 
Mitfa. In any case, experimental validation will be needed. One way to test if these 
genes are regulated by Sox10 or Mitfa would be to perform ISH using sox10 or mitfa 
mutant embryos for these genes. If their expression is reduced or absent in the 
mutant embryos that means that are regulated by those transcription factors. 
However with this method we would not know if the interaction is direct or indirect. 
In order to test if the interaction is direct, ChIP-seq could be used. The main issue 
with this approach is that we need suitable anti-Sox10 and anti-Mitfa antibodies, 
which are difficult to obtain. The advantage is that once we have an antibody that 
works with our sample we perform the ChIP-seq experiment and identify all the 
genes that are directly bound by Sox10 or Mitfa. 
Conclusion 
The aim of this chapter was to use the microarray data produced by Chipperfield in 
2009 to find novel genes involved in the GRN underlying melanocyte development. 
We repeated the analysis he did several years ago with up to date algorithms using 
the Bioconductor package for R, and found out that the list of top 100 downregulated 
genes in sox10 mutant embryos that we obtained is the same.  
Chipperfield performed an ISH screen of the those  top 100 downregulated genes to 
validate that atp6v1ab, atp6v1e1b, degs1, pah and tspan36 are expressed in 
melanocytes and downregulated in sox10 mutants. We carried out another ISH 
experiment to check the expression of these genes in mitfa mutant embryos, and 
found out that they are also downregulated. Therefore, those 5 genes are regulated 
(directly or indirectly) by Mitfa and we placed them downstream of Mitfa in the 
melanocyte GRN. 
We used the combined microarray dataset (obtained from both Tg(-7.2sox10:EGFP) 
and Tg(-4.9sox10:EGFP) lines) and an improved statistical analysis to obtain a new list 
of downregulated genes. This list contained 68 new candidate genes that were not 
present in the initial analysis of the Tg(-7.2sox10:EGFP) line. We used the ZFIN 
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database to investigate the expression profile of these 68 genes, and found that 7 of 
them are very likely to perform a key role in melanocyte biology: rab32a, rab7, bace2, 
ednrba, gart, ppat and atp6ap1b; and 6 other genes that may have a role in 
melanocyte development, but whose function is still unclear. 
Finally, we designed a Perl program to locate Sox10 or Mitfa binding sites in the 
promoter of these 13 genes, which may indicate that are directly regulated by one of 
the transcription factors. Three of the genes (gart, ppat, and atp6ap1b) are likely to 
be regulated by Mitfa or Sox10, as they contained several transcription factor binding 
motifs in their promoter. Two other genes (rab32a and bace2) may also be regulated 
by the transcription factors. In any case, this would need to be tested experimentally. 
To sum up, the microarray analysis has provided five novel genes regulated by Mitfa 
that are important in melanocyte biology (atp6v1ab, atp6v1e1b, degs1, pah and 
tspan36) and have been validated experimentally; as well as seven candidate genes 
that are directly or indirectly regulated by Mitfa or Sox10 (rab32a, rab7, bace2, 
ednrba, gart, ppat and atp6ap1b) that may have a role in melanocyte biology, which 





Including kit in the GRN 
Introduction 
As described in the introduction, the GRN published by Greenhill et al. (2011) 
identified the need for some unknown factors (genes) in order to describe 
melanocyte development adequately. One of those factors was Factor Y, which is a 
Sox10-independent, Mitfa-dependent transcriptional activator of mitfa that provides 
a positive feedback loop allowing stable melanocyte differentiation. Mc1R was one 
of the candidates for Factor Y but Greenhill et al. (2011) concluded that Mc1R 
signalling was not contributing to Factor Y. 
Hence, a different gene had to be considered to act as Factor Y in the current GRN, 
and based on studies carried out by many research groups kita (termed kit in the rest 
of the chapter) appeared as a very interesting candidate to investigate. This section 
will describe the evidence that supports the selection of kit as candidate for Factor 
Y. 
Kit is a type III receptor tyrosine kinase expressed by melanocytes and melanoblasts 
(melanocyte precursors) that that binds to the Stem Cell Factor (SCF, also called Steel 
factor) which is its ligand. Upon binding with its ligand, Kit transduces the signal 
through the PI(3) kinase and MAP kinase signalling cascades. MITF protein contains 
a phosphorylation site that is phosphorylated by ERK2, which lies in the MAP kinase 





Figure 13. A simplified schematic showing the features of the kit signalling pathways in 
melanocyte development. Kit regulates Mitf activity through the MAP kinase cascade upon 
binding with its ligand. Modified from Hou & Pavan (2008). 
 
Kit signalling was proposed to initiate melanoblast migration, attracting them onto 
the dorsolateral pathway lined by cells expressing SCF. In zebrafish kit mutants, 
melanocytes are specified and differentiate, however they fail to migrate properly 
and tend to accumulate in premigratory positions (dorsal to the neural tube, and in 
a cluster posterior to the inner ear), and ultimately they enter the epidermis where 
they start to synthesise melanin (Parichy et al. 1999; Kelsh et al. 2000). Using a 
conditional mutant, the sensitive phase for Kit activity in melanocyte migration is 
restricted to between 1 and 2 dpf. After that, the migration machinery of the cells 
and the extracellular matrix have changed, and the melanocytes cannot migrate 
more (Rawls and Johnson, 2003). Elegant studies of the phases of Kit requirement 
during murine melanocyte development used blocking antibody injections to 
demonstrate the early phase requirement, but also a later one for population of hair 
follicles (Nishikawa et al., 1991). This second role of Kit is proposed to be a 
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chemokinetic effect: Kit increases the melanoblasts’ rate of movement and, 
therefore, their chance of encountering the follicle (Jordan and Jackson, 2000). 
A temperature shifting experiment, carried out using a kit temperature sensitive 
mutant (which acts as a null mutant when reared at the restrictive temperature of 
33ºC) showed that kit is required for survival in a transient period of time between 2 
and 4 dpf, as kitts mutant embryos reared at the permissive temperature of 25ºC and 
shifted to the restricted temperature between 2 and 4 dpf caused melanocyte death 
(Rawls and Johnson, 2003). Melanoblast apoptosis in Kit mutants results from a 
failure of the receptor tyrosine kinase to activate the PI(3) kinase and MAP kinase 
cascades. PI(3) kinase delivers a powerful anti-apoptotic signal via the activation of 
the kinases PDK1 and Akt (Goding, 2000). Another target of Kit signalling is Bcl2, a 
known pro-survival gene (McGill et al., 2002). 
kit is not required for melanocyte differentiation, but it may promote that a 
maximum number of melanocyte are differentiated (Mellgren and Johnson, 2004; 
Parichy et al., 1999). kit is also involved in the maintenance of melanocytes: in the 
absence of kit the melanocytes undergo cell death, and are extruded from the skin 
(Parichy et al., 1999; Kelsh et al., 2000). 
In mouse Kit mutants, there are fewer melanoblasts expressing Dct, suggesting that 
Kit could be required for expansion or survival of melanoblasts. Zebrafish kit mutants 
have a lower number of melanocytes than wild type embryos, suggesting that some 
melanoblasts may require kit to develop normally (Kelsh et al., 2000). In zebrafish, 
an experiment where mitfa-MO was injected into wild type embryos showed no kit 
expressing melanoblasts at 24 hpf, suggesting that kit requires mitfa for its 
expression (Mellgren and Johnson, 2004). 
All the previous evidence suggests that kit is a key gene in melanocyte development, 
involved in melanocyte migration and maintenance, as well as promoting its 
differentiation in a maximum number. However the following experiments were the 




In a study using Mitf mutant mast cells that lacked Kit expression, transfection with 
a Mitf plasmid resulted in Kit expression. This was shown to be because the Kit 
promoter contains an E-box motif that is recognised by MITF to activate Kit 
transcription (Tsujimura et al., 1996). In melanoblasts, MITF was also shown to be 
required to drive Kit transcription (Opdecamp et al., 1997). This suggests the 
possibility of a positive feedback loop between Kit signalling and Mitf. 
A different study showed that KIT-negative cells in culture express MITF and several 
other pigment cell genes directly regulated by MITF, but lack Tyr expression. This 
indicates that KIT is not required for Mitf expression nor for the expression of other 
pigment cell genes. However, without Kit signalling, MITF is not sufficient do drive 
Tyr expression in developing melanoblasts (Hou et al., 2000). 
Based on the previous evidence our hypothesis (Figure 14) was that kit is performing 
the same role as Factor Y (at least partially) in the GRN: its expression is driven by 




Figure 14. Hypothesis of the role of kit in the GRN. Our initial hypothesis stated that kit 
plays the role of Factor Y in the Greenhill et al. (2011) GRN as a central actor in a feedback 
loop with mitfa. Mitfa, whose expression is directly regulated by Sox10, drives kit 
expression, and kit itself promotes mitfa transcription helping to maintain its expression 




The approach selected to test our hypothesis was to perform whole mount in situ 
hybridisation to detect kit expression in several zebrafish genetic backgrounds. In 
order to test if kit is driven by Mitfa we performed kit ISH in mitfa mutant embryos. 
Lack of melanocytes expressing kit would suggest that Mitfa regulates kit expression. 
To test whether Kit maintains mitfa expression we performed mitfa ISH in kit 
mutants. The reduction of mitfa expression in kit mutants may suggest that Kit 
signalling maintains mitfa expression. 
Results 
kit is driven by Mitfa 
It has been shown that the Kit promoter contains an E-box motif that is recognised 
by MITF to activate Kit transcription (Tsujimura et al., 1996). And the same time MITF 
was also shown to be required to drive Kit transcription (Opdecamp et al., 1997). 
Therefore we wanted to test our hypothesis: if kit is factor Y in the network, it is in 
the centre of a feedback loop, where its expression is driven by Mitfa, and Kit activity 
itself drives or, at least, maintains mitfa expression. First of all I checked if kit 
expression is driven by Mitfa. For that, an ISH of kit was done in wild type, sox10 and 
mitfa mutant embryos at 30hpf. If our hypothesis is right, kit expression should be 
absent in both sox10 (that directly drives mitfa (Elworthy, 2003)) and mitfa mutants 
(Figure 15). 
The results of the kit ISH in wild type, sox10 and mitfa mutant embryos can be seen 
in Figure 15. Panel A shows that as expected, kit is expressed in the melanocyte 
lineage as well as other tissues like the proctodeum or notochord (Ignatius et al., 
2008). However, it was rather surprising to observe that it was also widely expressed 
in mucus secreting cells in the epidermis, which had not been previously identified 
when studying the kit expression pattern through ISH. These round and small cells 
are located in the fish epidermis in high number. They had been previously described 
in other teleost fish as the cells that secrete the mucus that acts as a lubricant 
reducing drag while swimming, preventing fungal and bacterial infection and being 
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involved in osmoregulation (Marshall, 1976). These cells seem to have a non-neural 
crest origin and hence they would not be regulated by sox10 or mitfa. Thus, we 
expected to find them in the kit ISH for both mitfa and sox10 mutants. 
As we expected we could not see kit expressing melanocytes in sox10 mutants as 
mitfa would not be active and it could not drive kit expression (Figure 15 B). However, 
kit was still expressed in the mucus secreting cells and in the proctodeum, as 
predicted, since these tissues have no neural crest origin. 
In mitfa mutants we expected to find a lack of kit expressing melanocytes, as mitfa 
would not be able to drive kit expression, but we would still see mucus secreting cells 
and proctodeum expressing kit. Figure 15 C shows the ISH results where we could 
appreciate that kit was expressed in mucus secreting cells and proctodeum as 
predicted; however some there were some large cells located dorsally expressing kit. 
These cells were too big to be mucus secreting cells; therefore we hypothesised that 






Figure 15. kit ISH of 30 hpf embryos shows that kit may be unexpectedly expressed in mitfa 
mutant embryos. Wild type embryo (A) show kit expression in melanocytes (circle), mucus 
secreting cells (arrowhead), proctodeum (arrow) and notochord (tail region), as expected. 
(B) The sox10 mutant embryo shows kit expression in mucus secreting cells (small, round 
cells label with arrowhead), proctodeum (arrow) and notochord (tail region), but not in 
melanocytes as predicted. (C) The mitfa mutant embryo shows kit expression as expected in 
mucus secreting cells (arrowhead), proctodeum (arrow) and notochord (tail region), and 
some unexpected kit expressing cells dorsally (circle) that might be melanocytes. Image 
orientation: embryo head is on the left and tail on the right of the images. 
 
In the kit ISH of mitfa mutant embryos it was not expected to find kit expressing 
melanocytes according with our hypothesis. However we found some cells 
expressing kit that we thought might be melanocytes. We were not sure that those 
cells that we believed are melanocytes were not actually mucus secreting cells. 
Therefore we needed to find a way to distinguish between both cell types. The main 
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characteristic of the mucus secreting cells is that they are located in the epidermis in 
the surface of the embryo, whereas the melanocytes are located a bit deeper into 
the embryo body in the medial plane. So we could use this feature to distinguish 
them under a microscope as each cell type will be in a different focal plane.  
We performed a kit ISH for 24 hpf wild type, sox10 and mitfa mutant embryos and 
we imaged the anterior part of the embryo with two focal planes one of the lateral 
side of the embryo and one of the medial pathway. Figure 16 shows that in wild type 
fish there are mucus secreting cells expressing kit in the surface (round and small 
cells (A), and melanoblast deeper inside the embryo (D). Sox10 mutant embryos have 
mucus secreting in the epidermis (B), but no melanoblasts are present deeper inside 
the embryo (E). However, in mitfa mutant embryos we could find mucus secreting 
cells expressing kit in the surface of the embryo (like in wild type and sox10 mutants, 
C) and the cells that we suggested could be melanoblasts deeper inside the embryo 
(F), which are not present in sox10 mutants. However this was not conclusive 
enough, as these cells that we thought were melanoblasts could be mucus secreting 
cells located in the epidermis of the dorsal side of the embryo. Hence we needed to 





Figure 16. kit ISH of 24 hpf embryos shows presumptive melanoblasts in the mitfa mutants 
medial pathway.. A, B and C are images of the lateral focal plane, and D, E and F are images 
of the medial migration pathway of the same embryos. Wild type embryo shows kit 
expression in mucus secreting cells in the lateral plane (arrowheads) (A) and in melanoblast 
in the medial plane (stars) (D). sox10 mutant shows kit expression in mucus secreting cells 
(B) but not in melanoblasts in the medial plane (E). mitfa mutant shows kit expressing mucus 
secreting cells in the lateral plane (C) as well as larger kit expressing cells in the medial plane 
(probable melanoblasts) (F). Scale bar: 100 µm. Images taken from the mid trunk, above the 
yolk sac extension. Image orientation: embryo head is on the left and tail on the right of the 
images. 
 
To test the proposal that these larger kit positive cells in the mitfa mutants were 
melanoblasts, I used double fluorescent in situ hybridisation for mitfa and kit. If those 
kit expressing cells in the medial plane are melanocytes they should also express 
mitfa, and therefore we should detect co-localisation. If on the contrary they are 
mucus secreting cells we would see kit but not mitfa expression.  
As expected mitfa and kit co-localise in melanocytes on the medial plane of wild type 
embryos (Figure 17 A-C). In mitfa mutant some cells in the typical position of 
premigratory neural crest cells located above the dorsal neural tube co-express both 
mitfa and kit (Figure 17 D-F). This suggests that the presumptive melanocytes that 





Figure 17.medial pathway images of ISH of 30 hpf wild type, sox10 and mitfa mutant embryos 
for mitfa (green) and kit (red) suggest that mitfa mutants have mealnocytes in the dorsal 
trunk. As expected, mitfa and kit expression overlaps extensively in cells of typical neural 
crest morphology on both medial (A-C) and lateral (not shown) pathways. In mitfa mutants 
migratory cells are not seen, but some cells in the typical position of premigratory neural 
crest cells are seen above the dorsal neural tube; these cells show co-localisation of mitfa 
and kit (D-F). Scale bar: 100 µm. Images taken from the mid trunk, above the yolk sac 
extension. Image orientation: embryo head is on the left and tail on the right of the images. 
 
Our initial hypothesis proposed that kit expression was driven by mitfa, and hence 
no kit expressing melanocytes were supposed to be found in mitfa mutants. However 
the previous data suggests that there is some other factor driving kit expression in 
melanocytes even when mitfa is not functional. And we proposed that this factor 
might be sox10, as kit expressing melanocytes are not present in sox10 mutant. This 
finding led us to modify our initial hypothesis: kit might be driven by sox10, as well 
as being activated by Mitfa at the same time that it maintains mitfa expression as 
part of the feedback loop.  
Greenhill et al. (2011) established that all melanocytes showed detectable sox10 
expression at 30 hpf, but this rapidly decreased and by 50 hpf signal was not detected 
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in any cell. Hence, if sox10 is driving kit expression this must be limited to stages prior 
to 50 hpf, that is why we decided to evaluate the timeframe of sox10 driving kit 
expression. 
kit is transiently driven by Sox10 
In order to evaluate the timeframe of sox10 driving kit we performed an ISH for kit 
using three different stages (24, 30 and 48 hpf) and wild type, sox10 and mitfa mutant 
embryos. As we had described before we assumed we would not find melanocytes 
expressing kit in sox10 mutant embryos in any of the three stages. However, we 
expect to find melanoblasts expressing kit in mitfa mutants at 24 hpf, and 30 hpf. We 
do not expect to find melanocytes expressing kit at 48 hpf, as by this stage sox10 
expression in melanocytes is almost absent (Greenhill et al., 2011). 
We could identify melanocytes and their precursors expressing kit in wild type 
embryos in all three stages (24, 30 and 48 hpf). In addition, we could not see any 
melanocyte expressing kit in sox10 mutant in any of the stages as expected. There 
were some kit expressing melanoblasts in mitfa mutant at 24 hpf, which were absent 
from 48 hpf mitfa mutant embryos as predicted. However, contrary to our 
predictions, we could not detect any kit expressing melanocyte from 30 hpf mitfa 
mutant embryos. This may be because the levels of sox10 at 30 hpf are already 





Figure 18. sox10 may drive kit expression at early stages of development as kit expressing 
melanocytes were found in mitfa mutant embryos at 24 hpf but not at 30 or 48 hpf. At 24 
hpf kit is expressed in mucus secreting cells (stars) and melanoblast (arrowheads) in wild 
type embryos (A), just in mucus secreting cells in sox10 mutant embryos (B), and in mucus 
secreting cells and melanoblast in mitfa mutants (C). At 30 hpf kit is expressed in mucus 
secreting cells and melanocytes in wild type embryos (D), and only in mucus secreting cells 
in sox10 (E) mitfa mutants embryos (F). At 48 hpf kit is expressed in melanocytes in wild type 
embryos (G), and it is not expressed in any cells in sox10 or mitfa mutants (H-I). These ISH 
images are from the medial pathway focal plane and from the mid trunk, above the yolk sac 
extension. Image orientation: embryo head is on the left and tail on the right of the images. 
Scale bar: 100 µm 
 
To sum up, the previous results demonstrate that Mitfa controls kit expression and 
sox10 drives kit expression in early stages of melanocyte development (between 24 
and 30 hpf). This confirms part of the interactions that are consistent with kit acting 
as Factor Y. The other part of the interaction that we need to test is kit driving mitfa 
transcription, maintaining its expression in a feedback loop.  
103 
 
Kit drives mitfa and maintains its expression through a 
feedback loop. 
If kit acts as Factor Y in the Greenhill et al. (2011) GRN we needed to assess if kit 
drives and maintains mitfa expression through the feedback loop, as we have already 
demonstrated the other part of the interaction. To test this, an in situ hybridisation 
using kit mutant embryos was carried out for two genes: mitfa and dct. If kit plays a 
role in this loop mitfa expression levels should be decreased, as should the levels of 
the mitfa downstream target dct. 
According to our model, both mitfa and dct expression should be reduced in kit 
mutant embryos as kit would not be functional to drive and maintain the expression 
level of mitfa, which would decrease the expression of its downstream targets such 
as dct. However, Figure 19 shows a reduction in the number of mitfa and dct 
expressing cells in kit mutants compared to their wild type siblings, rather than a 
reduction in their expression levels. From Figure 19 it seems that mitfa expression 
level might be a bit weaker in kit mutant than in wild type, however dct looks similar. 
Therefore, we would need a quantitative measure of expression levels, which could 





Figure 19. mitfa and dct  ISH of 30 hpf wild type and kit mutant embryos. Kit mutant embryos 
show expression of both mitfa (B) and dct (D) in a reduced number of melanocytes compared 
to the wild type embryos (A and C). Not enough information about gene expression levels 
can be drawn from these ISH images. Images taken from the mid trunk. Image orientation: 
embryo head is on the left and tail on the right of the images. Scale bar: 100 µm 
 
Discussion 
kit is driven by Mitfa 
Based on the evidence gathered from the literature review presented in the 
introduction our initial hypothesis was that kit might be playing the role of Factor Y 
in the Greenhill et al. (2011) GRN at least in part (i.e. there might be another gene or 
genes sharing the role of Factor Y with kit). According to this hypothesis kit would be 
part of a feedback loop with mitfa, where kit expression is driven by Mitfa, and Kit 
drives and maintains Mitfa expression. This hypothesis is represented in Figure 14.  
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To test this hypothesis an ISH for kit was done using wild type, sox10 and mitfa 
mutant embryos. If the hypothesis is right, we would not expect to find kit expressing 
melanocytes in sox10 and mitfa mutants, because kit transcription would not be 
activated in those fish. Figure 15 A shows the expected kit expression pattern in wild 
type fish. We can detect kit expressed in melanocytes as well as in mucus secreting 
cells, which had not been reported in the previous studies in zebrafish (Parichy et al., 
1999; Cooper et al., 2009). These cells are completely unrelated to the melanocyte 
lineage (Marshall, 1976) and hence are not important in the process we are trying to 
understand. Figure 15 B shows the expected expression pattern: kit expressed in 
mucus secreting cells but not in melanocytes. However, the expression pattern of 
mitfa mutant embryos (Figure 15 C) was unexpected, as there seems to be some kit 
expressing cells that are bigger than mucus secreting cells, which may be 
melanocytes. In order to characterise this properly a more detail observation was 
done. Mucus secreting cells are located in the epidermis in the external layers of the 
embryo, whereas melanocytes are located deeper within the embryo (Kelsh 2004). 
Therefore we could use the two different focal planes in the microscope to elucidate 
if those cells that might be melanocytes in mitfa mutant embryos are indeed that. 
Figure 16 shows an ISH for kit using wild type, sox10 and mitfa mutant embryos with 
images of the lateral and medial planes of each of them. In wild type embryos we can 
see the mucus secreting cells in the external plane and the melanocytes expressing 
kit in the inner plane. In sox10 mutants we can only detect mucus secreting cells on 
the external plane of the embryo, and no cells in medial plane. In mitfa mutant we 
can see the mucus secreting cells expressing kit in the outer plane and some bigger 
cells in the inner plane, which are very likely to be melanocytes.  
This experiment however did not provide us a clear answer to our question. In order 
to get stronger evidence to support that the cells in the medial plane of mitfa mutant 
embryos are melanocytes, a double fluorescent in situ hybridisation was done. The 
aim of this experiment was to detect both mitfa and kit expression. Melanocytes 
express both genes, and thus we should detect co-expression. Therefore if those cells 
are melanocytes the signal should co-localise. In wild type we can clearly see 
melanocytes expressing both kit and mitfa. In mitfa mutants we can identify some 
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cells in the dorsal side of the medial plane of the embryo expressing both genes. 
Therefore these experiments suggest that these cells are likely to be melanocytes.  
This finding meant that there is some other factor driving kit expression even when 
Mitfa is inactive in mitfa mutants. One strong candidate for the factor that initiates 
kit expression is sox10, as kit is not expressed when sox10 is inactive in mutants. On 
these bases the initial hypothesis was modified: sox10 might drive kit expression, 
together with mitfa in the feedback loop (Figure 20). 
Greenhill et al. (2011) established that around 30 hpf most of the melanocytes 
showed sox10 expression, but this decreased rapidly and by around 50 hpf signal was 
not detected in any of these cells. Therefore if sox10 is supposed to drive kit 
expression in melanocyte this interaction may be transient, as sox10 expression is 
restricted in time. 
 
 
Figure 20. Revised hypothesis of the role of kit in the GRN. The second iteration of our 
hypothesis suggests that Sox10 drives kit expression at early stages of embryo development. 
kit is still at the centre of the feedback loop with mitfa, which drives kit expression, and kit 





kit is transiently driven by Sox10 
In order to test the timeframe where sox10 drives kit, we performed ISH for kit in 
wild type, sox10 and mitfa mutants at three stages: 24, 30 and 48 hpf. At 24 hpf there 
are melanocyte expressing kit in mitfa mutant (Figure 18 C) the same as in Figure 16, 
but not in sox10 mutant. By 30 hpf we cannot identify melanocytes expressing kit in 
mitfa mutant (Figure 18 F). This was surprising, as we could identify these cells in 
previous experiments at the same stage (Figure 15 and Figure 17). This might be 
because sox10 expression is already decreasing at that stage (Greenhill et al., 2011) 
and the sox10 dependent kit expression is likely to end at around that stage. Also, 
the embryos may be in slightly different stages in the different experiments, despite 
being all roughly at 30 hpf, which may add to the confusion. In any case, by 48hpf 
there are not melanocyte precursors expressing kit in mitfa mutant (Figure 18 I), 
which means that the only factor driving kit expression by this stage is mitfa. Hence, 
the sox10 dependent, mitfa independent kit expression seems to be limited to early 
stages of development and would end at approximately 30 hpf, being definitely not 
detectable by 48hpf. This is consistent with the sox10 expression observations by 
Greenhill et al. (2011) where they could not detect sox10 expression by 50 hpf. 
Kit drives mitfa and maintains its expression through a 
feedback loop 
The next aspect to be tested was the maintenance of mitfa expression by kit as part 
of the feedback loop. Mitfa expression is directly driven by sox10 (Elworthy et al. 
2003), but the maintenance of its expression at a high enough level to drive the 
melanogenic genes and drive melanocyte commitment may be achieved through the 
feedback loop with kit. Kit mutants were used to test this interaction. It has already 
been shown that in mitfa mutants, Mitfa target genes such as dct are absent. We also 
predicted that when Kit is not active, mitfa expression would be reduced, and that 
Mitfa target genes might also be reduced, although there might be a delay. The mitfa 
ISH in kit mutant embryos shows an expression pattern with fewer stained cells 
compared to the wild type embryos. The same happened with the dct ISH, there’s a 
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lower number of stained cells that is even more prominent in the ventral line. One of 
the possible explanations for the expression pattern reduction may be because kit is 
involved in melanocyte survival and by this stage the melanocytes have already died 
and cannot be detected. Parichy et al. (1999) demonstrated that in the absence of 
kit, melanocytes undergo programmed cell death and are extruded from the skin 
from around 4dpf, most evident between 5 and 6 dpf. They didn’t see cell death at 2 
dpf and they didn’t look at earlier stages. Rawls et al. (2003) did some elegant 
temperature shift experiments to address the effects of kit activity on melanocyte 
survival using a temperature sensitive allele. They reported that loss of kit activity at 
2dpf caused melanocyte death, and therefore kit is important for survival from 2dpf. 
Despite not studying stages as early as 30 hpf, they suggest that kit is not required 
for survival at this stage. 
Therefore if melanocytes have not already died by 30 hpf in kit mutants, the 
differences in expression pattern that we see in Figure 5 may be due to a defect in 
melanocyte migration. It has been reported that kit promotes the migration of 
melanoblasts while they disperse from the neural crest (Parichy et al., 1999). Using 
the same temperature shifting experiment Rawls et al (2003) determined that kit is 
required for melanocyte migration prior to 2 dpf. This might be because the 
migration machinery or signally pathway may no longer be available after 2 dpf or 
because the extracellular matrix composition have changed by 2 dpf. However, this 
role of kit in migration may be complete as soon as 24 hpf in some melanocytes 
(Rawls and Johnson, 2003). In the ISH from Figure 5 there seems to be a lower 
number of melanocytes expressing dct in the ventral line, as well as a lower number 
of mitfa expressing cells in the ventral and medial line. Consequently it is likely that 
the mitfa and dct expression patterns are due to migration defects in kit mutants, as 
it has been previously described (Kelsh et al., 2000). 
However, what can we say about the mitfa and dct expression in kit mutants? 
According to our model, the expression of these genes should be reduced in each cell 
in the mutant embryos. From Figure 5 it seems that mitfa expression might be a bit 
weaker than in wild type, however dct looks similar. This is probably because the dct 
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ISH staining is saturated. In order to characterise this better we would need a 
quantitative measure of expression levels, which could be obtained by RT-qPCR. 
Conclusion 
Kit is a key gene in melanocyte development involved in migration, survival and 
proliferation, as it has been reported in previous studies. Therefore it seemed logical 
that kit needed to be included in our melanocyte GRN. When Greenhill et al. (2011) 
established the GRN they identified the need of a gene (Factor Y) to allow stable 
melanocyte differentiation. The kit background studies suggested that it might be a 
strong candidate to fulfil that role.  
In this chapter we suggested that kit plays the role of Factor Y in the positive feedback 
loop in the GRN. We have confirmed that Mitfa, which is directly activated by Sox10, 
drives kit expression. Moreover, we have proposed that Sox10 also drives kit 
expression but just transiently at early stages of development until around 30hpf, 
while it is expressed in melanocytes. As part of the feedback loop, kit seems to drive 
and maintain mitfa expression. Despite not being essential for mitfa expression (Hou 
et al., 2000), Kit signalling seems to promote its maximal expression to enable stable 






Towards a quantitative 
model of the GRN 
Introduction 
Greenhill et al. (2011) used a systems biology approach to identify and develop the 
core GRN underlying melanocyte specification and differentiation in zebrafish. They 
used a mathematical modelling approach in combination with experimental data in 
an iterative process to create a model that makes specific predictions about the 
properties of unidentified factors in melanocyte differentiation and explains the 
melanocyte development in a semi-quantitative manner. 
They constructed a dynamical model of an initial GRN based on ordinary differential 
equations, considering the transcription levels as dynamic variables (Figure 5). The 
external activatory signal in the network was designed as Factor A, comprising 
several transcription factors whose function in the regulation of the network is poorly 
understood: Lef/Tcf (Wnt pathway), Sox9, FoxD3, Pax and AP2 (Greenhill et al., 
2011). These input factors regulate Sox10 which had been shown to directly activate 
the expression of Mitfa (Elworthy et al., 2003), termed the master regulator of 
melanocyte specification, which will activate the melanogenic genes (dct, tyr, tyrp1 
and Si), as well as the sox10 promoter in a positive feedback loop. Subsequently, 
Sox10 represses the expression of the melanogenic genes and its expression is 
repressed by the recruitment to the sox10 promoter of an Hdac1 complex that 
deacetylates its chromatin and represses sox10 transcription by Mitfa. In that way, 
Factor A-dependent sox10 expression as well as Mitfa-dependent expression will 
both be inactivated. The model proposed also the existence of a Sox10-independent, 
Mitf-dependent transcriptional activator of mitfa (Factor Y) that provides a positive 
feedback loop to allow stable melanocyte differentiation. This feature was not 
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initially part of the model, but was incorporated because the model simulations 
highlighted the need for such a factor to maintain stable melanocyte development. 
Finally, Sox9b drives Sox10 and Mitfa-independent melanisation (very low level, not 
detectable in single mutant) and it is activated by a poorly-defined Factor B, which 
has a transient role and is restricted to the early phase of melanocyte development 
(Greenhill et al., 2011). 
This model allowed them to predict the evolution of gene expression of the GRN 
genes along the first 100 h of zebrafish embryonic development. However, the data 
they had was very limited: in situ hybridisation expression patterns that they used to 
get coarse gene expression data. Therefore, when they needed to find values for the 
parameters of the model, they chose those that produced gene expression curves 
that were similar in shape to what they expected to happen based on the in situ 
hybridisation data. That means that the exact quantities and details of the curves are 
not very rigorous and may be erroneous. 
In order to develop a quantitative mathematical model to describe the GRN 
underlying the development of a melanocyte in the zebrafish embryo we would need 
to obtain gene expression measurements of the genes in the network from single 
melanocytes.  
Obtaining single cell gene expression measurements is very challenging, and we 
could not do it in the lab at that moment in time. Therefore, the experimental set up 
that we devised was to obtain embryos from two or three zebrafish pairs and mix 
them together. Then, we sampled 30 embryos per stage for the 12 stages we wanted 
to measure: 25 of them were fixed and reserved to perform ISH for each of the four 
genes we measured, and the remaining 5 were used for RNA extraction and 
subsequent qPCR measurement. One of the challenges of measuring gene expression 
levels from whole embryo is that most of the genes are expressed in other tissues in 
the embryo besides melanocytes (mainly in the head). Also, melanocytes originate at 
different times within the embryo so if we want to measure melanocyte gene 
expression at a certain stage some of them will be at exactly that stage, but others 
may be younger if they are closer to the tail, as the embryo develops from anterior 
to posterior. Hence, to tackle this issues we decided to cut off the head and the tail 
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of the 5 embryos that were going to be used for qPCR measurements, keeping just 
the trunk (from beginning to the end of the yolk sac extension). These 5 trunks were 
then used to perform RNA extraction, cDNA synthesis and qPCR measurements. 
 
 
Figure 21. Diagram describing the experimental set up. Five embryos were used to cut their 
trunks, extract their RNA and measure the gene copy numbers through qPCR for each stage. 
And 25 sibling embryos were fixed at the same stage and then were used for ISH to count 
the number of gene expressing cells. Both measurements (gene copy number and gene cell 
number) were used to estimate the gene copy number per cell. 
 
Therefore, from the qPCR data we have gene expression measurements from all the 
cells expressing a certain gene in the embryo trunk. To estimate the cell expression 
per cell we used the 25 embryos that we fixed to carry out ISH for each of the genes 
we are measuring. Then we counted the number of cells expressing each gene in the 
same region of embryo trunk that we used to obtain the qPCR measurements. Hence, 
113 
 
at the end we have a measurement of gene expression in an embryo trunk, and the 
number of cells expressing that gene in that region. So we can use the quotient of 
both measurements to estimate the gene expression per cell that we used to perform 
the parameter optimisation of the mathematical model.  
All these measurements were done in 12 stages, starting from 18 hpf to 96 hpf, with 
the early stages more densely surveyed to capture all the gene expression variation 
that happens at the beginning of development: 18, 20, 22, 24, 26, 30, 32, 36, 48, 60, 
72 and 96 hpf. 
Results 
To obtain an estimate of gene expression per melanocyte we measured the gene 
expression of the 4 genes we wanted to analyse (sox10, mitfa, kit and dct) in the 5 
embryo trunks, and then performed four ISH for the same genes in the rest of the 
embryos to count the number of cells expressing that particular gene in the trunk, as 
described in the workflow diagram above.  
To measure the gene expression through qPCR first we need to extract the RNA from 
the 5 embryo trunks using the TRIzol method, followed by a phenol:chloroform 
extraction, as described in Chapter 2. Then we need to perform a reverse 
transcription to produce cDNA using oligo-dT primers and finally we used that cDNA 
with specific primers for each of the four genes we want to measure to carry out the 
qPCR. 
To count the number of cells expressing each of the four genes we performed in situ 
hybridisation using FastRed to label cells expressing the gene with red fluorescence. 
Once the ISH were performed, the cells expressing the gene in the trunk had to be 
counted. Initially we tried to do it using High Content Microscopy, but it was not a 
good method for our experimental setup. Instead we photographed the specimens 
using a Zeiss Axio Imager 2 microscope. We used structured illumination (Zeiss 
Apotome) to generate images with high resolution in each of x, y and z planes. 
Initially, we attempted to use an image analysis programme (MINS (Lou et al., 2014)) 
to automate the process of quantitating  the fluorescence cells. However, the 
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program was not designed for zebrafish embryos and our type of cells, so it did not 
work for us. Instead we decided to count the cells manually from the fluorescence 
images. 
The copy number data for each gene together with the cell counts were used to 
estimate the copy number per cell in the embryo trunk for each stage. This data was 
then used in the parameter optimisation algorithm to find a set of parameters for the 
mathematical model that describes the evolution of the gene expression as closely 
as possible to the data we collected. 
Copy number quantification 
Polymerase Chain Reaction (PCR) is a technique for amplifying DNA that can be used 
when we need to amplify a tiny quantity of DNA so we get enough DNA to detect it, 
or when we want to compare two different samples of DNA to see which one is more 
abundant. If we amplify both samples at the same rate, it can be calculated which 
one had more copies of the target DNA to begin with. PCR is carried out by a 
thermostable polymerase enzyme, which synthesises a complementary strand to any 
single strand DNA, providing it has a double stranded starting point. This principle is 
what allows amplification of specific genes, as we can use primers that will hybridise 
with the single stranded DNA of our gene of interest to create a double stranded 
portion that the polymerase can use to synthesise the rest of the complementary 
strand. During the PCR the temperature is changed several times to control the action 
of the polymerase and the binding of primers. Usually the reaction starts with a rise 
in temperature to 95ºC to denature the initial double stranded DNA molecules. Then 
the temperature is lowered to around 60ºC (this will depend on the annealing 
temperature of the primers) to allow the primers to bind to the single stranded DNA 
molecule of our gene of interest. Lastly the temperature is raised to 72ºC as this is 
the optimal temperature for the polymerase. These temperature changes are 
repeated in cycles until we have enough amount of DNA. In every cycle the copies of 
our gene of interest double, so at the end of the PCR we well have 2n copies, where 
n is the number of cycles. Then we could use the product of the PCR to quantify our 
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gene of interest by for example running it on an agarose gel, where be brighter the 
band, the more copies of the target gene there are (Saiki et al., 1988).  
The principle behind real-time PCR (or quantitative PCR, qPCR) is the same, but 
instead of looking at bands on a gel the reaction is performed in a special 
thermocycler that monitors the amplification in “real-time”. There are many 
techniques to allow a PCR reaction to be monitored, but they all have in common the 
link of amplification of DNA and generation of fluorescence that can be detected with 
a camera during each PCR cycle. Hence, as the number of DNA molecules increase in 
the reaction, so does the fluorescence. The main benefit of this method over the 
normal PCR is that it allows quantitative analysis of gene expression; in comparison, 
normal PCR is semi-quantitative at best (Nolan et al., 2006). 
One of the main decisions when designing a qPCR experiment is choosing the right 
detection chemistry. These compounds generate fluorescence during the PCR 
amplification which allows the thermocycler to monitor the reaction in real time. The 
most commonly used chemistry (and the one we used in this project) are the 
intercalating dyes, in particular SYBRgreen. This dye is fluorescent on its own but in 
the presence of a double stranded DNA molecule, the dye intercalates with the DNA 
double helix, altering the dye chemical structure and increasing its fluorescence. So 
as the PCR generates more DNA, more dye binds to it and more fluorescence is 
produced. Intercalating dyes are the most economical detection chemistry method 
available, however they are not specific: if your PCR amplifies the wrong target, or 
more than one target, you will still get an amplification plot that will look like a real 
signal, as intercalating dyes will bind to any double stranded DNA molecule 
regardless of what it is (Bustin, 2000). This means that an additional analysis is 
required in the form of melt curve. This is carried out after the PCR reaction has 
finished and consists of heating the PCR products gradually from around 55ºC to 95ºC 
while fluorescence data is collected. At the beginning, the DNA is double stranded, 
bound to SYBRgreen, and therefore very fluorescent. As the PCR product is heated 
up the melting temperature of the PCR product will eventually be reached and the 
double strands will separate releasing the SYBRgreen. This results in a sudden drop 
in fluorescence. Subsequently all the PCR product is melted and the fluorescence 
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level plateaus again (Nolan et al., 2006). The data is usually presented as rate of 
change of fluorescence. The sudden change of fluorescence is seen at the melting 
temperature of the PCR product is visualised as a sharp peak in a flat background 
when only a small change in fluorescence is occurring. So in the perfect reaction 
where a single PCR product is amplified a single peak should be visualised. The 
melting temperature of our target gene amplicon can be calculated and therefore we 
can use the melting curve to check that we have amplified the right product. If more 
than one peak is observed it may indicate issues in the reaction such as primer dimers 
or amplification of genomic DNA. 
One of the most used ways to analyse gene expression is by relative quantification, 
which means assessing how the gene expression levels change between one sample 
relative to another. This is simpler to perform than absolute quantification and 
sometimes provides all the information we are looking for. This method is based on 
the doubling of the target DNA amount in every cycle of an efficient PCR reaction. If 
a PCR reaction reaches the exponential growth one cycle earlier than another 
reaction, then the former contained twice the target DNA at the beginning of the 
reaction (Wong and Medrano, 2005). However, for some experiments we need to 
know precisely the number of copies of a target DNA molecule in our sample. For 
example, when using qPCR for as a diagnostic tool to measure HIV viral load in the 
patient in order to know the dose of drug to be administer. In our case we need to 
know the exact copies to perform the parameter optimisation procedure in our 
mathematical model. To perform absolute quantification we need to use standard 
curves using a sample that contains our target gene at a known concertation. To 
achieve this we can clone our target amplicon into a vector (in our case a plasmid). 
The precise concentration of this vector is then measured to know the exact number 
of copies of the amplicon and then a serial dilution is performed (typically a 10 fold 
serial dilution). The user measured the Ct or Cp values (the cycle number at which 
the fluorescence signal crosses the threshold into the exponential growth) of the 
standard curve points and then compare them to the Ct values of the unknown 




For the standard curve we used plasmids containing the gene of interest cDNA that 
were initially designed and used to produce ISH probes. The gene insert, plasmid 
backbone and total length of the plasmid can be found in Table 3 in Chapter 2. These 
plasmids have been tested many times and they produce a probe that hybridises 
successfully with the mRNA in ISH. We used our primers to amplify our amplicon in a 
conventional PCR and all the four plasmids contained the right amplicon of 
approximately 100 bp. Therefore we used these plasmids to produce the 10-fold 
dilution standard curves. Initially we produced a 7 points curve, but when we tested 
it against our sample we realised that it was out of range in the bottom part of the 
curve, so we removed the top 4 points of the curves and added two more points at 
the bottom end of the curve, so our samples are in range. The standard curve results 
are usually plotted in a graph with Ct values versus the log of the cDNA quantities 
and a linear regression is obtained to fit these values. The slope of the linear 
regression equation measures the assay’s efficiency, with a slope of -3.32 indicating 
100% efficiency. This is because it takes 3.32 cycles in a 100% efficient qPCR 
amplification to increase the number of molecules 10-fold in each dilution (23.32=10) 
(Nolan et al., 2006). Figure 22 shows the standard curve for dct including the sample 
data points, as well as the linear regression equation and efficiency and R2 data. As it 
can be seen our unknown samples fit in the standard curve range and the efficiency 
is very close to 100%. Also R2 that measures the performance of the assay is very 
high, which indicates that the data fits very well the standard curve linear regression 
used to calculate copy numbers. The standard curves for the other three genes can 
be found in Appendix 5. The efficiencies of our assay are all within the acceptable 
PCR efficiency of 90-110% (or very close in the case of mitfa). The R2 of our assays 
are all higher than 0.98, which is the indicative of a stable and reliable assay (Nolan 




Figure 22. dct standard curve. The squares represent the five points of the standard curve by 
duplicate. The solid circles represent the unknown sample data points that are being 
measured. The linear regression equation is: y=-3.3x+37.84, R2=0-996, Efficiency=99.73%. 
 
A qPCR plate was run for each of the four genes. The samples were run in triplicate, 
and the standard curve points were run in duplicate. A no-template control (NTC) 
was also run, which contained all the reaction elements but the cDNA template. The 
NTC was negative in all of the plates, and the melt curve analysis carried out after the 
qPCR amplification showed a single sharp peak, indicating that only our target 
amplicon was amplified and that complications due to primer dimers or genomic 
DNA amplification were not an issue. 
The results of the qPCR can be seen in the graphs below. The bars represent the mean 






Figure 23. sox10 qPCR copy number data. Each of the columns represent the mean of the 
three measurements per stage and the error bars represent the associated standard 
deviation.  
 
Figure 24. kit  qPCR copy number data. Each of the columns represent the mean of the three 




Figure 25. mitfa qPCR copy number data. Each of the columns represent the mean of the 
three measurements per stage and the error bars represent the associated standard 
deviation. 
 
Figure 26. dct qPCR copy number data. Each of the columns represent the mean of the three 
measurements per stage and the error bars represent the associated standard deviation. 
 
As in many biological experiments our qPCR results are likely to be influenced by 
noise. Noise could be generated by organism-to-organism variation in mRNA levels, 
marginally different staging of the embryos within the same time point, or technical 
noise generated by slightly different measurements from the thermocycler 
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(Bengtsson et al., 2008; Brennecke et al., 2013). So it may be useful to try to reduce 
the noise by a process called smoothing. In smoothing, the data points of a signal are 
modified so that the points that are higher than the immediately adjacent points 
(presumably because of noise) are reduced, and points that are lower than the 
adjacent points are increased. This leads to a smoother signal with reduced noise 
without distorting the true signal too much (Spiess et al., 2015). 
The typical smoothing method is based on a moving average filter which smooths the 
data by replacing each data point with the average of the neighbouring data points. 
The method we used is called Savitzky-Golay filtering, and it is a generalised moving 
average with filter coefficients determined by an unweighted linear least-squares 
regression and a polynomial model of given degree (Matlab technical 
documentation). 
The smoothing procedure was carried out in Matlab (Appendix 6) and it started by 
loading the copy number data and associate standard deviation produced by the 
qPCR software. Then the copy number data was smoothed with the function 
“smooth” and the method “sgolay” (Savitzky-Golay). The smoothed, as well as the 




Figure 27. Smoothed copy number data from sox10, kit, mitfa and dct produced in Matlab 
using the Savitzky-Golay algorithm. The plots show the original data in the dotted line and 
the smoothed data in solid line with its associate standard deviation. 
 
As we can see in Figure 27 the smoothing procedure has reduced the big jumps in 
gene expression in between contiguous stages, making the changes in gene copy 
number more even in between closer stages, which it is what we expect to find in the 
organism: the copy number changes progressively rather than though big jumps. This 
data will be used in conjunction with the cell number counts to estimate the copy 
number per cell for each of the four genes. 
Cell number count 
We have obtained the copy number measurement of the four genes we are 
investigating through qPCR. To estimate the copy number per cell for the four genes 
we need to know how many cells are expressing our genes of interest in the trunk at 
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each of the stages we have measured. For this we carried out ISH for the four genes 
at the 12 stages selected using FastRed as a dye. Once the ISH were done we could 
start to count the labelled cells in the trunk region (same region we used to extract 
the RNA and perform the qPCR). Our aim was to develop an automated method to 
take the images and analyse them using a software to count the cells. That is why we 
investigated the use of high content microscopy (HCM), which allows the automation 
of image acquisition and its software has the capability of counting cells from the 
images acquired. Unexpected difficulties resulted in us adopting a manual imaging 
approach, using a Zeiss Axio Imager 2 with structured illumination attachment (Zeiss 
Apotome technology) to manually take Z-stack images of our ISH specimens. We 
initially attempted to implement an algorithm to perform automated cell counting. 
Regrettably this did not work as expected either. So finally we decided to count the 
relevant cells from the Apotome images manually. 
HCM 
High-content microscopy (HCM) is a powerful technique for high-throughput 
microscopic analysis of cells or tissues. HCM involves probing the cells or tissues, in a 
plate or on microscope slides, with single or multiple fluorescent dyes; capturing 
images of the cells very rapidly with a high-resolution imaging instrument; and then 
extracting detailed information from the images with powerful software. The 
automation and throughput provided by HCM allows you to get a lot of information 
and very quickly in comparison to normal microscopy. 
The high content microscope we used is the IN Cell Analyzer 2000. This microscope 
reads plates up to 96 wells, but it can also image microscope slides by using an 
adaptor. The plate (or slide adaptor) is placed at the top of the instrument and then 
it takes it inside to acquire the images. All the settings of the microscope are 
controlled from its software in the workstation. Once all your samples are in the plate 
wells and you have loaded the plate into the microscope, the next step involves the 
setup of the image acquisition parameters: wavelengths to record, objective to use, 
exposure, and focal plane to image. This last parameter is quite difficult to adjust. If 
your sample is a flat two dimensional tissue that sits on the bottom of the well surface 
imaging is relatively simple, but if you sample is a 3D tissue or organism you need to 
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tell the software an offset parameter that measures how far from the bottom of the 
well your plane of interest is. This microscope seems to be designed for cell culture 
or very thin tissues that sit on or very close to the bottom of the plate wells. The main 
issue we found when trying to image zebrafish embryo was that we needed to 
position them manually at the bottom of the well and on their side, which is the 
orientation we needed to image to obtain the best cell counts. Despite doing this, 
the embryos will sit in slightly different focal planes in each well so the focal offset 
parameter will be different in each well. All these issues made impossible for us to 
automate the image acquisition of ISH zebrafish embryos. Therefore we switched to 
manual mounting and individually imaging each embryo in the well of the plate. 
 
 
Figure 28. 30 hpf ISH embryos for dct using FastRed imaged by the IN Cell Analyser 2000 
HCM. These two images are from the same embryo and one single focal plane. Image A 
captures a region of the embryo closer to the head. Image B captures a region of the embryo 
closer to the tail. Image B is a continuation of A. Image orientation: embryo head is on the 
left and tail on the right of the images. 
Once the settings were adjusted, the microscope acquires the images that then can 
be analysed with the system’s software, which has tools to segment and count cells. 
The software works really well with cell cultures and thin tissue layers, but zebrafish 
embryos are very thick and the melanocytes stained are in different planes within 
the embryo. So when an image is captured from a focal plane we also get scattered 
fluorescence coming from the stained cells in the surrounding planes of the embryo, 
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decreasing the signal to background ratio (Figure 28). This makes very difficult for the 
software to identify and count the stained cells. Due to these issues with the HCM, 
we decided that this was not the right method to count cells in the zebrafish embryos 
for our experiment. Instead we decided that mounting and imaging the specimens in 
a conventional microscope, and then using software to identify and count the cells 
would be a better solution for us. 
Apotome and MINS software 
We have in the lab a state of the art Zeiss Axio Imager 2 with the Apotome.2 
technology. The Axio Imager 2 is a fluorescence microscope with outstanding optics, 
but what makes it very useful for our experiment is the structured illumination 
Apotome module integrated with the microscope. This technology allows you to 
perform optical sectioning in fluorescence images. Apotome projects a grid structure 
into the focal plane of your specimen, then moves it into three positions using a 
scanning mechanism. At each grid position, the system acquires an image. The three 
images are then processed to produce a resulting image of one optical section with 
improved contrast and increased resolution. It is especially useful to prevent 
scattered light from out of focus planes in thick specimens (such as embryos), 
producing images with high contrast and resolution, and very low background. It also 
has the advantage that the system remains as easy to operate as a conventional 
microscope (Zeiss technical documentation). 
We used this technology to take Z-stack Apotome images of our specimens. To take 
the best images with the microscope we needed the specimen on lateral position and 
as flat as possible, ideally just with a coverslip on top, without using spacers in 
between the slide and the coverslip. In this way we would reduce the number of 
planes to image on the Z-stack and will make sure that we have many cells in focus 
on each plane. When we initially tried to put a coverslip on top of the glycerol drop 
containing the embryo, the head and yolk sac were squashed and the yolk sac burst 
releasing a lot of debris that would hinder a good photography. Therefore to avoid 
this we dissected the head and the yolk sac of each embryo, keeping the trunk, which 
is the part we are interested in and we need to count, and the tail. This made the 
specimens very flat and allowed us to use just one coverslip on top of the embryo. 
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3D images of four individual embryos were taken for each stage. These 3D images 
were then used to count the cell number. 
The software that we selected to perform this task was MINS (Modular Interactive 
Nuclei Segmentation) software developed by Xinghua Lou (Lou et al., 2014), and 
recommended by our colleague Silvia Muñoz Descalzo, as she used it successfully to 
count and analyse stem cell cultures and preimplantation stage mouse embryos (Le 
Bin et al., 2014). MINS is a program that runs in Matlab and was designed for nuclei 
segmentation. The software consists of three modules: detection, segmentation, and 
classification. The detection parts locates the cell nuclei. Then by segmentation, the 
detection output is expanded to cover the full nuclear body. And finally the 
classification module removes outliers, gives a result table with a quantitative 
analysis of fluorescently labelled cells, and allows classification of the cells depending 
on their position in the image (Lou et al., 2014). The software was designed to analyse 
confocal Z-stack images, so it worked well with our Apotome 3D files. However, MINS 
was programmed to identify nuclei, and therefore it struggled to recognise the red 
labelled melanocytes, as their shape is very different to that of nuclei.  
We then asked whether staining of the melanocyte nuclei (Hoechst stain, post ISH; 
nuclei blue) would allow the software to identify them and then allow the expansion 
of the nuclei to include the entire cell. Initially we tried it in just a batch of embryos 
from mitfa ISH to test the method. The idea was that first the nuclei would be 
detected using the blue channel image, then the segmentation tool would assess the 
red channel data, expanding the nuclear area in those cases where it found red 
fluorescence surrounding the nucleus to cover the whole melanocyte, and finally 
those cells with red fluorescence were counted as  melanocytes. However, zebrafish 
embryos have thousands of cells in the trunk, and when using the detecting module 
it needed a lot of time and a huge computer power, which was not available, 
therefore it crashed every time. We arranged the use of a high performance 
computer to do this analysis but first we needed to probe that it worked. So we 
extracted a subset of 4 planes from the original Z-stack to try to reduce the number 
of nuclei on the images to be identified. We run the detection module for over a 
weekend and we managed to obtain a file with the nuclei identified (Figure 29), but 
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when we tried to segment the melanocytes by expanding the nuclear signal the 
program detected way more melanocytes that there actually were on the image, as 
it assumed some of the background (even as low as it was) to be real red signal 
coming from the melanocytes. Also, these cells have an irregular shape which make 
them a quite challenging to segment. Moreover, the segmentation took several 
hours again. After all these testing we concluded that this method was not useful to 




Figure 29. Image from a mitfa ISH stained with Hoechst to label the nuclei. The image was 
taken using a 63x objective, and a subset of 4 planes out the whole Z-stack was used to detect 
the nuclei using MINS (Panel B), which managed to identify most of the nuclei quite 
successfully. Images taken from the mid trunk, above the yolk sac extension. Image 
orientation: embryo head is on the right and tail on the left of the images. Scale bar for both 






We came to the conclusion that the fastest and more accurate way to count the cells 
was by doing it manually by eye using the Apotome 3D images and the software 
ImageJ. 
Microscopy 
We acquired four Z-stacks of the trunk region per stage using the Apotome. We took 
images of the 12 stages processed for the four genes.  
 
 
Figure 30. This panel shows an example of single plane of the Z-stacks imaged using the 
Apotome from mitfa and dct ISH at stages 24 and 36 hpf. The Apotome technology produces 
high contrast and high resolution images where cells are quite easy to count manually. 
Images taken from the mid trunk, above the yolk sac extension. Image orientation: embryo 
head is on the left and tail on the right of the images. Scale bar for all images: 50 µm. 
 
Once the images were collected we proceeded to count the cells. For that we used a 
cell counter plug-in in ImageJ that allows you to mark each cell you have counted 
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with the mouse. It also keeps those markers in the different planes of the Z-stack to 
avoid double counting of the same cell present in adjacent planes. Once you have 
gone through all the planes in a stack, the plug-in gives you the number of cells you 
have counted. 
First of all we counted the dct ISH, as this gene is a melanocyte differentiation marker 
and provides the better estimate of melanocytes and their precursors at each stage 
(Elworthy et al., 2003). We imaged four specimens per stage and we counted each 
image three times, producing cell counts that can be seen in Figure 31. However, as 
dct is a marker for melanocyte differentiation it is not the best gene to estimate the 
cell number at early stages development, when the cell is differentiation. For that 
the best estimate comes from the mitfa ISH (Montero-Balaguer et al., 2006; Nguyen 
et al., 2010). Nevertheless, not all the neural crest that turn on mitfa will become 
melanocytes. Some will become iridophores instead, as there is a bipotent 
melanophore/iridophore precursor that expresses mitfa. By 32 hpf, mitfa positive 
bipotent precursors will have chosen to become melanocytes or iridophores. Hence, 
we predicted that at some point, likely around 32 hpf, the two markers of melanocyte 
lineage cells would coincide, at a stage when all cells were expressing both markers 
at detectable levels (Curran et al., 2010). We counted mitfa expressing cells until the 
stage when both mitfa and dct numbers match, which happened at 32 and 36 hpf, as 
can be seen in Figure 32. For sox10 and kit we counted only half of the stages, as we 
soon realised that these were not going to be used to calculate the copy number per 
cell, since both sox10 and kit are expressed in many tissues other than melanocyte 




Figure 31. The plots above represent the mean cell number count per stage in the four 
different genes that we are investigating. The plots show also the associated standard 




Figure 32. mitfa and dct cell counts. The number of cells match at 32 and 36 hpf, Therefore 
mitfa cell counts were used until 32 hpf and the dct cell counts were used for the rest of the 
stages. 
 
In order to be sure that the melanocyte cell counts from the ISH represent the real 
melanocyte number, we compared the dct ISH counts at 60, 72 and 96 hpf with 
counts of melanised melanocytes in wild type embryos that did not go through an 
ISH experiment. The melanised melanocyte count (Figure 33) numbers for the three 
stages are very similar to the numbers of the dct ISH for those same stages, 






Figure 33. Melanised melanocyte mean counts from untreated zebrafish embryos with 
standard deviation error bars 
 
As with the qPCR copy number data we performed a smoothing procedure with the 
cell number data. We used the cell count numbers from the mitfa ISH for the early 
stages of development, as this gene is a better marker of melanocyte specification 
than dct, which is a better marker of differentiated melanocytes (Lister et al., 1999; 
Elworthy et al., 2003). Therefore we used mitfa cell numbers until they match the 
number of dct expressing cells (32-36 hpf); from that point onwards we use the dct 
cell count. 
The data smoothing process was carried out using Matlab and the same method as 
before (Savitzky-Golay). The smoothed data (Figure 34) will be used with the 




Figure 34. This graph shows the cell count smooth data in the solid line and the original data 
in the dotted line. This cell number counts come from the mitfa counts from 18 to 32 hpf and 
the dct counts from then onwards. 
 
Copy number per cell estimation 
The copy number measured from the four genes through qPCR together with the cell 
number estimated from mitfa and dct cell counts were going to be used to estimate 
the copy number per cell that we needed to perform the parameter optimisation of 
the mathematical model to make it quantitative.  
Sox10 is expressed in many tissues other than melanocyte lineage cells: glial cells, 
enteric and sensory neurons, dorsal root ganglia, oligodendrocytes, among others 
(ZFIN). Kit is also expressed in a wide variety of tissues besides melanocytes: 
epiphysis, gut, heart, mucus secreting cells, notochord, optic vesicle, proctodeum, 
among others (ZFIN). Therefore the copy numbers that we measured though qPCR 
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come from all those tissues, not only melanocytes. The same happened with the cell 
numbers we counted: only a portion of the sox10 or kit expressing cells are 
melanocytes, the rest would be other cells expressing those same genes. Because of 
this, we concluded that the copy number per cell calculated using the copy number 
and cell number measurements for both sox10 and kit would be very far away from 
a real estimate, and hence we decided not to use produce this estimate and not to 
use it for the parameter optimisation procedure. 
Therefore, we used the smoothed data for both copy numbers and cell numbers for 
mitfa and dct to estimate the copy numbers per cell in the zebrafish embryo trunk. 
 
 
Figure 35. Copy number per cell in the embryo trunk calculated dividing copy number by the 
cell number for each gene. The plots show the standard deviation error bars.   
 
For mitfa we saw no detectable expression in melanoblasts at 18 hpf (Figure 31). It 
was therefore surprising to see quite a high copy number for mitfa expression at 18 
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hpf. When the quotient of copy numbers and cell numbers was calculated the result 
for 18hpf was undefined, as we had to divide by 0. In this instance the Matlab script 
produced a value of 0 copies per cell at 18 hpf. For dct both copy number and cell 
number were 0 at 18 hpf. Hence we decided to remove the 18hpf time point from 
our analysis as this estimate was probably erroneous and would be a confounding 
factor in the parameter optimisation. 
Parameter optimisation 
The parameter optimisation aims to find the best parameter values so the 
mathematical model predictions are as close as possible to the experimental data 
collected. For that we use an objective function that calculates the error from the 
predicted trajectory calculated with a set of parameters and the measured data; and 
we try to minimise that error finding new parameter values through a nonlinear least-
squares solver. 
The error function calculates the difference between the copy number value from 
the data (Ymeas) produced by qPCR and the copy number value predicted by the 
differential equation solver (ode45) with a set of parameter values (Ypred). This is then 
divided by the standard deviation of the measured data (σmeas) as a way to penalise 




          (1) 
This is calculated for every time point of the data values. Then the objective function 
returns a vector (called lsqerr in our Matlab code) for the 'squares' to be minimised 
by the nonlinear least-squares optimisation algorithm (lsqnonlin). 
In the error function Ymeas represents the copy number per cells value that was 
calculated by the quotient of the copy number and the cell number for each gene. 
However, to calculate the σmeas we cannot use the quotient of σ from the copy 




          (2) 
137 
 
Where ∆C represents the copies per cell standard deviation, ?̅? is the cell number, ∆X 
is the copy number standard deviation, ?̅? is the copy number, and ∆Y is the cell 
number standard deviation; this is calculated for each stage. 
The nonlinear least-squares optimisation algorithm starts looking for a parameter set 
that minimised the objective function using an initial value of the parameter set. 
Then it will modify the values of the parameters until it finds a minimum for the 
objective function. After that, our Matlab script will calculate again the mathematical 
model trajectories using the ODE solver and will plot them in a graph together with 
the data points to be evaluated. 
This is repeated several times using as initial parameter values the output values from 
the previous optimisation round. We can also adjust the error function so the 
optimised parameters produce solutions that are as close as possible to the data. 
The first time that we ran the optimisation algorithm (Appendix 8) we used the 
parameter set from Greenhill et al. (2011) as initial parameter values to be optimised. 
In this list of 59 parameters the first 8 correspond to the value of the initial 
concentration of each of the genes of the network at time 0, which was set at 0 
(Appendix 1). We selected parameters from 9 to 59 to be optimised through the 
nonlinear least-squares optimisation algorithm using this objective function 
lsqerr=(Ymeas-Ypred)./(YmeasStD) (same as in equation 1). 
Figure 36 represents the trajectories of the mathematical model from Greenhill et al 
(2011) using their parameter values. As it can be seen the units in the Y axis of the 
graph are in the order of ten or less, as the parameter values. However, our copies 
per cell data for mitfa and dct are in the order of ten thousand (Figure 15). If we 
perform the parameter optimisation using the Greenhill parameters as initial values 
the algorithm will struggle to fit the ODE trajectories to the data as it will be several 
orders of magnitude higher. Hence, we re-scaled the data so it was in similar 
dimensions to the parameters, under which conditions the parameter optimisation 
algorithm is able to find a parameter set that minimises the objective function. The 
factor that used to re-scale the data is (2/3000), which will bring the copies per cell 
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numbers to around ten or less. This re-scaling is reverted after the parameter 
optimisation is done, allowing estimates of copies per cell to be presented accurately. 
 
Figure 36. Mathematical model simulation using the Greenhill et al. (2011) parameter values. 
 
After the first iteration of parameter optimisation algorithm using the parameter 
values from Greenhill et al (2011), the solutions to the ODEs with the newly found 
set of parameters were very far from the data points. Therefore some changes were 
dome in our algorithm to try to get the nonlinear least-squares optimisation 
algorithm to find parameters that produce ODEs solutions closer to our data points. 
First of all we changed the objective error function to a logarithmic one. The new 
error function is as follows: 
𝐸 =
log (𝑌𝑚𝑒𝑎𝑠) − log (𝑌𝑝𝑟𝑒𝑑)
𝜎𝑚𝑒𝑎𝑠
𝑌𝑚𝑒𝑎𝑠
          (3) 
139 
 
In this equation Ymeas represents the copies per cell data measured, Ypred represents 
the copies per cell data predicted by the differential equation solver (ode45) with a 
set of parameter values, and σmeas represents the standard deviation of the measured 
data. 
We also artificially reduced the standard deviation of the measured data (σmeas) that 
is used in the objective error function to be minimised. This will force the algorithm 
to find a set of parameters that produces a predicted data that is more similar to the 
measured one for the error function to be small. As it can be seen in the error 
function above (Equation 3), the standard deviation of the measured data is on the 
denominator of the error quotient. Let’s imagine that the data predicted (Ypred) with 
one set of parameters is far from the measured data (Ymeas), which would make the 
subtraction of the numerator of Equation 3 large. If this subtraction is divided by a 
large measured standard deviation (σmeas) the resulting error (E) would be small. 
However, if the subtraction is divided by a small measured standard deviation the 
resulting error would be large. This would tell to the nonlinear least-squares 
optimisation algorithm (lsqnonlin) that the current set of parameters produce a 
solution for the ODEs that is far from the measured data. Hence, the lsqnonlin 
function will have to keep looking for parameters until it finds a set that minimise the 
error function. Based on this principle we divided the standard deviation of both the 
measured dct and mitfa copies per cell data by a certain factor that would be 
adjusted in successive rounds of the parameter optimisation algorithm. 
A reason why the nonlinear least-squares optimisation algorithm may struggle to find 
a good set of parameters that produce solutions for the ODE that match the data is 
that we do not have enough data. The algorithm tries to find optimal values for 50 
parameters using just 22 data points. This seems to be insufficient as the algorithm 
could not find a minimum for the objective error function. To try to overcome this 
issue we used the smoothed measured data points to construct new data points in 
between each of the measured data points through interpolation. These new data 
points will be more densely constructed at early stages (from 20 to 30 hpf) of 
development. These are the stages where our data changes the most, and where we 
need a closer match of the data and the predicted ODEs trajectories. We created 22 
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extra points for each gene, so we had a total of 66 data points to fit, 33 from each 
gene mitfa and dct: 11 measured data points and 22 newly constructed data points. 
Thus, the number of data points was now higher than the number of parameters to 
fit (66 versus 50), which should help the parameter optimisation algorithm. 
After the previous modifications to the algorithm we performed several iterations of 
the parameter optimisation procedure. As mention before, we used the new 
parameters found in each round, as the initial parameters for the next one. We also 
changed the factor by which we modified the measured standard deviation of the 
data trying to get a better fit of the ODEs trajectories and the data. After several 
iterations we got a set of parameters (Appendix 9) that produced the ODE 
trajectories in Figure 37. 
 
Figure 37. Mathematical model simulation for the new parameters obtained from the 
parameter optimisation algorithm. The graph plots the solutions for the ordinary differential 
equations of the model using the new parameter values for each of the GRN genes (solid 
lines). The figure also shows the measure data points (x) with their associated standard 
deviation error bars and the constructed data points by interpolation (dots) The new 
solutions for mitfa and dct (green and red lines) are very close to the mitfa and dct 




These new parameter values produced the closest trajectories for the mitfa and dct 
genes to the experimental data measured. As it can be seen in the figure above, their 
trajectories fit within the standard deviation error bars for all the data points in both 
genes. These new parameters have changed the shape of both curves substantially 
when compared with the trajectories of the Greenhill et al. (2011) simulation (Figure 
36). Both curves still have their maximum point at approximately the same 
developmental times: mitfa at around 20-24 hpf and dct at around 55 hpf. However, 
in the new simulation mitfa expression rises very rapidly early in development, then 
it goes down substantially and stays down, while in the Greenhill simulation mitfa 
expression was increasing more steadily and stayed up thoughout development. In 
the new simulation dct goes up gradually, like in the Greenhill simulation, but its 
expression decreases at later stages, unlike in the Greenhill simulation where it 
stayed up through development. 
If we look at the rest of the genes, sox10 expression is much lower that in the 
Greenhill simulation throughout. The opposite occurs with sox9b, whose expression 
is much higher than in the Greenhill simulation. The kick off time for Factors A and B 
are now different (they started at the same time with the Greenhill parameters). 
Factor B now stays on for longer than in the Greenhill scenario, and it has became 
the main factor driving dct expression via sox9b. The trajectories for both kit and 
tyrp1 gene expression levels seem oddly low in comparison to the Greenhill 
simulation. The GRN establishes that Factor A drives sox10 expression, and then 
sox10 regulates mitfa activity. However in the simulation above, Factor A, sox10 and 
mitfa expression seemed to start at same time. When we studied a close-up of the 
trajectories at early stages of development (Figure 38) it could be seen that Factor A 




Figure 38. Close-up of the mathematical model trajectories from Figure 37 at early stages of 
development that show the details of Factor A, sox10 and mitfa induction. 
 
Studying the new parameter values in more detail can help us understand how the 
model works and why some of the trajectories do not fit the experimental data 
available. Most of the new parameter values obtained are in the same order of 
magnitude and are quite similar to the Greenhill et al. (2011) values, but some of 
them are very different in order to produce trajectories to fit the experimental data. 
The first new parameter value that is significantly different to the Greenhill et al. 
(2011) value is 𝛽 which represent the steepness of the Hill like function that regulates 
the activity of the input factors A and B. The new value is 50 and the old 2, this is 
because the new model needs A and B to rise rapidly to activate sox10 and lead to a 
rapid increase in mitfa expression to reach the high concentrations that we find at 20 
hpf in the experimental data. Both 𝛽1 and 𝜙0 have significantly higher values in our 
new parameter optimisation than the values in the Greenhill model. These 
parameters control the growth rate of sox10 due to the activation signal from factor 
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A and Mitfa, and represent the rate of binding and unbinding of the transcription 
factor to the regulatory element of sox10. The new values of parameters 𝜆1 and 𝜈0 
are considerably higher than the values from the old model. These parameters are 
part of the equation that regulates the growth rate of dct due to the signalling coming 
from mitfa and sox9b. Therefore it makes sense that these parameter are quite high, 
as the model needs to produce a very high dct expression trajectory to fit the 
experimental data. The parameter that regulates the growth rate of mitfa expression 
𝑔𝑀 is also considerably higher in the new model than in the previous one, which is 
necessary to produce high enough mitfa expression to fit the experimental data. If 
we consider the parameters that regulate the rate of change of tyrp1 over time, the 
new value for 𝑔𝑇 is significantly lower than the old one, and 𝑑𝑇 is a bit higher than 
before. This would explain why the levels of tryp1 in the new model are so low. The 
dynamics of hdac1 are similar in both models, as the new parameter values from the 
equation that describes the dynamics of hdac1 are very similar to the Greenhill ones. 
The table below (Table 9) shows a detailed comparison of all the parameter values 
from the Greenhill model and the new values obtained in this project after fitting the 
model to the experimental data that collected. 
Table 9. This table shows a comparison of the parameter values used in the Greenhill et al. 
(2011) model and the new parameter values that we obtained in this project through the 
parameter optimisation procedure using the experimental data. 
Parameter Greenhill values New values 
𝑍 (𝑡0) – Sox9b 0 0 
𝑆 (𝑡0) – Sox10 0 0 
𝑀 (𝑡0) – Mitfa 0 0 
𝑌 (𝑡0) – Kit 0 0 
𝐻 (𝑡0) – Hdac1 0 0 
𝑇 (𝑡0) – Tyrp1 0 0 
𝐷 (𝑡0) – Dct 0 0 
𝛽  2 50 
𝑡𝐴  12 17.3836 
𝑡1  12 19.7444 
𝑡2  24 21.5723 
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𝐴0  1 0.7879 
𝐵0  1 1.5166 
𝜌0  1 1.5163 
𝜌1  0.5 0.3125 
𝛼0  2.2 1.7649 
𝛼1  1 1.5014 
𝛽0  1.3 0.5054 
𝛽1  1.2 5.5983 
𝜙0  2 7.5692 
𝜙1  0.1 0.0537 
𝜉0  1.6 0.7246 
𝜉1  1.1 2.8502 
𝑌∗  0.01 0.1452 
𝑀∗  0.01 0.5032 
𝛾0
(1)
  1.5 2.5221 
𝛾0
(2)
  1 3.1304 
𝛾1
(1)
  1 2.5167 
𝛾1
(2)
  0.8 0.8393 
𝑘1  1 3.1280 
𝑘2  1 0.9034 
𝜎0  1.6 0.5804 
𝜎1  1.1 2.4771 
𝛿0  1.6 1.2058 
𝛿1  0.5 1.7523 
𝜃0  0.1 0.0290 
𝜃1  0.5 1.2133 
𝜇0  0.1 0.0019 
𝜇1  1.3 1.2893 
𝜆0  1 0.0337 
𝜆1  1 51.8319 
𝜈0  1 15.3247 
𝜈1  1.2 1.5921 
𝜀0  0.2 0.1899 
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𝜀1  1.3 1.6547 
𝑔𝑍  0.1 0.1873 
𝑑𝑍  0.2 0.0443 
𝑔𝑆  0.3 0.6880 
𝑑𝑆  0.3 3.2927 
𝑔𝑀  0.3 22.8155 
𝑑𝑀  0.3 3.0681 
𝑔𝑌  0.15 0.0204 
𝑑𝑌  0.2 0.0998 
𝑔𝐻  0.3 0.3465 
𝑑𝐻  0.03 0.0000 
𝑔𝑇  3.1 0.0165 
𝑑𝑇  0.2 0.3770 
𝑔𝐷  0.3 1.4234 
𝑑𝐷  0.1 0.0736 
 
The new parameter values obtained in the parameter optimisation procedure 
produce a simulation that predicts high levels of sox9b and very low levels of tyrp1 
throughout (Figure 37). However, this is incompatible with the experimental data 
gathered by Greenhill et al. (2011) where expression of sox9b was low and restricted 
just to the early phase of melanocyte development, and tyrp1 was expressed at high 
levels at least until 36 hpf (Greenhill et al., 2011).  
Therefore we thought that maybe a change in the model equations could produce a 
better fit to the data. The positive feedback loop between mitfa and kit should be 
the main driving force that produce high levels of Dct enzyme, however in the 
previous simulation is sox9b (with a very high expression) the factor that takes up 
this role, driving enough dct expression to make the model fit the data, while kit 
expression is low. Hence we proposed that a change in the kit equation, specifically 
in the way kit is activated, could translate in kit expression rising to maintain higher 
levels of mitfa and drive high dct expression. 
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In addition, we established on chapter 3 that sox10 drives kit expression earlier in 
melanocyte development. Hence, we thought that by modifying the kit equation to 
account for this interaction we could achieve enough kit expression levels early in 
melanocyte development to maintain higher levels of mitfa and drive enough dct 
expression to fit the data. 
Following this reasoning we modified the activation term of the kit equation (labelled 
Y in the model) that describes the variation of kit over time, to include the effects of 





𝑀 − 𝑑𝑌𝑌          (4) 






𝑆) − 𝑑𝑌𝑌          (5) 
In this equation 𝑔𝑌
𝑀 represents the activation rate of kit by Mitfa and this term is 
described in the appendix, as it remains the same as in the Greenhill et al. (2011) 
model. 𝑔𝑌
𝑆 is the new term that describes the activation rate of kit by Sox10, and it is 
described by equation (6) bellow. 𝑑𝑌 represents the degradation rate of Kit. To 
describe the activation of kit by Sox10 we used a Michaelis-Menten type of function 
and we assumed that the Sox10 transcription factor binds to the kit promoter as a 





          (6) 
In this equation 𝑔𝑌 represents the rate at which Kit is produced. 𝜂0 and 𝜂1 describe 
the rates of binding and unbinding of the transcription factor Sox10 to the kit 
promoter. S represents the concentration of Sox10. 
In addition, as Greenhill et al. (2011) established experimentally that the expression 
of sox9b was low and restricted to the early phase of melanocyte development, and 
hence the activation of dct by Sox9b was close to negligible, we decided to not 
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include the parameters related to the equation that describes the change of sox9b 
expression over time in the model. In this way we may avoid the parameter 
optimisation algorithm to use sox9b as the main driver of dct expression, and it will 
be forced to look at the other mayor diver of dct expression, mitfa, when finding new 
parameter values.  
It was also noticed that the 20hpf data point for mitfa had very large standard 
deviation bars and that it may have been overestimated. This might have been 
because mitfa is expressed in many cells but under the detection levels of the in situ 
hybridisation techniques at 20 hpf. It might be that the expression per embryo trunk 
was very high but the number of cells expressing mitfa that were detected at that 
time point was low, as many mitfa-expressing cells would be under the detection 
threshold and would have not been counted. Both of these pieces of data produced 
a copy number per cell estimation that could be aberrant. As a consequence, it seems 
reasonable to penalise less those parameter value combinations that produce a mitfa 
trajectory that is not that close to the mitfa data point at 20 hpf. To do that its 
standard deviation was artificially made 100 times bigger than the standard deviation 
of the rest of the data points. Hence, those models that produce a curve for mitfa 
which does not come close to the 20 hpf data point will not be too penalised, as this 
point might be an outlier. 
Thus, we performed these changes in the parameter optimisation algorithm and ran 
the procedure again in Matlab to see if a better parameter values is achieved, and 
hence better trajectories in the model. The optimisation algorithm was run for 17 




Figure 39. Mathematical model simulation for the new parameters obtained from the 
parameter optimisation algorithm after making modifications in the kit equation, mitfa 20 
hpf data point, and sox9b parameters. The graph plots the solutions for the ordinary 
differential equations of the model using the new parameter values for each of the GRN 
genes (solid lines). The figure also shows the measure data points (x) with their associated 
standard deviation error bars and the constructed data points by interpolation (dots). 
 
After making these changes, the trajectory for sox10 is higher than before and it is 
closer in shape to the one in the Greenhill model. mitfa now does not go up sharply 
to try to reach the data point at 20 hpf, as we have modified its standard deviation, 
and its trajectory is quite close to the mitfa data points if we do not take into account 
the 20 hpf point. kit expression seems to be higher than previously. tyrp1 expression 
is still very low, and due to the changes made we have decreased the expression 
levels of sox9b, although it might have been too much, as its trajectory is much lower 
in relative terms than that in the Greenhill model. Unfortunately, these changes have 
not achieve a dct trajectory that goes close to the data points. hdac1 trajectory 




Our aim was to develop a quantitative mathematical model to describe the gene 
regulatory network that drives melanocyte development. To produce a quantitative 
mathematical model we need to collect data so we can generate the equations and 
parameter values to describe that data. Therefore, if we want to model a single cell 
behaviour we should measure single cell data. However, measuring single cell gene 
expression data is very challenging. Our initial idea was to use a transgenic line that 
uses the sox10 promoter to drive EGFP expression with a FACS machine to select 
sox10 expressing cells, that then we would use to measure gene expression. However 
a sox10:EGFP transgenic line would label many other cells besides melanocytes, so a 
better line to use would be mitfa:EGFP, as mitfa only labels cells with potential to 
become melanocytes. With this approach we would count the number of 
melanocytes sorted and then we would use them to extract RNA and measure the 
gene expression of the GRN players through qPCR. We would get a measurement of 
gene copy number per cell. Unfortunately at the start of this project the laboratory 
did not have local access to a FACS machine able to do sorting.  
Therefore we came up with a different experimental set up. We would obtain an 
estimate of gene expression per melanocyte measuring the gene expression of the 4 
genes we wanted to analyse (sox10, mitfa, kit and dct) in 5 embryo trunks, and then 
we would do four ISH for the same genes in sibling embryos to count the number of 
cells expressing that particular gene in the trunk. In this way we would be able to 
produce an estimate of gene copy number per melanocyte that could be used to 
perform the parameter optimisation.  
Copy number quantification 
Three of the primers that we used to amplify our four gene of interest (sox10, kit and 
dct) were designed by the company PrimerDesign and described in Table 1 in Chapter 
2. We chose this company to design the primers because we got a sponsorship from 
them, but also because they guarantee primer specificity and an efficiency of more 
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than 90%, as well as validating the primer on zebrafish embryo cDNA that I sent them. 
Therefore we were sure the primers we got were of very good quality and were going 
to work in our samples. They did not design the mitfa primer for us because we used 
a primer previously designed by Laura Vibert in her thesis. 
The qPCR reaction produced no amplification in any of the NTC (with water and 
reaction mix, instead of template and reaction mix) wells for all the four genes, which 
means that there are no primer dimers or contamination that would lead to non-
specific amplification. The melt curves of all the genes showed a single sharp peak, 
which means that only one amplicon was amplified, and no primer dimers or genomic 
DNA amplification was produced, so our primers are very specific for our amplicons. 
Every stage was measured in triplicate for each gene, and a mean and standard 
deviation of the three measurements was produced. Then the qPCR program 
(Illumina Eco software) used the standard curve to produce a copy number average 
and its associated standard deviation. This average value was measured from 5 
embryo trunks, so we divided it by 5 to calculate the copy number per trunk for each 
stage and gene, and this is what we plotted in Figure 23 to Figure 26.  
These data showed that there are some big jumps on gene expression in most of the 
genes between contiguous stages. This happens in mitfa (Figure 25) for example, 
where gene expression is high at 18 hpf then it goes down drastically at 20 hpf, to 
then come back up again at 22 hpf. This is unlikely to happen in reality, especially at 
the beginning of development when we sampled every 2 hours. This most likely 
represents noise in the gene expression measurement that could be caused by 
several causes: embryo-to-embryo gene expression level variation, marginally 
different staging of the embryos within the same time point, slightly different 
dissected trunks used for the measurements, or variation in the amount of cDNA 
incorporated into each of the qPCR triplicates. That is why we decided to smooth the 
data to reduce the influence of noise (Spiess et al., 2015). By smoothing the data 
points of a signal are modified taking into account the signal of the contiguous data 
points. So the points with a signal that is higher than that of the adjacent points are 
reduced, and points that have a lower signal than the nearby ones are increased. This 
reduces the noise of the signal making the data smoother. The method that we 
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selected to perform the data smoothing in Matlab was the Savitzky-Golay, which has 
been used before with qPCR data (Spiess et al., 2015).  
After the smoothing procedure the noise has been reduced and the data seems to 
show less jumps in gene copy number in between contiguous stages. However, there 
are still some dips in the copy number of some genes such as mitfa at early stages 
that do not look very likely in a biological context. The cell counts would shed some 
light into the copy number results and will help us make more sense of it. 
Cell number count 
We had measured the gene expression levels for each gene in five embryo trunks and 
have estimated the gene copy numbers per stage in one trunk. In order to calculate 
the gene copy number per cell on the trunk we need to know the number of cells 
expressing each of the genes that there are in an embryo trunk. For that we carried 
out ISH for each gene and stage. 
In the lab we normally use NBT/BCIP to label the signal in ISH, but in this case we 
used FastRed, which emits red fluorescence under a fluorescent microscope. We 
decided to use FastRed because fluorescence signal is much easier to identify and 
distinguish from the background by software. This is because a fluorescence image is 
captured in black and white where intense white pixels represent signal, black pixels 
indicate lack of signal, and background is denoted by pixels with low intensity values 
of white. This is easier to identify by software than a colour image from a NBT/BCIP 
ISH where purple would represent signal but at the same time there are many other 
confounding colours on the image representing background and other structures in 
the embryo. Also FastRed has the advantage that it works very similarly to NBT/BCIP: 
the specimens have to be incubated with the FastRed solution, which the alkaline 
phosphatase will transform and deposit in the gene expressing cells. This means that 
the whole ISH protocol is just the same as the conventional one, just changing the 
staining solution. 
Initially we thought about using the High Content Microscope (HCM) to image all our 
specimens. We have four genes, with 12 stages each, and we wanted to count four 
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ISH embryos per stage, which make a total of 192 embryos to image and count. The 
high throughput capabilities of the HCM made it ideal for our purpose. The initial idea 
was to put each of our embryos in one of the wells of a 96-wells plate and then image 
them using a Z-stack to capture the whole width of the trunk. However, when I did a 
test with just some embryos to learn how to use the microscope we realised that it 
was not going to be as simple as that. If we randomly placed our embryos in glycerol 
to the well it was very likely that they were not position laterally but even more 
important it was very unlikely that they were right at the bottom of the well, so each 
embryo would be in slightly different plane relative to the bottom of the well. The 
HCM has a setting to account for that Z offset (if the sample is in a different plane 
than the bottom of the well), however once you set this offset it is the same for the 
96 wells of the plate, and in our case each embryo would be different. Therefore we 
came to the conclusion that the only way to make this work was to mount each 
embryo individually in a lateral position and at the bottom of the well. For that we 
could not use 96-well plates, as there was not enough room to mount the embryos 
so we used 12-well plates. Nevertheless, even though we placed the embryo right at 
the bottom of the well, there was enough difference in between the embryo in one 
well to the one in the next one so that we could not use the same offset parameter. 
Thus we realised that it was not going to be possible to automate the image 
acquisition in a time effective way and that we needed to do it one by one. This meant 
that we could not use the major advantage of the HCM (high throughput and 
automation), and if we were going to use it like a normal microscope it was difficult 
to operate as all the controls were through the software. Moreover, even when we 
managed to take a photo of our embryos, the background was quite high as the 
system could not eliminate the out of focus signal from the rest of the planes. This 
made the images very difficult to analyse using the microscope software, and we 
were never capable of successfully segmenting the melanocytes in the embryo trunk 
to count them. Finally, we concluded that the best option was to use a stereoscope 
to acquire high quality images of our embryos and then analyse those images with a 
software to count the melanocytes. 
153 
 
At this time, we acquired a Zeiss Axio Imager 2 fluorescence microscope with the 
Apotome technology in the lab. The Apotome technology allows you to perform 
optical sectioning in fluorescence images, preventing the scattered light from out of 
focus planes in thick specimens. It produces images with high contrast and resolution 
and very low background. The main advantage is that is as easy to use as a 
conventional microscope. We decided to use this technology to take our images and 
then analyse them with a software called MINS. 
To take the images we mounted the specimen on a slide and coverslip and used the 
Zeiss Axio Imager 2 microscope with the Apotome module to take Z-stack images. 
We used the 20x magnification objective, the one with the lowest numerical aperture 
that fitted the whole trunk region in a single plane, to focus on the region of the trunk 
we needed to count (between the beginning and end of the yolk sac extension), and 
imaged the whole thickness of the embryo using Z-stacks. 
We initially intended to analyse these images with the software MINS (Modular 
Interactive Nuclei Segmentation), which had been previously used to analyse and 
count stem cell cultures and early stage mouse embryos (Lou et al., 2014). The 
program is designed to segment nuclei so when we tried to use it to detect ISH 
labelled melanocytes in our embryos the program failed, as the melanocytes 
morphology is more complex than the nuclei one. Therefore we thought that maybe 
by staining the nuclei of all the cells of the embryo with Hoechst staining the program 
would be able to detect all the nuclei in the blue channel and then expand the nuclei 
area and look for signal in the red channel. Then it would just count the cells with 
signal in the red channel, which are the melanocytes.  
We tested this first with one embryo, and to get enough resolution for the program 
to segment the nuclei, we had to image the embryo with the 63x objective. The nuclei 
segmentation did not work when using the whole Z-stack as the images were too 
heavy. We reduced the number of nuclei present in the Z-stack by using a subset of 
4 planes from the original Z-stack and we tried to analyse it again. It took almost 48 
hours, but we got a result with all our nuclei segmented quite nicely (Figure 29 B). 
However when we tried to expand the nuclear area and look for signal in the red 
channel the program detected way more melanocytes that there actually were on 
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the image, as it assumed that some of the background (even as low as it was) was 
real signal coming from the melanocytes. Moreover, this segmentation took several 
hours again. That is why we concluded that the most time efficient and 
straightforward way to count our cells was to do it manually by eye. 
In order to count manually the cells we used a plugin from ImageJ that allows you to 
click a cell and put a marker on it so you can see the ones you have already counted 
in an image plane. This marker helps you see if a cell in the next plane is the same 
one that you have already counted in the previous plane, as the marker will be in the 
same position. Counting the cells in this way was labour intensive and you needed to 
be focused to avoid counting the same cell twice. Because there is a lot of room for 
human error while counting, we performed the counts randomly i.e. we selected the 
stages to count randomly so we reduced the human expectation of counting more 
cells in older stages. Also we counted every image three times in the case of dct, and 
twice in the case of mitfa, sox10 and kit at different points in time. By doing this we 
try to reduce the human error in the counts as much as possible.  
We started counting dct cells, as this gene is a melanocyte differentiation marker and 
provides the best estimate of melanocytes at each stage (Elworthy et al., 2003; 
Greenhill et al., 2011). We imaged four specimens per stage and we counted three 
times each image. As it can be seen in Figure 31, we could not count any dct 
expressing cell in the trunk at 18 hpf, and we could detect very few at 20 and 22 hpf. 
However the number of dct expressing cells was high by 26 hpf. 
In order to evaluate how accurate our dct cell counts are, and how well they 
represent the melanocyte number we decided to count melanised melanocytes in 
fixed WT fish at 60, 72 and 96 hpf stages. The number of melanised cells at 60 hpf is 
slightly higher than the number of dct expressing cells counted (71 vs 60 average). 
The number at 72 hpf is very similar (58 vs 56). And the number at 96 hpf is 
considerably higher in melanised melanocytes (89 vs 54). Even though some of the 
numbers are higher in melanised melanocytes they are in the same order of 
magnitude, and some are very similar. That suggest that the number of dct 
expressing cells represents a good estimate of the real number of melanocytes. We 
may be under-counting dct expressing cells because when we counted melanised 
155 
 
cells the embryos were treated with epinephrine prior to fixation, which contracts 
the melanosomes into the cell body, making the cells smaller and easier to distinguish 
(Johnson et al., 1995). This is likely to explain why the number of melanised cells is 
slightly higher in some cases than the number of dct expressing cells. 
Mitfa is a better melanocyte marker for early stages of melanocyte development (20 
or 22 hpf) in the embryo trunk (Montero-Balaguer et al., 2006; Nguyen et al., 2010). 
Therefore we started counting mitfa expressing cells until the cell counts match the 
dct cell count. From that point onwards (32 hpf) we assume that dct is a better 
melanocyte marker (Figure 32). 
Johnson et al. (1995) carried out some melanocyte counts in whole fish body, where 
they count all the melanocytes. Their first data point is at half a week after 
fertilisation, and they counted around 400-500 cells (exact number was not known 
as data was only provided in graphic form). This stage would be similar to our 96 hpf 
data point, where we counted around 60 dct positive cells or 89 melanised 
melanocytes. Taking into account that we only counted a section of the trunk which 
might represent approximately a third of the whole embryo, our measurements 
seem to be slightly lower, but still within the same order of magnitude to theirs, 
which is reassuring (Johnson et al., 1995). 
Sox10 is expressed in many other tissues beside melanocytes. Therefore just a part 
of the sox10 expressing cells counted would be melanocytes. Also the sox10 
expressing cells are very close together and they are not well defined, which make 
very difficult to distinguish one cell from another while counting. We counted sox10 
expressing cells in half of the stages (six) but we realised that we would not be able 
to use these numbers, as they do not represent only melanocytes, which are the cells 
we are focusing in our GRN. 
The same happened with kit. It is expressed in many other tissues other than 
melanocytes. Only some of the kit expressing cells will be melanocytes. The main 
confounding cell type in this case were the mucus secreting cells. These are small and 
round cells located in the epidermis of the whole fish in a very high number. When 
we counted the cells laterally was relatively easy to avoid counting the first and last 
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two or three planes at both sides of the embryo which contained the epidermis and 
the mucus secreting cells. However, these cells were also present dorsally in every 
plane throughout the embryo, and it was very difficult to distinguish them from 
melanocytes when counting. We counted half of the stages (six again) but came to 
the conclusion that we could not use these counts to estimate melanocyte numbers. 
As we concluded before, we could not use the sox10 and kit qPCR copy number data 
for the same reasons: melanocytes would contribute to those numbers only in part, 
with the rest being expressed by many other cell types. Therefore we used just the 
mitfa and dct copy number data for the copy number per cell estimation. The cell 
number count needed came from the mitfa expressing cells counts from 18 hpf to 32 
hpf, and the dct expressing cell counts from 36 hpf onwards.  
As I did with the copy number data we performed a smoothing procedure to reduce 
the noise in the data that may have been caused by errors in the counting. We used 
the same algorithm as in the copy number smoothing and the resulting data looked 
very similar to the original data although slightly smoother. 
Copy number per cell estimation 
The GRN mathematical model describes the behaviour of a single melanocyte. 
Hence, to perform the parameter optimisation we need the copy number per cell 
data for every stage of both genes. To get this we need to get the quotient of the 
copy number per stage and the number of cells we counted at that stage for both 
genes. 






Where ?̅? represents the cell number, ∆X is the copy number standard deviation, ?̅? is 
the copy number and ∆Y is the cell number standard deviation. 
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Figure 35 shows the copies per cell of both mitfa and dct throughout the different 
stages measured. mitfa seems to have a high copy number per cell at early stages of 
development (20 hpf) and the copies decrease quite rapidly and plateau. Dct copies 
per cell start low at early stages of development, then grow to reach a maximum at 
around 48 hpf and then come down towards the later stages of development 
measured. The result for mitfa at 18 hpf was unusual. When we produced the 
quotient of copy number and cell number, our Matlab script assigned a value of zero 
copies per cell for the 18 hpf time point because the result was undefined. That is 
because at 18 hpf we have mitfa expressed at a fairly high copy number but we could 
not identify any mitfa expressing cell in the trunk (Figure 31). This might be because 
there is widespread mitfa expression that is below the detection limit of the ISH, or 
maybe it was contamination. A repeat of this experiment would certainly help to 
determine if this is an artefact or is real widespread low expression. For dct both copy 
number and cell number were 0 at 18 hpf. Therefore, we decided not to use the 18 
hpf time point of either of the genes for the parameter optimisation, as it is probably 
erroneous.  
It seems odd that the number of copies per cell of mitfa at 20 hpf is so high, and then 
it decreases by approximately 6000 copies per cell in just two hours. We would 
expect changes taking place in a less abrupt manner in biology. However this data 
point (20 hpf) has a huge standard deviation, so it may be that if we repeat this 
measurement, the new number of copies per cells is in the bottom part of the 
standard deviation (around 5000 copies per cell) and then the change to the next 
stage would be smoother and make more sense. The number of copies per cell is 
fairly stable for the rest of the development at around 3000 copies per cell. This 
agrees with the data suggesting that mitfa expression stays on in melanocytes though 
development, as there are some structural genes for melanosome biogenesis or 
melanin synthesis that are driven by mitfa after melanocyte specification (Johnson 
et al. 2011). 
It has been shown that dct is expressed immediately after mitfa in melanocyte 
development (Opdecamp et al., 1997b; Jiao et al., 2004), so we would expect to see 
dct expression rising fast at around 24 or 26 hpf, just after mitfa expression peak 
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(Figure 35). However, this does not seem to be the case if we look at our dct copies 
per cell plot: dct expression starts rising fast at around 30 hpf, reaching maximum 
expression at around 48 hpf, which is slightly later than expected. Having said that, if 
we look carefully at the scale of the plot we can see that at 24 or 26 hpf we have 
around 1000 or 1500 copies per cell, which is quite significant, and very similar to the 
number of mitfa copies per cell if we omit the 20 hpf time point. Then dct expression 
seems to shoot off and reach very high numbers at 36, 48 or 60 hpf. However, it is 
worth pointing out that the standard deviation of these time points is fairly high, so 
it may be that when repeating the experiment the number at these stages come 
down to a more lower level. 
The copy number per cell data is not a direct measure of gene expression in a single 
cell. It is an estimate obtained from a copy number measured by qPCR and a cell 
number count from ISH images. The copy number data measured by qPCR is also an 
estimate as initially we measured the gene copy numbers in five embryo trunks and 
then assuming they have the same gene copies we divided by five to calculate the 
copy number per trunk. At the same time the five trunks per stage that we used to 
extract RNA and measure gene expression were dissected manually, so it is quite 
likely that there are some trunks slightly bigger, which means they will have more 
copies of our gene of interest. Hence there are lots of opportunities for error and to 
introduce noise in this whole process that will make our final gene copy number 
measurement per trunk not very accurate. Ideally, we would have measured the 
gene copy number in cDNA obtained from a single embryo trunk, but we did not 
manage to extract enough RNA material from one trunk to measure it through qPCR.  
We had a measurement of gene copy number in a trunk, so we needed to know the 
number of cells expressing that gene in the trunk. We could not use the same trunk 
to perform the qPCR and to count the number of cells. Therefore we used sibling 
embryos, fixed at the same time as we extracted the RNA from the other trunks, and 
assumed they will have the same cell numbers. It is quite unlikely that one embryo 
has exactly the same number of melanocytes than another, so we decided that in the 
same way that we were measuring by qPCR 5 embryos and then divide by 5 to get 
the average gene copy number in one trunk, we would do the same for the cell 
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counts. We counted 4 embryo trunks and then we obtained the average number of 
gene expressing cells for one trunk. We counted the embryos from a microscope Z-
stack image, so it was likely that the trunk section that we counted was slightly 
different to the section we used to measure gene expression by qPCR. At the same 
time, when counting Z-stacks there will be cells that extend over more than one 
plane, so we had to keep track of the cells that we counted in one plane and avoid 
counting them in the next one. This would introduce some error in our counts, to try 
to avoid this we counted every image two or three times and we had four embryos 
per stage; so we averaged the number of cells from all the four embryos and the 
repeated counts to obtain the number of gene expressing cells per stage. 
Therefore, in the process of obtaining the copy number per cell data that we needed 
to perform the parameter optimisation procedure we made a lot of assumptions and 
introduce quite a lot of errors. But nevertheless, it is likely to be the most accurate, 
thorough and more densely populated measurement of gene expression of zebrafish 
melanocytes available to date, which we think is a big step forward. 
Ideally we would have liked to measure directly gene expression in single cells. For 
that we could use Percoll density gradient and a subsequent FACS procedure to sort 
out melanised cells, as they will be the only ones absorbing light when excited by the 
laser following a similar protocol as the one used by Higdon et al. (2013). However, 
if this method is used melanocytes could only be isolated from around 26-28 hpf 
when they become melanised (Karlsson et al., 2001), meaning that we would not be 
able to isolate melanocytes prior to this stage. To overcome this issue, we could set 
up a transgenic fish with mitfa promotor driving EGFP expression which would label 
melanocytes from early stages. Then FACS could be used to sort green fluorescence 
single cells, whose gene expression measurements could be done using the 
Nanostring nCounter technology. This technology is capable of detecting and count 
a specific nucleic acid in a complex mixture. A multiplexed probe library is made with 
two sequence-specific probes for each gene of interest. The first probe, a capture 
probe, contains a sequence complementary to a particular target mRNA plus a short 
common sequence coupled to an affinity tag such as biotin. The second probe, the 
reporter probe, contains a sequence complementary to the target mRNA, which is 
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coupled to a color-coded tag that provides the detection signal. These differently 
coloured probes create a unique code for each gene of interest and allows the 
detection of hundreds of targets at the same time. Each target molecule of interest 
is identified by the colour code present on the reporter probe. The level of expression 
is measured by counting the number of codes for each mRNA. This technology offers 
high levels of precision and sensitivity being able to detect even less than a copy of 
the gene of interest per cell (Geiss et al., 2008). However this technology is very 
expensive, and the budget or equipment was not available to do it in this project. Still 
single cell genomics is the direction that our lab is taking.  
Parameter optimisation 
Greenhill et al. (2011) produced a mathematical model together with a set of 
parameters that described in a semi-quantitative manner the development of a 
single melanocyte. When solving the ordinary differential equations using the 
parameters they obtained the plot in Figure 36 is produced. This graph represents 
how the gene expression of the different players of the network varies along 
development. In order to select the parameters for their model they used ISH 
expression data and information on the expression of the GRN genes from the 
literature to find a set of parameters that produced the curves with a shape that 
matched the data available. Hence the concentration and exact measurements 
predicted by the ODEs are not very accurate. 
Our aim was to begin to make this model quantitative, and for that we needed to 
modify the parameters so the ODEs predicted trajectories match the data we 
collected as accurately as possible. The first issue we faced is that the units of our 
data were different to the units that Greenhill et al (2011) used in their model. The 
data that we collected is measured in gene copy number per cell, whereas their data 
is measured in µM units. We think that our units are more intuitive to represent 
absolute gene expression because when using molar units one needs to know the 
volume of a melanocyte, which is fairly difficult to measure. Therefore the units of 
the parameters selected by Greenhill et al (2011) were in the order of one, and if we 
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try to use our parameter optimisation algorithm to modify those parameters to fit 
our data it will never work, as the units of our data are thousands of times higher 
than the units of the parameters. So we had two options, to modify the Greenhill 
parameters so they are in similar units to our data or to scale down our data to have 
it in similar units to the Greenhill et al. (2011) parameters. The rigorous way to do it 
would be to scale the Greenhill parameters, but this cannot be done using the same 
scaling factor for all of them, as some parameters represent initial gene 
concentrations, some are gene kick-off times, some are degradation rates, and other 
TF binding rates. Hence the scaling for each parameter would need to be done 
individually, evaluating the equation in which the parameter is acting. We decided 
that the second option was more straightforward, as Greenhill et al. (2011) already 
probed that those parameters produce a set of trajectories for the mathematical 
model that matched their data.  
When the first round of the parameter optimisation procedure was done the 
trajectories of mitfa and dct were very far from the data. One of the main reasons 
for that is that the nonlinear least-squares optimisation algorithm was trying to find 
values for the 50 parameters of the model that minimised the objective error 
function by using only 22 data points. We did not have more measured data, but we 
used interpolation to construct new data points in between our measured data 
points. We produced data every hour from 20 to 30 hpf, every two hours from 32 to 
52 hpf and every four hours from 56 to 96 hpf. Our newly constructed data points 
were denser at early stages of development because our measured data was also 
denser at this stages. We measured the gene expression levels every two hours until 
30 hpf, which meant that we only needed to create a new data point in between our 
measured data points by interpolation for these stages. Also, the gene expression 
levels of our measured genes changed more at early stages of development, so we 
needed more data points at these stages if we wanted an accurate match of the 
predicted trajectories to the data. We created 22 data points extra for each gene, 
making a total of 66 data points for both mitfa and dct. With this new data the 




Another way to force the optimisation algorithm to find parameters that produce 
trajectories closer to the mitfa and dct data was to reduce the standard deviation 
measured for both genes. This standard deviation is part of the objective error 
function that the lsqnonlin algorithm needs to minimise. Hence, a smaller measured 
standard deviation will penalise more the predicted trajectories that are very far 
from the measured data. 
These modifications proved successful as the parameter optimisation algorithm 
found a set of parameters that produced trajectories for mitfa and dct genes that 
were very close to the data after several iterations of the algorithm. sox10 expression 
levels are much lower in the new simulation than in the Greenhill one. This was 
unexpected as sox10 is the driving factor of mitfa, whose expression was high. 
However, our model suggests that low quantities of sox10 are sufficient to drive 
enough mitfa expression to fit our data. Moreover, the low level of kit expression 
they seemed to be enough to maintain enough mitfa expression through the 
feedback loop to fit the data.  
The simulation suggests that Factor A, sox10 and mitfa expression start at same time, 
although our GRN states that Factor A activates sox10, which then drives mitfa 
expression. When we studied a close-up of the simulation trajectories at early stages 
of development, we saw that indeed Factor A started expressing first, followed by 
sox10 and immediately after, mitfa. We expected a delay in between expression of 
sox10 and activation of mitfa, however this model assumes that the binding of TF to 
DNA to regulate protein production is a single step. And the ODE equations that 
describe the gene expression changes are built in a way where they only need a few 
molecules to start the exponential growth. That is why we see a huge increase of 
mitfa with very few sox10 molecules. 
The main feature that our model with new parameters highlighted is that for dct to 
be expressed at such a high values, the sox9b activation of dct needed to be much 
higher than in the Greenhill simulation. This was achieved by increasing the 
expression levels and expression timespan of factor B, which drives sox9b. Hence, 
contrary to the Greenhill et al. (2011) model where the effect of sox9b activation of 
dct was restricted to the early phase of melanocyte development, our model 
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suggests that this interaction last for longer and become a very important activation 
route of dct. This is a very interesting outcome of the model that makes specific 
predictions that need to be experimentally tested. For that we need to obtain gene 
expression levels of sox9b throughout development. If the measured sox9b 
expression levels match the sox9b trajectory predicted by of our model, it means that 
sox9b plays a more important role in melanocyte differentiation than Greenhill et al. 
suggested. If however, the experimental data confirms that sox9b expression levels 
are much lower than the ones predicted by the model, it means that our model is 
wrong and hence the parameter values obtained would need to be changed again. 
We would need to use those sox9b measurements in our parameter optimisation 
algorithm to find new parameter values. The new resulting model will need to find a 
new interaction that can explain the high dct expression levels measured in the data. 
Our model also predicts very low levels of tyrp1 throughout. This was unexpected as 
ISH data from Greenhill et al. (2011) demonstrated that tyrp1 is expressed at high 
levels at 36 hpf. This would mean that our model needs to be improved further, and 
the measurement of tyrp1 expression levels throughout development would be a key 
dataset to perform the next rounds of parameter optimisation. 
Both sox9b and tyrp1 gene expression measurements would optimise the parameter 
set to obtain a mathematical model that explains the data better. This would very 
likely highlight new genetic interactions to explain the data that would involve the 
modification of the GRN, or it would confirm that that the current GRN is a good 
model for melanocyte development. 
A detailed look at the new parameter values obtained from the parameter 
optimisation procedure can help us understand some of the new features of the 
model. The parameter 𝛽 that controls the steepness of the function that regulates the 
activity of the input factors A and B is too high, making the function gradient very sharp. This 
is very unlikely to happen in nature, where the gene expression grows more smoothly. 
However this sharp step was necessary to activate very rapidly the expression of sox10, so 
that mitfa expression could increase enough to be close to the first data point at 20 hpf. As 
we need mitfa expression to go up fast and quite high some of the parameters regulating its 
expression growth rate have increased significantly. The same happened with the 
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parameters involved in the equations that describe the dynamics of dct expression. Both 
mitfa and dct expression has to be very high to fit the experimental data collected, and hence 
the values of the new parameters are considerably higher. The new values are between 20 
and 50 times higher than in the Greenhill et al. (2011) model for 𝜆1, 𝜈0 and 𝑔𝑀, which is 
probably unrealistic as it is quite unlikely that some of the rates of transcription factor 
binding and unbinding to the gene promoter in the same model change from approximately 
1 to around 20 or 50. The value of most of the new parameters remain in the same order of 
magnitude to the ones in the Greenhill model, however some parameters had to be changed 
quite significantly by the parameter optimisation algorithm to fit the trajectories to the data 
collected, whose expression levels were higher than those displayed in the Greenhill model.  
Experimental evidence from Greenhill et al. (2011) showed that sox9b is expressed 
at low levels and just at early stages of melanocyte development, and tyrp1 is 
expressed at high levels throughout.  Hence we attempted to change the model to 
try to achieve a better fit to the data. The equation that regulates the change in kit 
expression over time was modified to include a term that describes the activation of 
kit by Sox10, as it was experimentally tested in chapter 3. This term is described by a 
Michaelis-Menten type of function that describes the activation of kit by Sox10 taking 
into account the binding and unbinding rates of the transcription factor to the kit 
promoter. This type of function is quite widely used to describe binding of 
transcription factors to regulatory elements (Greenhill et al., 2011; Leal Valentim et 
al., 2015; Aguilar-Hidalgo et al., 2013). 
The sox9b parameters were excluded from the parameter optimisation to avoid that 
they are used as the main driver of dct expression because this is not what happens 
in the experiments. The first experimental data point of mitfa expression seems to 
be aberrant, and hence its weight in the algorithm was modified so trajectories that 
do not come close to it are not penalised very much.  
This changes made mitfa to come closer to the experimental data collected, if the 20 
hpf data point is not taken into account. However the fit of the dct trajectory to the 
experimental data is very poor. The trajectory does not come even close, only being 
close in the last time point at 96 hpf. The sox10 trajectory seems to be better after 
the modifications, as it goes up rapidly early on, driving mitfa expression and kit. kit 
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expression is higher than in the first model, which is probably due to the new term 
in the equation that accounts for the Sox10 activation of kit. tyrp1 expression is still 
low, but it should be quite high according to the Greenhill et al. (2011) experimental 
data. hdac1 shoots off like in the Greenhill model. The modifications have also 
reduced the expression levels of sox9b. It may be that dct expression is that low, 
because we have not allowed sox9b expression to rise to drive dct.  
This highlights that the new model with the changes is not much better than the 
previous one. It certainly produce better trajectories for some genes such as sox10, 
mitfa or kit. But some other trajectories like dct or tyrp1 are still very far from the 
experimental data.  It might be that going through more iterations of the parameter 
optimisation procedure could help to refine the parameters and bring the gene 
trajectories closer to the data. However the trajectories did not change very much in 
the last 4 iterations of the parameter optimisation algorithm that were carried out. 
Hence, it may be that the algorithm has found a local minima and is looking for 
parameter values in the wrong place of the parameter landscape, which is the n-
dimensional space made up of all the possible parameter value combinations. To try 
to force the algorithm to look in a different place of the landscape we could randomly  
change the values of the parameters and run the algorithm in an iterative way to 
check if it produces better trajectories. The other alternative would be to use Monte 
Carlo simulation, which is a method to sample randomly the parameter space by 
varying the parameters and checking if the trajectories are close to the data points 
(Matlab documentation). This is a very powerful method as it would search the whole 
parameter landscape, and it is less likely to get stuck in a local minima. However due 
to time constrains we were unable to test it in our project. This, together with 
obtaining data from more genes and more time points, would certainly help to find 
a parameter value combination that can produce trajectories that fit the 





Greenhill et al. (2011) developed a core GRN underlying melanocyte specification and 
differentiation in zebrafish. They used semi-quantitative ISH data to build a 
mathematical model that explains melanocyte development and makes predictions 
about the gene expression changes during melanocyte differentiation. We sought to 
improve this mathematical model making it quantitative. For that we measured gene 
expression data throughout development to produce the parameter values that will 
allow the ordinary differential equations of the model to describe that data. 
We measured the gene expression levels of sox10, mitfa, kit and dct at 12 stages 
along development in 5 embryo trunks through qPCR. We also did four ISH for those 
genes with sibling embryos for the 12 stages and counted the number of cells 
expressing each gene in the embryo trunk. We used both measurements to produce 
an estimate of gene copy number per melanocyte that was used to perform the 
parameter optimisation of the mathematical model. 
The parameter optimisation aims to find the best parameter values for the 
mathematical model so its predictions are as close as possible to the experimental 
data collected. For that we developed a Matlab algorithm that was based on the use 
of an objective function that calculates the error from the predicted trajectory 
calculated with a set of parameters and the measured data; and we try to minimise 
that error finding new parameter values through a nonlinear least-squares solver. 
The parameter optimisation algorithm initially struggled to find a set of parameters 
that minimised the objective error function with the data we collected, so we 
constructed more data around our measurements through interpolation. Thanks to 
that extra data the parameter optimisation algorithm found a set of parameters that 
produced mitfa and dct trajectories that were very close to the experimental data.  
The new model suggests that low expression values of sox10 are sufficient to drive 
mitfa expression in high levels. It also highlights that kit is not required to be highly 
expressed either to maintain those high mitfa levels. The model predicts that mitfa 
expression alone is not enough to reach the high expression levels of dct seen in the 
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data. This is achieved by the high expression of sox9b which becomes an important 
player in driving dct expression. This prediction was unexpected considering the 
experimental data available which suggested that the sox9b dependent dct 
expression is not as important as the activation via mitfa. Hence the model was 
modified to try to accommodate this experimental observations: the kit equation 
was modified, the parameters that control the sox9b trajectory were left out of the 
optimisation, and the 20 hpf mitfa data point was made less important in the 
parameter optimisation algorithm. After these changes the model produced better 
trajectories for some genes and worse for some others. 
The parameter optimisation procedure has highlighted that more data is needed to 
obtain good parameter values that can explain the data: both from more genes in 
the network and from more stages. This model represents an initial attempt to 
develop a quantitative mathematical model for the melanocyte GRN. The step 
forward would be to collect single cell gene expression measurements from these 
and more genes at the same time using a multiplex technology such as nCounter from 
Nanostring. In this way we would have accurate single cell data to perform a 






The complex genetic interactions that regulate the differentiation and specification 
of neural crest cells to melanocytes make these cells a very interesting and powerful 
model to understand differentiation and stem cell fate choice. As a multipotent stem 
cell differentiates, its GRN becomes reconfigured from a state where multiple fates 
can be chosen to a more stable state that indicates commitment to a specific cell 
fate. In the Waddington’s epigenetic landscape the cell fate commitment is 
represented by a ball rolling into a valley separated by a ridge, and the different 
genetic interactions impose developmental constrains in the multipotent progenitor 
that will determine which of the available fates or valleys a particular cell chooses. 
The modern picture of the Waddington’s epigenetic landscape is explained better by 
GRN dynamics (Kauffman, 1969; Mendoza and Alvarez-Buylla, 1998; Zhou et al., 
2012). A cell is considered a dynamical system, and its state at a certain time can be 
described by a set of time-dependent variables: the amount of the different proteins 
within the cell or the levels of gene expression (Huang and Kauffman, 2013). Each 
gene in the cell's GRN representing one variable.  
To understand this dynamical system concept it is useful to image an abstract space 
called state space, which in the GRNs context comprises all the theoretically possible 
states a cell can display; each point in this abstract space represents one particular 
expression profile. Furthermore, it is assumed that the cell state at a certain time and 
the cell state at a later time are connected (Velderrain et al., 2015). 
However, within the whole state space only a small number of stationary or quasi-
stationary gene configurations will satisfy the constraints imposed by the GRN 
(Kauffman, 1969). When these steady states are also resilient to perturbations, that 
is, if they return back to the steady state after being kicked away by internal or 
external variations, we refer to them as attractors. All other states are either unstable 
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or form part of transitory trajectories that are guided toward one of these attractor 
states. The theory suggests that attractor states correspond to the different cell 
types; and that these emerge as a consequence of the dynamical constraints imposed 
by the underlying GRN (Huang et al., 2009; Huang and Kauffman, 2013). 
In this project we are trying to understand the properties and constrains of a GRN 
that make a cell state become an attractor, and hence a stable differentiated cell 
type. We are using the differentiation of melanocytes from their neural crest cells 
progenitors as a model to understand the properties of its GRN that produce a stable 
cell state. 
Melanocytes, one of the neural crest derived pigment cells, are characterised by the 
production of melanin, a pigment molecule located in special organelles called 
melanosomes. They have been thoroughly studied to understand development and 
fate choice, but also because they are the cause of many severe human diseases 
(melanoma, Waardenburg syndrome or Tietz syndrome, for example). Some of the 
main genes driving melanocyte development have been studied for a long time and 
we have a good picture of some of their interactions that regulate melanocyte 
development. Greenhill et al. (2011) developed a gene regulatory network 
incorporating the main genes and interactions known to play a role in melanocyte 
biology, and generated a mathematical model to help understand this complex 
network and make specific predictions about its properties. 
They build the GRN and mathematical model in an iterative way starting with an 
initial model which allowed us to make predictions on how the gene expression 
would behave, then they tested those predictions and modified the initial model until 
they got a complete enough model that was able to explain their experiments. In 
order to build this model they used ISH gene expression data, which meant that they 
have semi quantitative data at best. Therefore they were able to obtain a model that 
was able to describe the trends and shape of the curves of gene expression along 
time to match what they saw in their ISH data. Despite this model being semi-
quantitative they manage to make predictions and validate them in experiments, so 
it proved to be a useful tool (Greenhill et al., 2011). 
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In this project we sought to collect a dense time series gene expression data of four 
of the main genes of the melanocyte GRN (sox10, kit, mitfa and dct) to transform the 
semi-quantitative mathematical model established by Greenhill et al. (2011) into a 
quantitative model that is able to describe the data we collected. Moreover, we 
intended to identify more genes that are part of the melanocyte development 
process to be incorporated in the GRN by analysing microarray data and performing 
ISH experiments. 
The Greenhill et al. (2011) GRN describes the behaviour of nine genes involved in 
melanocyte development, but these are not the only genes that play a role in this 
process. Hence, we aimed to find more genes involved in melanocyte development 
to incorporate into the GRN. For that we analysed the microarray data produced by 
Chipperfield in 2009 using a more advance and versatile approach based in R.  
Microarray studies have been successfully used in other examples to identify genes 
related to a certain cell type or biological function in zebrafish before. Weger et al. 
(2011) used a similar setup to ours (Affymetrix array and Bioconductor analysis) to 
identify over 100 genes that are upregulated by light in zebrafish. They were able to 
identify genes involved in circadian clock function, DNA repair, retinal light reception 
and metabolism, as well as the enrichment of both E- and D-box elements in the 
promoters of the light induced genes. Many other examples have used microarray 
analysis comparing wild type with mutant gene expression; for example, van der 
Vaart et al. (2013) compared the expression profile of myd88 mutant and wild type 
embryos and identified several transcription factors central to innate immunity that 
are regulated by Myd88 signalling.  
In our microarray analysis and subsequent validation through in situ hybridisation, 
we have identified five genes as downregulated in mitfa mutant embryos: atp6v1ab, 
atp6v1e1b, degs1, pah and tspan36. These genes have a clear role in melanocyte 
biology, as they are involved in melanosome maturation, melanin synthesis and 
melanocyte migration. We suggest that these genes are placed downstream of mitfa 
in the GRN. We also used the list of downregulated genes in sox10 mutant embryos 
obtained from the microarray analysis to explore the ZFIN database looking for 
information available on the expression of these genes. From this analysis we found 
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seven more genes that are likely to be part of the GRN as they have a role in 
melanocyte biology: rab32a, rab7, bace2, ednrba, gart, ppat and atp6ap1b. However 
these genes would need to be investigated in further experiments.  
By using microarrays to find downregulated genes in a mutant background we 
identified genes that are regulated by the mutated gene (sox10) but we do not know 
if that interaction is direct or indirect. Therefore, in order to find out if the candidate 
genes are directly regulated by sox10 we should perform a ChIP-seq analysis. This 
kind on analysis was successfully used to identify that the transcription factor FOXD3, 
which plays an essential role in pre-migratory neural crest development, directly 
binds to regions of the TWIST1 promoter, leading to its repression in human mutant 
BRAF melanoma cells (Weiss et al., 2014). The main issue with this approach is that 
we need suitable anti-Sox10 antibodies, which are difficult to obtain. However, there 
are companies that are working on this issue. The advantage is that once we have an 
antibody that works with our sample we can perform the ChIP-seq experiment and 
identify all the genes that are directly regulated by Sox10. Despite the difficulty of 
obtaining suitable antibodies some studies have successfully used ChIP-seq with 
zebrafish embryos. Leichsenring et al. (2013) found that zebrafish pou5f1, a homolog 
of the mammalian pluripotency transcription factor Oct4, activates many of the first 
zygotically expressed genes in the zebrafish embryo. In mammalian ES cells, the 
Pou5f1-Sox2 complex cooperatively assembles to target early zygotic genes for 
activation (Loh et al., 2006). To detect in vivo Pou5f1 and Sox2 chromatin binding 
events, Leichsenring et al. performed chromatin immunoprecipitation followed by 
sequencing (ChIP-seq) and identified many genes regulated by these transcription 
factors. Their data position Pou5f1 and Sox2 transcription factors at the centre of the 
zygotic gene activation network of vertebrates (Leichsenring et al., 2013). These 
studies prove how useful and powerful ChIP-seq is to identify transcriptional 
regulation. 
Greenhill et al. (2011) identified though their mathematical model the need of a 
factor (named factor Y) in the network to maintain mitfa expression and allow stable 
melanocyte differentiation. It has been shown that the presence of positive feedback 
loops in gene regulatory networks increase the robustness and stability of the 
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system. Positive feedback loops, like the one in between mitfa and factor Y, promote 
the ability of a system to become activated in response to small input signal 
(Mitrophanov and Groisman, 2008). This means that our gene regulatory network 
does not need a high amount of Sox10 to drive enough mitfa expression and allow 
melanocyte specification. We sought to find the gene that may take the role of factor 
Y. We proposed that kit may be this factor as the literature suggested that kit 
expression might be driven by Mitfa while kit itself may regulate mitfa transcription 
(Hou et al., 2000).  We have confirmed that Mitfa drives kit expression, as well as 
shown that kit expression is transiently driven by Sox10 at early stages of 
development. As part of the feedback loop, kit seems to drive and maintain mitfa 
expression, as mitfa expression appears to be reduced in kit mutants. However this 
needs to be quantified. Therefore we will need to perform a mitfa qPCR in kit mutants 
and compare it with wild type fish, at several stages to confirm if lack of kit activity 
hinders mitfa expression, and hence if kit regulates mitfa transcription. 
Qualitative models of gene regulatory networks have been used quite widely as they 
have two main advantages: they can be built from limited experimental observations 
or knowledge-based information; and they make possible to hypothesise about the 
dynamics of biological regulatory systems despite the lack of kinetic information at 
transcriptional level (Bourdon et al., 2011). Although these approaches provide high-
level insights into the functioning of gene networks, they do not accurately describe 
the real dynamics of GRNs. Hence our aim was to transform the qualitative or semi-
quantitative model developed by Greenhill et al. (2011) into a quantitative one. For 
that we needed to collect data that we used to obtain the parameter values for the 
ordinary differential equations of the mathematical model that describes our data. 
We obtained an estimate of gene expression per melanocyte by measuring gene 
expression in 5 embryo trunks and then counting the gene expressing cells in the 
trunk. We extracted and measured through qPCR the gene expression of sox10, kit, 
mitfa and dct from 5 embryo trunks. As sox10 and kit are expressed in many other 
cell types besides melanocytes their gene expression measurement is not only 
measuring melanocyte gene expression, which is what we were modelling, so it was 
not used. To get a measurement of the cells expressing those genes in the trunk, we 
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performed ISH for our four genes and counted the gene expressing cells in the trunk. 
We used both of these measurements qPCR copy number and cell number, to 
estimate the copy number per cell for mitfa and dct. This estimate was used to 
perform the parameter optimisation, which aims to find the best parameter values 
for the mathematical model so its predictions are as close as possible to the 
experimental data collected. For that we created a Matlab algorithm that uses an 
objective function to calculate the error between the predicted trajectory calculated 
with a new set of parameters and the measured data. Then the nonlinear least-
squares solver finds new parameter values that minimise that error function. 
Our algorithm struggled to fit the model to the data as despite having collected a very 
dense time series expression data for our genes the number of parameters to fit 
exceeded by far the amount of data available. So we constructed more data around 
our measurements through interpolation. Thanks to that extra data the parameter 
optimisation algorithm found a set of parameters that produced mitfa and dct 
trajectories that were very close to the experimental data.  
Davidson formulated the concept of developmental gene regulatory networks, and 
his laboratory has been investigating the GRN that controls the development of sea 
urchin embryos for many years. They have built a GRN with over 60 regulatory and 
signalling genes that regulates the specification of the endomesoderm in sea urchin 
embryos (Smith et al., 2008). They established a predictive, dynamic Boolean model 
that describes spatial and temporal gene expression according to the regulatory logic 
and gene interactions specified in the GRN for embryonic development in the sea 
urchin. Additional information that was used as input into this model included the 
embryonic geometry and gene expression kinetics (Bolouri and Davidson, 2003). The 
resulting model predicted gene expression patterns for a large number of genes each 
hour up to gastrulation in different spatial domains of the embryo. Despite being a 
Boolean model that only takes into account if an interaction is acting or not, a direct 
comparison with experimental observations showed that the model predicted the 
gene expression patterns with notable spatial and temporal accuracy, proving that 
even simpler Boolean models are sufficient to explain complex developmental 
process (Peter et al., 2012). Davidson’s GRN is much more complex in term of number 
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of genes than the melanocyte GRN, however their mathematical model is simpler 
that the one we are aiming to produce, as we aim to develop a dynamical model that 
describes the rate of change of gene expression over time.  
An example of a dynamical model whose set up is very similar to ours is the 
development of a model for the regulation of flowering time in Arabidopsis thaliana 
by Valentim et al. (2015). Model parameters were estimated based on expression 
time-courses for relevant genes obtained by qPCR from leaves. They modelled 6 
genes, which is more similar to the number of genes in the melanocyte GRN than to 
the Davidson’s model. They used Hill equations to model the kinetics of the gene 
expression like I did, and used ordinary differential equations to describe the 
interactions between the network components. Like us they assumed that the 
relationship between RNA and protein levels is linear. They used a Matlab algorithm 
to fit the model to the data and estimated the model parameters using the lsqnonlin 
solver as I did. Their model predicts that a disturbance in a particular gene has not 
necessarily a big impact on directly connected genes. They also predicted some other 
more specific features of their GNR, such as the importance of cooperativity in the 
regulation of APETALA1 by LFY. Lastly, they validated the model by comparing 
predicted expression time-courses for mutants in components of the network with 
experimental data (Valentim et al., 2015). Another example of dynamical models is 
the one produced by Aguilar-Hidalgo et al. (2013) of the GRN underlying the 
Drosophila ocellar complex. Unlike ours, their model distinguish between mRNA 
transcription and translation. However, they also use Hill equations to model the 
changes of gene expression in time, like I did. Their model comprises 13 ordinary 
differential equations to describe the behaviour of each one of the system variables. 
Unlike us, or Valentim et al. (2015) that used qPCR expression data to test the model, 
they used immunostaining and quantification of those images to validate the model. 
The mathematical model provided them a better understanding of how the 
hedgehog signalling gradient and the gene regulatory network interact to generation 
a fully developed ocellar complex (Aguilar-Hidalgo et al., 2013). Therefore our model 




The new model obtained after the parameter optimisation procedure suggests that 
low expression values of sox10 are sufficient to drive mitfa expression in high levels. 
It also highlights that kit is not required to be highly expressed either to maintain 
those high mitfa levels. The model predicts that mitfa expression alone is not enough 
to reach the high expression levels of dct seen in the data. This is achieved by the 
high expression of sox9b which becomes an important player in driving dct 
expression. This prediction was unexpected considering the experimental data 
available which suggested that the sox9b dependent dct expression is not as 
important as the activation via mitfa. We modified the model to improve the 
equation that regulate kit expression, exclude the sox9b parameters from the 
optimisation so this gene is not used as the main driver of dct expression, and exclude 
the first mitfa data point as it seems to be an outlier. These changes improve the 
trajectories for some genes such as sox10, mitfa and kit; however the trajectories for 
some other genes (dct or tyrp1) are still very far from the experimental data. In order 
to improve our mathematical model we would need to obtain more data, ideally 
from more genes and more stages. In that way the parameter optimisation algorithm 
will be able to find better values to produce a model that explains more accurately 
the data. We could also use other parameter optimisation methods available such as 
the Monter Carlo method. Eventually the long term objective is to measure gene 
expression in single cells. For that we could use FACS to sort single cells and a 
technology like nCounter from NanoString that allows to measure hundreds of genes 
at the same time even in diluted DNA samples coming from single cells. The 
NanoString nCounter technology was used by Sandler and Stathopoulos (2016) to 
study maternal-to-zygotic transition in Drosophila melanogaster embryos. This event 
marks the rapid turning point when zygotic transcription begins and control of 
development is transferred from maternal transcripts. Characterising the sequential 
activation of the genome during the MZT requires precise timing and a sensitive assay 
to measure changes in expression. They used the nCounter technology, which 
directly counts mRNA transcripts without reverse transcription or amplification, to 
study more than 70 genes expressed early in Drosophila embryos. The study provided 
new insights into how the GRN players are sequentially activated in the maternal-to-
zygotic transition and suggested that network properties regulate levels of 
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transcription for groups of genes (Sandler and Stathopoulos, 2016). This study 
demonstrates that the NanoString technology can be used to precisely quantify 
transcripts and create a fine-scale time course of gene expression along embryonic 
development, and hence it would be a very powerful technology to use in our 
research. 
There have been some efforts in building gene regulatory networks to understand 
neural crest development in zebrafish before, such as the studies carried out by Van 
Otterloo and Wang, which established the interactions between the transcriptions 
factors, Tfap2a, Foxd3, Bmp, Wnt and Sox10 to regulate neural crest induction (Van 
Otterloo et al., 2012; Wang et al., 2011). The Pavan laboratory has also put a lot of 
effort in building the GRN that describes the genes involved in the regulation of 
melanocytes and RPE cells in mice (Gorkin et al., 2012; Fufa et al., 2015). With their 
own genomic data obtained through ChIP-seq, microarrays and qPCR, and the data 
they compiled from other sources they have built one of the most comprehensive 
GRNs for pigment cells. However, despite all the knowledge about the genes involved 
in melanocyte development, ours is one of the first and major attempts to produce 
a mathematical modelling of the GRN that aims to get a better understanding of the 
emergent properties of the gene network. 
To sum up in this project we have identified several genes that play a role in 
melanocyte biology and have included some of them in the GRN. The next step would 
be to develop the equations in the mathematical model to describe them. We have 
identified kit as Factor Y in the Greenhill et al. (2011) model, although we need 
further testing to assess some of the details of its interaction with mitfa. Finally we 
have obtained quantitative gene expression data from four genes and 12 stages 
along development that have allowed us to start the first steps into the parameter 
optimisation of the model towards developing a fully quantitative mathematical 
model. The modelling has allowed us to make some predictions that would need to 
be experimentally tested in the future. Further work is needed, but this study 
represents the first attempt to obtain densely populated gene expression data from 
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Here He(·) is the Heaviside function. The initial data at time t0 = 0 and known 
parameters are 
 





















Figure 40. ISH expression pattern of the 5 verified melanocyte genes in 30 hpf wild type and 
sox10 mutant embryos. All images are lateral views of the mid-trunk embryo. All 5 genes 
(atp6v1ab, atp6v1e1b, degs1, pah and tspan36) are expressed in melanocytes of wild type 





R script used to analyse the combined microarray dataset: 
#******************************************* 
# 





# Clear workspace 
rm(list=ls()) 
  

















#__________LOADING THE DATA__________ 
 













#Normalise the data using the RMA.2 background correction 
method;quantile normalisation;no perfect match evaluation and 










#Performs the Wilcoxon signed rank-based gene expression 
presence/absence detection algorithm 
eset.mas5calls<-mas5calls(total.data) 
 
#Create a funcion 
mas5callsfilter<-function(cutoff="A",number){ 
 function(x){ 


















#Create the design matrix 
design<- model.matrix(~ 0+factor(c(1,1,1,1,1,2,2,2,2,2))) 
colnames(design)<- c("Mutant","WT") 
 
#Fit a linar model to the data set 
fit<-lmFit(filtered,design) 
 
#Generate a contrast matrix, because we want to identify genes 




#Fit the contrast to the linear model and compute the t-




#Correct the raw p-values in order to control the false positive 
rate. Using procedure Benjamini and Hochberg 
multadjust<-mt.rawp2adjp(fit2$p.value, proc=c("BH")) 
 





#___________RESULTS GENE LIST____________ 
 
#Extract all the differenctially expressed gene with a p-value 
smaller than 0.05  
200 
 
#USING THE MULTITEST CORRECTED P-VALUE 
results<-NULL 
j<-1 
for(i in 1:dim(eBpvalues)[1]){ 
 if(eBpvalues[i,2]<=0.05){ 
  results<-rbind(results,eBpvalues[i,]) 
  row.names(results)[j]<-row.names(eBpvalues)[i] 





 cat("\nTHERE'S NO DIFFERENCTIALLY EXPRESSED GENES\n") 











symbols <- rep(NA, dim(results)[1]) 
 









#Assign to the gene list row names the names of the genes 
instead of the microarray ID 
#genelist has now the gene name as row names and then 3 colums 
with the raw Pvalue, the corrected Pvalue and the t statistics 


















Perl script used to locate the Sox10 binding sites. The one to locate the Mitfa binding 







# get command-line arguments, or die with a usage statement 
my $usage = "testScript.pl infile outfile\n"; 
my $infile = shift or die $usage; 
 
# create a SeqIO object to read in the file 
my $seq_in = Bio::SeqIO-> new(-file => "<$infile"); 





# write each entry in the input file to the output file 
#First instance promotors with just the S1 motif 
my $count=0; 
my @seq_array; 
while (my $seq=$seq_in->next_seq){ 
 
 if(($seq->seq =~ /$motifS1/) && ($seq->seq =~ 
/$motifS3/)){ 
  $count++; 
  print $count,"\n"; 
  push(@seq_array,$seq->id); 





my $id = join("\n",@seq_array); 
 
open FILE, ">idsWithS1andS3.txt" or die $!; 













Figure 41. sox10 standard curve. Equation y=-3.1x+35.1 R2=0.992 Efficiency=110.11% 
 









Data smoothing algorithm: 






%Import the cell number data from Excell 
[Stage,cellnumb,cellnumbStDev]=importGeneralii('cellcount'); 
  
%choose the smoothing method 
method='sgolay'; 
  















%smooth the cell count data  
cellnumbsmooth=smooth(cellnumb,method); 
%round each element of cellnumbsmooth to the nearest integer 
cellnumbsmooth = round(cellnumbsmooth); 
  
  























































legend('Original data', ['Smoothed (',method,') 
data'],'Location','SouthEast'); 
  
%save the figure 
print('smoothCopyNumbGraphs','-dtiff','-r400'); 
  












legend('Original data', ['Smoothed (',method,') 
data'],'Location','SouthEast'); 
  
%save the figure 
print('smoothCellNumbGraphs','-dtiff','-r400'); 
  
%divide the smoothed copy number data by the smoothed cell number 
data to 
%get copies per cell for mitfa and dct as are the only ones I'm 
gonna use 
mitfacopiespercell = (mitfacopiessmooth./cellnumbsmooth); 
dctcopiespercell = (dctcopiessmooth./cellnumbsmooth); 
  




%The St. Dev. of the copy numbers has to be divided by the St.Dev of 
the 










%Plot the copy number per cell data of mitfa and dct as these are 
the only 





















%save the figure 
print('copiespercell','-dtiff','-r400'); 
  
%write the stages, copies per cell and its St Dev to a csv file for 
later 









Mathematical model equations:  
function dy = RHS(t,y) 









































Parameter optimisation algorithm: 




%Import the copy number per cell data from the mitfa and dct csv 









tspan=[20:1:30, 32:2:52, 56:4:96]'; 
dctcopies = interp1(stages,dctcopies,tspan); 
dctcopiesStDev = interp1(stages,dctcopiesStDev,tspan); 
mitfacopies = interp1(stages,mitfacopies,tspan); 






selec=[9:59];   
  
% load initial parameters and 
% plot trajectories for this IC 
odeSolver; 
  
%look for the best parameters using the Greenhill parameter values 
as first 
%guess 




lsoptions = optimset('Display','iter'); 
  
% load y from file 
load parameterfilemm;  
  


















































New parameter set after the optimisation algorithm: 
y=[      0 
         0 
         0 
         0 
         0 
         0 
         0 
   50.0000 
   17.3836 
   19.7444 
   21.5732 
    0.7879 
    1.5166 
    1.5163 
    0.3125 
    1.7649 
    1.5014 
    0.5054 
    5.5983 
    7.5692 
    0.0537 
    0.7246 
    2.8502 
    0.1452 
    0.5032 
    2.5221 
    3.1304 
    2.5167 
    0.8393 
    3.1280
    0.9034 
    0.5804 
    2.4771 
    1.2058 
    1.7523 
    0.0290 
    1.2133 
    0.0019 
    1.2893 
    0.0337 
   51.8319 
   15.3247 
    1.5921 
    0.1899 
    1.6547 
    0.1873 
    0.0443 
    0.6880 
    3.2927 
   22.8155 
    3.0681 
    0.0204 
    0.0998 
    0.3465 
    0.0000 
    0.0165 
    0.3770 
    1.4234 
    0.0736 
    ]; 
